1
|
Marcos Garces V, Gabaldon-Perez A, Gavara J, Lopez-Lereu MP, Monmeneu JV, Perez N, Rios-Navarro C, De Dios E, Merenciano-Gonzalez H, Chorro FJ, Valente F, Lorenzatti D, Ortiz-Perez JT, Rodriguez-Palomares JF, Bodi V. Prognostic value of cardiac magnetic resonance in elderly patients soon after ST-segment elevation myocardial infarction. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.2552] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Elderly patients with ST-segment elevation myocardial infarction (STEMI) represent a very high-risk population. Data on the prognostic value of cardiac magnetic resonance (CMR) in this scenario are scarce.
Purpose
We aim to study the prognostic value of an early (1-week) CMR in elderly patients after STEMI and to create a simple risk score including clinical and CMR variables.
Methods
The registry comprised 247 patients over 70 years of age discharged for a first STEMI treated with percutaneous intervention and included in a multicenter registry. Baseline characteristics, echocardiographic parameters and CMR-derived left ventricular ejection fraction (LVEF, %), infarct size (% of left ventricular mass) and microvascular obstruction (MVO, number of segments) were prospectively collected. The additional prognostic power of CMR was assessed using adjusted C-statistic, net reclassification index (NRI) and integrated discrimination improvement index (IDI).
Results
During a 4.8-year mean follow-up, 66 (26.7%) first major adverse cardiac events (MACE) occurred (27 all-cause deaths and 39 re-admissions for acute heart failure). Higher GRACE score (HR 1.03 [1.02–1.04], p<0.001), more depressed CMR-LVEF (HR 0.97 [0.95–0.99] per increased %, p=0.006) and more extensive MVO (HR 1.24 [1.09–1.4] per segment, p=0.001) predicted MACE occurrence. The addition of CMR data significantly improved MACE prediction compared to the model with baseline and echocardiographic characteristics (C-statistic 0.759 [0.694–0.824] vs. 0.685 [0.613–0.756], NRI=0.6, IDI=0.08, p<0.001). The best cut-offs for independent variables were GRACE score >155, LVEF <40%, and MVO ≥2 segments. A simple score (0, 1, 2, and 3) based on the number of altered factors accurately predicted the MACE per 100 person-years: 0.78, 5.53, 11.51 and 78.79, respectively (p<0.001).
Conclusions
CMR data contribute valuable prognostic information in elderly patients submitted to undergo CMR soon after STEMI.
Funding Acknowledgement
Type of funding sources: Public grant(s) – EU funding. Main funding source(s): Instituto de Salud Carlos III and “Fondos Europeos de Desarrollo Regional FEDER” and Conselleria de Educaciόn – Generalitat Valenciana.
Collapse
Affiliation(s)
- V Marcos Garces
- University Hospital Clinic of Valencia, Department of Cardiology , Valencia , Spain
| | - A Gabaldon-Perez
- University Hospital Clinic of Valencia, Department of Cardiology , Valencia , Spain
| | - J Gavara
- Instituto de Investigacion Sanitaria INCLIVA , Valencia , Spain
| | - M P Lopez-Lereu
- ERESA Medical Group, Cardiovascular Magnetic Resonance Unit , Valencia , Spain
| | - J V Monmeneu
- ERESA Medical Group, Cardiovascular Magnetic Resonance Unit , Valencia , Spain
| | - N Perez
- Instituto de Investigacion Sanitaria INCLIVA , Valencia , Spain
| | - C Rios-Navarro
- Instituto de Investigacion Sanitaria INCLIVA , Valencia , Spain
| | - E De Dios
- Center for Networked Biomedical Research – Cardiovascular (CIBER-CV) , Madrid , Spain
| | | | - F J Chorro
- University Hospital Clinic of Valencia, Department of Cardiology , Valencia , Spain
| | - F Valente
- University Hospital Vall d'Hebron, Department of Cardiology , Barcelona , Spain
| | - D Lorenzatti
- Institute of Biomedical Research August Pi Sunyer (IDIBAPS) , Barcelona , Spain
| | - J T Ortiz-Perez
- Barcelona Hospital Clinic, Department of Cardiology , Barcelona , Spain
| | | | - V Bodi
- University Hospital Clinic of Valencia, Department of Cardiology , Valencia , Spain
| |
Collapse
|
2
|
Alonso Tello A, Sambola A, Valente F, Sao A, Rello P, Maymi M, Barrabes J, Otaegui I, Garcia Del Blanco B, Gavara J, Marcos-Garces V, Ferreira I, Ortiz JT, Bodi V, Rodriguez-Palomares JF. Sex-based differences on adverse left ventricular remodeling and clinical outcomes after an ST-segment elevation myocardial infarction in the PCI era. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.348] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
There is conflicting evidence regarding sex-based differences in myocardial salvage and clinical outcome in patients after an ST-segment elevation myocardial infarction (STEMI) in the contemporary era of primary percutaneous coronary intervention (PCI) and optimal medical treatment.
Adverse left ventricular remodelling (LVR) after a STEMI worsens outcomes, however, the influence of sex is not yet clear.
Aim/Purpose
To analyze whether there are sex differences in clinical outcomes and adverse LVR in patients after a STEMI.
Methods
Patients with STEMI who underwent primary PCI were included and a cardiac magnetic resonance (CMR) was performed during hospitalization (6.2±2.6 days) and after 6 months (6.1±1.8 months). LVR, myocardial salvage (MS), infarct size (IS), microvascular obstruction (MVO), and area at risk (AAR) were quantified. Adverse LVR was defined as a 15% increase in LV end-diastolic volume and a relative fall in LV ejection fraction of 3% at 6 months. The primary outcome was a composite of cardiovascular death, admission for heart failure, or ventricular arrhythmia.
Results
A total of 1046 patients were included (mean age: 59.8±9 years; 16.6% women), and a second CMR was completed in 589 patients. Women were older (58.8±8 years vs 65.0±10 years, p<0.0001) and presented more cardiovascular risk factors (Table). The primary outcome occurred in 310 patients during follow-up of 75 months (range: 36–112 months) and was more frequent in women than in men (35.8% vs 22.3%, p<0.001). After adjusting for baseline differences (age, diabetes, hypertension, Killip class, and time to reperfusion), female sex was not an independent predictor of major adverse cardiac events (Fig. 1A & B).
Although adverse LVR was a strong independent predictor for the primary outcome, no interaction was present between sex and LVR (women 6.4% vs men 8%, p=0.46) (Fig 1B), nor did we find significant differences between sex and other CMR derived variables such as MS, IS, MVO and AAR.
Conclusions
After a STEMI, women present worse clinical outcomes than men. However, these differences are related to their clinical characteristics and higher incidence of cardiovascular risk factors, and not to a higher incidence of adverse left ventricular remodeling.
Funding Acknowledgement
Type of funding sources: None.
Collapse
Affiliation(s)
| | - A Sambola
- University Hospital Vall d'Hebron , Barcelona , Spain
| | - F Valente
- University Hospital Vall d'Hebron , Barcelona , Spain
| | - A Sao
- University Hospital Vall d'Hebron , Barcelona , Spain
| | - P Rello
- University Hospital Vall d'Hebron , Barcelona , Spain
| | - M Maymi
- University Hospital Vall d'Hebron , Barcelona , Spain
| | - J Barrabes
- University Hospital Vall d'Hebron , Barcelona , Spain
| | - I Otaegui
- University Hospital Vall d'Hebron , Barcelona , Spain
| | | | - J Gavara
- Valencia University Clinical Hospital , Valencia , Spain
| | | | - I Ferreira
- Valencia University Clinical Hospital , Valencia , Spain
| | - J T Ortiz
- Barcelona Hospital Clinic, Cardiology , Barcelona , Spain
| | - V Bodi
- Valencia University Clinical Hospital , Valencia , Spain
| | | |
Collapse
|
3
|
Marcos Garces V, Perez N, Gavara J, Lopez-Lereu MP, Monmeneu JV, Rios-Navarro C, De Dios E, Merenciano-Gonzalez H, Gabaldon-Perez A, Chorro FJ, Valente F, Lorenzatti D, Ortiz-Perez JT, Rodriguez-Palomares JF, Bodi V. A novel clinical and cardiac magnetic resonance risk score for early risk prediction after ST-segment elevation myocardial infarction. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.347] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Cardiac magnetic resonance (CMR) performed early after ST-segment elevation myocardial infarction (STEMI) can improve major adverse cardiac event (MACE) risk prediction. However, predictive models including clinical and CMR variables are scarce and not routinely implemented in clinical practice.
Purpose
We aimed to create a simple clinical-CMR risk score for early MACE risk stratification in STEMI patients.
Methods
We performed a multicenter prospective registry in three Spanish university hospitals of reperfused STEMI patients (n=1118) in whom early (1-week) CMR-derived left ventricular ejection fraction (LVEF), infarct size and microvascular obstruction (MVO) were quantified. MACE was defined as a combined clinical endpoint of cardiovascular (CV) death, non-fatal myocardial infarction (NF-MI) or re-admission for acute decompensated heart failure (HF), whichever occurred first. Univariate and multivariate analyses were performed and a risk score was computed using the variables which independently predicted the risk of MACE.
Results
During a median follow-up of 5.52 [2.63–7.44] years, 216 first MACE (58 CV deaths, 71 NF-MI and 87 HF) were registered. Mean age was 59.3±12.3 years and most patients (82.8%) were male. Based on the four variables independently associated with MACE, we computed an 8-point risk score: time to reperfusion >4.15h (1 point), GRACE risk score >155 (3 points), CMR-LVEF <40% (3 points), and MVO >1.5 segments (1 point). This score permitted MACE risk stratification: MACE per 100 person-years was 1.96 in the low-risk category (0–2 points), 5.44 in the intermediate-risk category (3–5 points), and 19.7 in the high-risk category (6–8 points): p<0.001 in multivariable Cox survival analysis.
Conclusions
A novel risk score including clinical (time to reperfusion >4.15h and GRACE risk score >155) and CMR (LVEF <40% and MVO >1.5 segments) variables allows for simple and straightforward MACE risk stratification early after STEMI. External validation should confirm the applicability of the risk score.
Funding Acknowledgement
Type of funding sources: Public grant(s) – EU funding. Main funding source(s): Instituto de Salud Carlos III and Fondo Europeo de Desarrollo Regional (FEDER) and Sociedad Española de Cardiología.
Collapse
Affiliation(s)
- V Marcos Garces
- University Hospital Clinic of Valencia, Department of Cardiology , Valencia , Spain
| | - N Perez
- Instituto de Investigacion Sanitaria INCLIVA , Valencia , Spain
| | - J Gavara
- Instituto de Investigacion Sanitaria INCLIVA , Valencia , Spain
| | - M P Lopez-Lereu
- ERESA Medical Group, Cardiovascular Magnetic Resonance Unit , Valencia , Spain
| | - J V Monmeneu
- ERESA Medical Group, Cardiovascular Magnetic Resonance Unit , Valencia , Spain
| | - C Rios-Navarro
- Instituto de Investigacion Sanitaria INCLIVA , Valencia , Spain
| | - E De Dios
- Center for Networked Biomedical Research – Cardiovascular (CIBER-CV) , Madrid , Spain
| | | | - A Gabaldon-Perez
- University Hospital Clinic of Valencia, Department of Cardiology , Valencia , Spain
| | - F J Chorro
- University Hospital Clinic of Valencia, Department of Cardiology , Valencia , Spain
| | - F Valente
- University Hospital Vall d'Hebron, Department of Cardiology , Barcelona , Spain
| | - D Lorenzatti
- Institute of Biomedical Research August Pi Sunyer (IDIBAPS) , Barcelona , Spain
| | - J T Ortiz-Perez
- Barcelona Hospital Clinic, Department of Cardiology , Barcelona , Spain
| | | | - V Bodi
- University Hospital Clinic of Valencia, Department of Cardiology , Valencia , Spain
| |
Collapse
|
4
|
Gavara J, Rios Navarro C, Lopez-Lereu MP, Monmeneu JV, De Dios E, Perez-Sole N, Marcos-Garces V, Canoves J, Nunez J, Chorro FJ, Rodriguez-Palomares JF, Freixa A, Borras R, Ortiz-Perez JT, Bodi V. Impact of persistent MVO late after STEMI on adverse left ventricular remodelling: a CMR study. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.150] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Despite successful revascularization at the epicardial level, microvascular obstruction (MVO) appears soon after reperfusion in up to 50% of cases. Early MVO has been solidly associated with adverse resulting cardiac structure and heightened risk of future cardiovascular events. Although clinical and experimental studies demostrated the spontaneous repair of MVO, little is known about the occurrence and implications of persistent MVO late after infarction.
Purpose
We used cardiovascular magnetic resonance (CMR) to characterize the impact of persistent MVO late after reperfused ST-segment elevation myocardial infarction (STEMI) on adverse left ventricular (LV) remodelling (ALVR).
Methods
A prospective registry of 471 STEMI patients underwent CMR 7 [5–10] and 198 [167–231] days post infarction, and MVO (>1 segment) and ALVR (relative increase >15% at follow-up CMR) of LV end-diastolic (LVEDVI) and end-systolic volume indices (LVESVI) were determined.
Results
One-week MVO occurred in 209 patients (44%) and persisted in 30 of these (6%). Most patients with persistent MVO (22/30, 73%) displayed extensive (>2.5% of LV mass) MVO at 1 week. Compared with patients without MVO (n=262, 56%) or with MVO only at 1 week (n=179, 38%), those with persistent MVO at follow-up (n=30, 6%) showed higher rates of ALVR-LVEDVI (22%, 27%, 50% p=0.003) and ALVR-LVESVI (20%, 21%, 53% p<0.001). After adjustment, the extent (% of LV mass) of MVO at follow-up was independently associated with ΔLVEDVI (relative increase, %) (p=0.01) and ΔLVESVI (p=0.03). Compared to a 1:1 matched population of 30 patients with MVO only at 1 week, patients with persistent MVO more frequently displayed ALVR-LVEDVI (12% vs. 50%, p=0.003) and ALVR-LVESVI (12% vs. 53%, p=0.001).
Conclusion
MVO persists in a small percentage of patients in chronic phase after STEMI and exerts deleterious effects in terms of LV remodelling. These findings fuel the need for further research on microvascular injury repair.
Funding Acknowledgement
Type of funding sources: Public grant(s) – National budget only. Main funding source(s): This work was supported by “Instituto de Salud Carlos III” and “Fondos Europeos de Desarrollo Regional FEDER” [grant numbers PI20/00637, PI15/00531, FI18/00320, and CIBERCV16/11/00486] and by Conselleria de Educaciόn – Generalitat Valenciana (PROMETEO/2021/008).
Collapse
Affiliation(s)
- J Gavara
- Polytechnic University of Valencia , Valencia , Spain
| | - C Rios Navarro
- Research Foundation Hospital of Valencia (INCLIVA) , Valencia , Spain
| | | | | | - E De Dios
- University of Valencia , Valencia , Spain
| | - N Perez-Sole
- Research Foundation Hospital of Valencia (INCLIVA) , Valencia , Spain
| | - V Marcos-Garces
- Research Foundation Hospital of Valencia (INCLIVA) , Valencia , Spain
| | - J Canoves
- Hospital Clínico Universitario de Valencia , Valencia , Spain
| | - J Nunez
- Hospital Clínico Universitario de Valencia , Valencia , Spain
| | - F J Chorro
- Hospital Clínico Universitario de Valencia , Valencia , Spain
| | | | - A Freixa
- Barcelona Hospital Clinic , Barcelona , Spain
| | - R Borras
- Barcelona Hospital Clinic , Barcelona , Spain
| | | | - V Bodi
- Hospital Clínico Universitario de Valencia , Valencia , Spain
| |
Collapse
|
5
|
Ruiz Munoz A, Guala A, Dux-Santoy L, Rodriguez-Palomares JF, Garcia-Duran A, Garrido-Oliver J, Galian-Gay L, Valente F, Casas G, Fernandez-Galera R, Johnson K, Wieben O, Ferreira-Gonzalez I, Evangelista A, Teixido-Tura G. Aortic flow patterns by 4D flow CMR in Marfan and Loeys-Dietz patients before and after valve sparing aortic root replacement: a comparison with healthy volunteers. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.1944] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Introduction
Abnormal aortic flow patterns in patients with a connective tissue disorder (CTD), such as Marfan or Loeys-Dietz syndrome, may contribute to aortic root dilation [1,2]. Valve sparing aortic root replacement, which is effective in reducing the risk of aortic dissection in case of severe dilation, may also normalize flow patterns beyond the replaced aorta and potentially slow its progressive aortic dilation.
Purpose
To assess aortic flow dynamics in patients with a CTD by 4D flow cardiovascular magnetic resonance (CMR) before and after valve sparing aortic root replacement, and to compare the results with those of healthy volunteers (HV).
Methods
Patients with Marfan or Loeys-Dietz syndrome underwent two non-contrast enhanced 4D flow CMR, one before and another after undergoing valve sparing aortic root replacement. Healthy volunteers matched for age, sex and BSA were also included for comparison. Maximum velocity, in-plane rotational flow (IRF), systolic flow reversal ratio (SFRR) and wall shear stress (WSS) magnitude and its axial and circumferential components were obtained at 24 planes covering the thoracic aorta from the sinotubular junction to the descending aorta at the diaphragmatic level [3–5].
Results
Sixteen patients and 21 healthy volunteers were included. Demographic and clinical data is presented in Table. The mean time between the CMR prior and posterior to surgery was 15 months. Compared to HV, patients with CTD before intervention presented lower maximum velocity at the proximal ascending aorta (Fig. 1A), lower IRF and circumferential WSS at the arch and the proximal descending aorta (Fig. 1B and F), lower magnitude and axial WSS at the proximal ascending and descending aorta (Fig. 1E and D), and increased SFRR at the proximal descending aorta (Fig. 1C). The intervention completely restored maximum velocity and partially-restored physiological helical flow and circumferential WSS, but barely improved axial WSS and SFRR.
Conclusion
Valve sparing aortic root replacement in patients with Marfan or Loeys-Dietz syndrome partially restore to physiological level both in-plane rotational flow and circumferential wall shear stress in the descending aorta. This flow normalization may contribute to prevent progressive dilation after the surgery.
Funding Acknowledgement
Type of funding sources: Public grant(s) – National budget only. Main funding source(s): Instituto de Salud Carlos III (Spain) (PI17/00381)Spanish Society of Cardiology (SEC/FEC-INV-CLI 20/015)
Collapse
Affiliation(s)
- A Ruiz Munoz
- University Hospital Vall d'Hebron, Cardiology , Barcelona , Spain
| | - A Guala
- University Hospital Vall d'Hebron, Cardiology , Barcelona , Spain
| | - L Dux-Santoy
- University Hospital Vall d'Hebron, Cardiology , Barcelona , Spain
| | | | - A Garcia-Duran
- University Hospital Vall d'Hebron, Cardiology , Barcelona , Spain
| | - J Garrido-Oliver
- University Hospital Vall d'Hebron, Cardiology , Barcelona , Spain
| | - L Galian-Gay
- University Hospital Vall d'Hebron, Cardiology , Barcelona , Spain
| | - F Valente
- University Hospital Vall d'Hebron, Cardiology , Barcelona , Spain
| | - G Casas
- University Hospital Vall d'Hebron, Cardiology , Barcelona , Spain
| | | | - K Johnson
- University of Wisconsin , Wisconsin , United States of America
| | - O Wieben
- University of Wisconsin , Wisconsin , United States of America
| | | | - A Evangelista
- University Hospital Vall d'Hebron, Cardiology , Barcelona , Spain
| | - G Teixido-Tura
- University Hospital Vall d'Hebron, Cardiology , Barcelona , Spain
| |
Collapse
|
6
|
Merenciano-Gonzalez H, Marcos Garces V, Gabaldon-Perez A, Gavara J, Lopez-Lereu MP, Monmeneu JV, Perez N, Rios-Navarro C, De Dios E, Chorro FJ, Valente F, Lorenzatti D, Ortiz-Perez JT, Rodriguez-Palomares JF, Bodi V. Cardiac magnetic resonance predictors of readmission for heart failure in elderly vs not elderly patients after ST-segment elevation myocardial infarction. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.931] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Background
Patients with ST-segment elevation acute myocardial infarction (STEMI) have an increased risk of re-admission for acute heart failure (AHF). However, identification of patients at higher risk of AHF is challenging, especially in elderly individuals. The implications of cardiac magnetic resonance (CMR) imaging soon after the acute event for this specific purpose are unknown.
Purpose
We aim to study the clinical and CMR predictors of AHF in elderly and not elderly patients after STEMI.
Methods
STEMI patients treated with percutaneous coronary intervention and discharged from three university hospitals were included in a multicenter registry. We registered baseline clinical characteristics, echocardiographic parameters and early (1-week) CMR parameters - left ventricular ejection fraction (LVEF, %), infarct size (% of left ventricular mass) and microvascular obstruction (MVO, number of segments). Univariate and multivariate comparisons were performed in elderly (>70 years) and not elderly (≤70 years) patients to predict AHF during follow-up.
Results
The cohort was comprised of 759 patients, of which 177 (23.3%) were elderly (>70 years). During a mean follow-up of 5.23±3.54 years, 79 (10.4%) patients presented AHF. In not elderly patients, Killip class at admission (HR 2.05 [1.32–3.17], p=0.001), anterior infarction (HR 3.43 [1.13–10.36], p=0.03) and CMR-LVEF (HR 0.94 [0.91–0.98] per increased %, p=0.001) independently predicted AHF. However, a combined risk score comprising these variables was not superior to CMR-LVEF alone to predict AHF during follow-up (AUC 0.81 [0.74–0.88] vs. 0.81 [0.73–0.88], p=NS). In elderly patients, CMR-LVEF was the only predictor of AHF in the final multivariable model (HR 0.94 [0.91–0.97], p<0.001), although its predictive power was moderate (AUC 0.68 [0.56–0.80], p=0.001). Most AHF events in the not elderly subgroup occurred in patients with reduced (≤40%) CMR-LVEF (71%), while in the elderly subgroup AHF occurred more frequently in patients with preserved (≥50%, 30%) or mildly reduced (40–49%, 32%) CMR-LVEF than reduced (≤40%) CMR-LVEF (38%).
Conclusions
LVEF quantified by CMR soon after STEMI can accurately predict the risk of AHF in not elderly (≤70 years) patients and identify those individuals at higher risk (i.e. CMR-LVEF ≤40%). However, in elderly (>70 years) patients most AHF occur in patients with CMR-LVEF >40%, emphasizing the need for better predictive strategies in this population.
Funding Acknowledgement
Type of funding sources: Public grant(s) – EU funding. Main funding source(s): Instituto de Salud Carlos III and “Fondos Europeos de Desarrollo Regional FEDER” and Conselleria de Educaciόn – Generalitat Valenciana.
Collapse
Affiliation(s)
| | - V Marcos Garces
- University Hospital Clinic of Valencia, Department of Cardiology , Valencia , Spain
| | - A Gabaldon-Perez
- University Hospital Clinic of Valencia, Department of Cardiology , Valencia , Spain
| | - J Gavara
- Instituto de Investigacion Sanitaria INCLIVA , Valencia , Spain
| | - M P Lopez-Lereu
- ERESA Medical Group, Cardiovascular Magnetic Resonance Unit , Valencia , Spain
| | - J V Monmeneu
- ERESA Medical Group, Cardiovascular Magnetic Resonance Unit , Valencia , Spain
| | - N Perez
- Instituto de Investigacion Sanitaria INCLIVA , Valencia , Spain
| | - C Rios-Navarro
- Instituto de Investigacion Sanitaria INCLIVA , Valencia , Spain
| | - E De Dios
- Center for Networked Biomedical Research – Cardiovascular (CIBER-CV) , Madrid , Spain
| | - F J Chorro
- University Hospital Clinic of Valencia, Department of Cardiology , Valencia , Spain
| | - F Valente
- University Hospital Vall d'Hebron, Department of Cardiology , Barcelona , Spain
| | - D Lorenzatti
- Institute of Biomedical Research August Pi Sunyer (IDIBAPS) , Barcelona , Spain
| | - J T Ortiz-Perez
- Barcelona Hospital Clinic, Department of Cardiology , Barcelona , Spain
| | | | - V Bodi
- University Hospital Clinic of Valencia, Department of Cardiology , Valencia , Spain
| |
Collapse
|
7
|
Dux-Santoy L, Garrido-Oliver J, Rodriguez-Palomares JF, Teixido-Tura G, Ruiz-Munoz A, Casas G, Valente F, Galian-Gay L, Gutierrez L, Gonzalez-Alujas T, Fernandez-Galera R, Cuellar H, Evangelista A, Ferreira-Gonzalez I, Guala A. Mapping of thoracic aorta growth rate on serial self-navigated 3D whole-heart magnetic resonance angiographies by image registration. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.227] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
Abstract
Introduction
Accurate and reproducible assessment of aortic diameters and their growth rate is of key importance for the management of patients with thoracic aortic aneurysms [1,2]. It has been recently shown that image registration permits the assessment of progressive aortic dilation on ECG-gated contrast-enhanced CT angiography, outperforming manual quantification and allowing for 3D aortic size and growth mapping [3]. However, exposure to radiation makes it convenient to limit the use of CT for serial follow-up, especially in young patients. Self-navigated 3D whole-heart CMR acquisitions provides excellent image quality overcoming these limitations [4].
Purpose
To evaluate the accuracy and reproducibility of registration-based assessment of aortic dilation using self-navigated 3D whole-heart CMR acquisitions.
Methods
Fifteen patients with two self-navigated 3D whole-heart CMR images obtained at least 1 year apart were included. Aortic root and thoracic aorta diameters were measured by 2 independent observers both manually (multiplanar reconstruction) and with the registration-based technique. To perform registration-based assessment, the aorta was semi-automatically segmented and typical anatomical landmarks were placed by each observer at baseline [3]. Geometrical mapping between baseline and follow-up acquisitions was obtained using deformable image registration, and applied to the baseline aortic surface points to obtain their location at follow-up. Finally, aortic diameters and their growth rate were automatically measured and used to calculated 3D aortic dilation maps. Agreement between techniques and their inter-observer reproducibility were calculated.
Results
Patients age was 27.2±14.5 years and 40% were male. Mean follow-up duration was 2.7±1.6 years. Compared to manual assessment, the registration-based technique presented low bias and excellent agreement for aortic diameters (Table 1), and low bias and moderate agreement for growth rates both in the aortic root and the thoracic aorta (Table, Fig. 1A). The techniques presented similar inter-observer reproducibility in the assessment of aortic diameters (Table 1), while the registration-based method demonstrated much higher inter-observer reproducibility in the assessment of growth rates in the aortic root and the thoracic aorta (Table 1, Fig. 1A and B). Three-dimensional mapping of thoracic aortic diameters and growth was highly reproducible (mean regional ICC=0.90 for diameters; 0.82 for growth rate).
Conclusion
The assessment of the dilation rate of the thoracic aorta via registration of serial self-navigated 3D whole-heart CMR acquisitions is accurate and reproducible in the aortic root and the thoracic aorta. Thus, it allows to assess local aortic growth without the drawbacks of CT.
Funding Acknowledgement
Type of funding sources: Public grant(s) – National budget only. Main funding source(s): Instituto de Salud Carlos III and Ministerio de Ciencia e Innovaciόn (Spain)
Collapse
Affiliation(s)
- L Dux-Santoy
- University Hospital Vall d'Hebron, VHIR, Universtitat Autonoma De Barcelona , Barcelona , Spain
| | - J Garrido-Oliver
- University Hospital Vall d'Hebron, VHIR, Universtitat Autonoma De Barcelona , Barcelona , Spain
| | - J F Rodriguez-Palomares
- University Hospital Vall d'Hebron, VHIR, Universtitat Autonoma De Barcelona , Barcelona , Spain
| | - G Teixido-Tura
- University Hospital Vall d'Hebron, VHIR, Universtitat Autonoma De Barcelona , Barcelona , Spain
| | - A Ruiz-Munoz
- University Hospital Vall d'Hebron, VHIR, Universtitat Autonoma De Barcelona , Barcelona , Spain
| | - G Casas
- University Hospital Vall d'Hebron, VHIR, Universtitat Autonoma De Barcelona , Barcelona , Spain
| | - F Valente
- University Hospital Vall d'Hebron, VHIR, Universtitat Autonoma De Barcelona , Barcelona , Spain
| | - L Galian-Gay
- University Hospital Vall d'Hebron, VHIR, Universtitat Autonoma De Barcelona , Barcelona , Spain
| | - L Gutierrez
- University Hospital Vall d'Hebron, VHIR, Universtitat Autonoma De Barcelona , Barcelona , Spain
| | - T Gonzalez-Alujas
- University Hospital Vall d'Hebron, VHIR, Universtitat Autonoma De Barcelona , Barcelona , Spain
| | - R Fernandez-Galera
- University Hospital Vall d'Hebron, VHIR, Universtitat Autonoma De Barcelona , Barcelona , Spain
| | - H Cuellar
- University Hospital Vall d'Hebron, VHIR, Universtitat Autonoma De Barcelona , Barcelona , Spain
| | - A Evangelista
- University Hospital Vall d'Hebron, VHIR, Universtitat Autonoma De Barcelona , Barcelona , Spain
| | - I Ferreira-Gonzalez
- University Hospital Vall d'Hebron, VHIR, Universtitat Autonoma De Barcelona , Barcelona , Spain
| | - A Guala
- University Hospital Vall d'Hebron, VHIR, Universtitat Autonoma De Barcelona , Barcelona , Spain
| |
Collapse
|
8
|
Casas G, Escalona R, Gonzalez Del Hoyo MI, Palomino-Doza J, Garcia-Pinilla JM, Bayes-Genis A, Ripoll-Vera T, Jimenez-Jaimez J, Villacorta E, Gimeno-Blanes JR, Zorio E, Garcia-Pavia P, Barriales-Villa R, Ferreira-Gonzalez I, Rodriguez-Palomares JF. Outcomes of patients with left ventricular noncompaction and preserved ejection fraction. Eur Heart J Cardiovasc Imaging 2022. [DOI: 10.1093/ehjci/jeab289.419] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: None.
INTRODUCTION
Left ventricular noncompaction (LVNC) is a poorly defined entity with heterogeneous prognosis. LV ejection fraction (LVEF) is one of the main predictors of major adverse cardiovascular events (MACE). However, outcomes of LVNC patients with preserved LVEF (pEF) remain uncertain.
PURPOSE
The aim of our study was to determine the incidence and predictors of MACE in LVNC patients with pEF as well as to assess the evolution of LVEF throughout follow-up.
METHODS
We conducted a retrospective, longitudinal, multicentre cohort study. Consecutive patients with transthoracic echocardiography (TTE) and/or cardiac magnetic resonance (CMR) diagnostic criteria for LVNC and initially pEF (LVEF≥50%) were recruited. MACE were defined as a composite of heart failure (HF), ventricular arrhythmias (VA), systemic embolisms (SE) and/or all-cause mortality. Progressive systolic dysfunction was defined as an LVEF < 50% at last TTE and/or an absolute ≥10-point decrease in LVEF from first to last TTE. Lower limit of LVEF CMR values were considered 50-57% according to current recommendations. Cox-regression analysis was used for MACE and logistic regression was used for progressive systolic dysfunction (only first and last TTE were available).
RESULTS
A total of 305 patients from 12 centres were included from 2000 to 2018. Age was 38 ± 19 years and 165 (54%) were men. LVEF was 62 ± 8% and 8% had late gadolinium enhancement (LGE). During a median follow-up of 4.7 (IQR 2.1-7.4) years, MACE occurred in 40 (13%) patients with an incidence rate of 2.73 (95% CI 2.00-3.72) events per 100 person-years: 8 HF, 27 VA, 3 SE and 5 deaths. LVEF by CMR (HR 0.95, 95% CI 0.91-0.99, p = 0.0048) and hypertension (HR 2.30, 95% CI 1.08-4.89, p = 0.031) were the only variables independently associated with the endpoint. Patients with lower limit LVEF values showed an increased risk of MACE (Figure 1). LGE was not associated.
Sixty-one (21%) patients experienced progressive systolic dysfunction: 31 (11%) had an LVEF < 50% and 48 (17%) an absolute ≥10-point decrease in LVEF at last follow-up. On multivariate analysis, LVEF by CMR was the only independent predictor (OR 0.93, 95% CI 0.89-0.98, p = 0.008). Patients with lower limit LVEF values had an increased risk (Figure 2). In this subgroup, LGE was also associated with the endpoint (HR 10.69, 95% CI 1.97-58.13, p = 0.006).
CONCLUSIONS
Patients with left ventricular noncompaction and preserved ejection fraction carry a moderate risk of major adverse cardiovascular events and progressive systolic dysfunction. LVEF remains the main predictor of outcomes in this subgroup. Patients with lower limit LVEF values are at increased risk, probably suggesting subclinical systolic dysfunction. Therefore, they should be carefully monitored. Abstract Figure. Kaplan Meier cuves for MACE Abstract Figure. Risk of progressive systolic dysfunction
Collapse
Affiliation(s)
- G Casas
- University Hospital Vall d"Hebron, Cardiology, Barcelona, Spain
| | - R Escalona
- University Hospital Vall d"Hebron, Cardiology, Barcelona, Spain
| | | | | | | | | | | | | | - E Villacorta
- Complejo Asistencial Universitario de Salamanca, Salamanca, Spain
| | - JR Gimeno-Blanes
- Hospital Clinico Universitario Virgen de la Arrixaca, Murcia, Spain
| | - E Zorio
- Hospital Universitario y Politecnico La Fe, Valencia, Spain
| | - P Garcia-Pavia
- University Hospital Puerta de Hierro Majadahonda, Madrid, Spain
| | | | | | | |
Collapse
|
9
|
Servato ML, Lopez-Sainz A, Valente F, Fernandez-Galera R, Casas-Masnou G, Gutierrez L, Galian-Gay L, Limeres J, Sao-Aviles A, Gonzalez-Alujas MT, Rodriguez-Palomares JF, Evangelista A, Teixido-Tura G. Mitral valve prolapse but no mitral annular disjunction is related to mitral regurgitation progression in patients with Marfan syndrome. Eur Heart J Cardiovasc Imaging 2022. [DOI: 10.1093/ehjci/jeab289.306] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: None.
Background
Mitral annular disjunction (MAD) is a structural abnormality of the mitral annular fibrosus characterized by a separation between the atrial wall-mitral valve junction, and the left ventricular attachment (1,2). It has been associated with mitral valve prolapse (MVP). Limited data is available regarding the impact of the presence of MVP on the evolution of mitral regurgitation in these syndromic entities.
Purpose
To evaluate the prevalence of MAD, PMV, and the combination of both in patients with syndromic hereditary thoracic aortic disease (HTAD) including Marfan (MFS), Loeys-Dietz (LDS), and vascular Ehlers-Danlos syndromes (vEDS), and its relationship with mitral regurgitation (MR) severity and the need for mitral surgery at the follow-up.
Methods
Adult patients with syndromic HTAD seen at our specialized unit were retrospectively included. The presence of MAD, MVP, and significant MR at the first echocardiogram were evaluated. Electronic medical records were reviewed to register the need for mitral surgery. The last echocardiogram available was also assessed to evaluate MR progression.
Results
A total of 295 patients were included (235 MFS, 42 LDS, and 18 vEDS). The mean age at baseline was 39.0+-14.4 and 52.9% were female. MAD was present in 87 (37.0%) of MFS, 6 (14.3 %) of LDS and was not present in vEDS (p< 0.001). MVP was found in 105 (44.7%) of MFS, 6 (14.3%) of LDS and 0 in vEDS (p< 0.001).
In MFS, MAD was significantly associated with MVP (p= <0.001) (Table 1). Concretely, 73 (31.1%) of the MFS patients had the concurrence of MAD and MVP and 14 (6.0%) of patients had isolated MAD (Table 2). At baseline, significant MR was observed in 30 (12.8%) of the MFS and in 18 (24.7%) of patients with concurrent MAD and MVP. Interestingly, significant MR was absent in patients with isolated MAD (Figure 1). MVP (OR 16.85 CI 4.43 – 64.07) but not MAD (p = 0.607), was associated with significant MR in the multivariate analysis.
A second echocardiogram was available in 220 patients at > = 1 year (mean 4.1 +- 1.4 years). Overall, 25 (11.4%) presented significant progression of MR, 0 in the isolated MAD group, 13 (19.4%) in the MAD/MVP group and 6 (20.0%) of the isolated MVP (p = 0.007).
After a mean clinical follow-up of 7.5 +- 3.2yrs, 10 patients required mitral surgery (6 prostheses, 4 valvuloplasties).
After adjustment for the presence of MVP and time of follow-up, MAD was not associated with progression of MR (p= 0.529) but MVP was (OR 5.2 IC 1.70 - 15.93). Similarly, MVP (OR 5.6 CI 1.23 - 25.86) but not MAD (P= 0.096) was associated with the need for mitral surgery .,
Conclusions
The prevalence of MAD in syndromic HTAD is high, especially in Marfan syndrome, and absent in vEDS. In this retrospective observational study, the presence of MVP but not MAD was associated with mitral regurgitation evolution and the need for mitral surgery. Abstract Table 1 Abstract Figure 1
Collapse
Affiliation(s)
- ML Servato
- University Hospital Vall d"Hebron, Barcelona, Spain
| | | | - F Valente
- University Hospital Vall d"Hebron, Barcelona, Spain
| | | | | | - L Gutierrez
- University Hospital Vall d"Hebron, Barcelona, Spain
| | - L Galian-Gay
- University Hospital Vall d"Hebron, Barcelona, Spain
| | - J Limeres
- University Hospital Vall d"Hebron, Barcelona, Spain
| | - A Sao-Aviles
- University Hospital Vall d"Hebron, Barcelona, Spain
| | | | | | | | | |
Collapse
|
10
|
Fernandez Galera R, Belahnech Y, Dentamaro I, Cia X, Gutierrez L, Galian L, Teixido G, Casas G, Servato L, Gonzalez-Alujas MT, Gonzalez MT, Guala A, Cuellar H, Burcet G, Rodriguez-Palomares JF. Clinical, laboratory, electrocardiogaphic and multimodality imaging outcome predictors in cardiac amyloidosis. Eur Heart J 2021. [DOI: 10.1093/eurheartj/ehab724.1805] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Background
Cardiac affectation in amyloidosis is presented among 50% patients what implies worse prognostic. Early diagnosis and prognostic stratification is mandatory after the appearance of new therapies that could modify the course of the disease.
Purpose
The aim of the present study was to evaluate the main outcome predictors with multiparametric approach including clinical, laboratory, electrocardiographic and imaging parameters in patients with cardiac amyloidosis (CA).
Methods
We recruited patients (p) prospectively followed in our cardiomyopathy unit, for a mean period of 10 years (from 2010 to 2020) who were diagnosed with CA. Baseline clinical, laboratory and echocardiographic data were obtained. We collected cardiovascular risk factors and previous events. We performed a multimodality imaging study including echocardiogram (TTE) and cardiac magnetic resonance (CMR). TTE hallmarks of CA were recorded, as well as CMR parameters of cardiac function, myocardial mass and tissue characterization. Finally we evaluated the parameters related with mortality in the follow-up.
Results
A total of 98 p were included, with a mean age of 67.5±16.9 years old. Mean follow-up was 42,2±32 months. 22 p (24,4%) had light-chain amyloidosis (AL), 34 p (37,8%) wild type transthyretin amyloidosis (ATTRwt) and 34 p (37,8%) familiar transthyretin amyloidosis (ATTRm). 43p (47.78%) died in the follow-up. Factors related with mortality in the the follow-up where the age (HR 1.08, ppresence of hypertension (HR 2.81, p=0,002) diabetes (HR 3.12, p=0,001) and previous stroke (HR 2.69, p=0,01); NYHA class at diagnosis (HR 2.49, p<0.001), low voltage (HR 2.31, p=0,008) and pseudoinfarct pattern at ECG (HR 1.9, p=0,003); elevated BNP (HR 10.29, p<0.001) and creatinine (HR 1.42, p=0,02); septum (HR 1.09, p=0,001) and posterior wall (HR 1,14, p<0,001)thickness, left ventricular ejection fraction (HR 0.96, p=0,0031) global longitudinal strain (HR 1.18, p<0.001), ratio E/A (HR 2.29, p<0,001) and E/e' (HR 1.13, p=0,003) and left atrium size (HR 1,05, p=0,006) at echo; and the presence of left atrium fibrosis (HR 4.17, p>0,001) and extension of late gadolinium enhancement (HR 1,06, p=0,03) at CMR. When evaluated within a multivariate analysis in a Cox regression model, the independent variables associated with mortality were NYHA class at diagnosis (p=0.002) and amyloidosis type (p=0.002) ATTRm had a better prognosis than ATTRwt and AL (Log-rank p<0.001).
Conclusion
Mortality in cardiac amyloid patients is high. Clinical parameters like hypertension, diabetes, previous stroke and NYHA class at diagnosis; laboratory parameters like BNP and creatinine, main systolic and diastolic function at TTE, presence of auricular fibrosis and extension of late gadolinium enhancement at CRM are related with mortality in the follow-up. Among different types of CA, patients with ATTRm had a better prognosis, which may have therapeutic implications with the appearance of new therapies.
Funding Acknowledgement
Type of funding sources: None. Mortality
Collapse
Affiliation(s)
| | - Y Belahnech
- University Hospital Vall d'Hebron, Barcelona, Spain
| | - I Dentamaro
- University Hospital Vall d'Hebron, Barcelona, Spain
| | - X Cia
- University Hospital Vall d'Hebron, Barcelona, Spain
| | - L Gutierrez
- University Hospital Vall d'Hebron, Barcelona, Spain
| | - L Galian
- University Hospital Vall d'Hebron, Barcelona, Spain
| | - G Teixido
- University Hospital Vall d'Hebron, Barcelona, Spain
| | - G Casas
- University Hospital Vall d'Hebron, Barcelona, Spain
| | - L Servato
- University Hospital Vall d'Hebron, Barcelona, Spain
| | | | - M T Gonzalez
- University Hospital Vall d'Hebron, Barcelona, Spain
| | - A Guala
- University Hospital Vall d'Hebron, Barcelona, Spain
| | - H Cuellar
- University Hospital Vall d'Hebron, Barcelona, Spain
| | - G Burcet
- University Hospital Vall d'Hebron, Barcelona, Spain
| | | |
Collapse
|
11
|
Gonzalez Del Hoyo M, Servato L, Fernandez-Galera R, Rodenas E, Garcia M, Casas G, Jordan P, Herrador L, Bach M, Valente F, Gutierrez L, Baneras J, Evangelista A, Ferreira I, Rodriguez-Palomares J. Clinical impact on treatment and prognosis of advanced cardiac imaging with echocardiography in the acute setting of a COVID-19 infection. Eur Heart J 2021. [DOI: 10.1093/eurheartj/ehab724.0136] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background and objectives
Despite myocardial injury being related to excess mortality in acute COVID-19 infection, its impact on imaging findings remains unclear. This study aimed to characterize transthoracic echocardiographic (TTE) findings in patients admitted with COVID-19 infections and its impact on management and prognosis.
Methods
A prospective observational cohort study was performed among 66 COVID-19 patients who were admitted to a tertiary center between March 1 and May 25, 2020 and underwent TTE. High-sensitivity troponin I (hs-cTnI) data, echocardiographic assessment of right and left ventricular (LV) functional parameters, strain, and myocardial work analysis were obtained.
Results
2025 patients were admitted with COVID-19 and in 200 a complete TTE study was performed. Due to poor image quality, only 66 studies were included in the final analysis. The median age was 62 years (IQR, 55–70) and 59.1% of patients were males. The most common comorbidity was hypertension (47%), followed by smoking history (30.3%), atrial fibrillation (9.1%), and chronic obstructive pulmonary disease (7.9%). More than half of the patients (39, 59%) were admitted to the ICU, and half of them (33, 50%) required invasive mechanical ventilation. TTE was mainly indicated because of concerns for systemic conditions (50%) and evaluation of hemodynamic assessment (30%). Thirty-six patients (54.5%) had an abnormal TTE result and 57% had elevated hs-cTnI levels. The most common cardiac abnormality was LV diastolic dysfunction in 33% of the patients, followed by right ventricular dysfunction (12%) and LV dysfunction (6%) (Figure 1). LV GLS was reduced in 48.5% of the cases. Myocardial work performance indices were all reduced in patients with an abnormal TTE (GWI 30%, GCW 30%, GWW 40%, and GWE 40%), although differences were not significant (P>0.2 for all parameters). Patients with an abnormal TTE were older and presented a higher cardiovascular risk profile. There were no significant differences in the levels of D-dimer, NTproBNP, and hs-cTnI between patients with and without diastolic dysfunction, RV, or LV dysfunction (P>0.3 for all parameters). Using Spearman rank correlation, there was an inverse relationship between hs-cTnI and LV strain and myocardial work analysis. TTE results impacted clinical management in 60 patients, mainly de-escalation of medical treatment (Figure 2). Abnormal TTE results did not impact in-hospital outcomes.
Conclusions
Severe echocardiographic abnormalities are uncommon in hospitalized patients with COVID-19 infections, presenting mostly with subclinical myocardial changes, such as diastolic dysfunction, reduced LV GLS, and myocardial work indices, both associated with high-sensitivity troponin I elevation. An echocardiographic study should be limited to rule out long-term ICU complications or to evaluate hemodynamic instability. Although TTE was a valuable tool for guiding management, it had no significant impact on prognosis.
Funding Acknowledgement
Type of funding sources: None. Figure 1. Findings on TTE studies.Figure 2. Changes in management.
Collapse
Affiliation(s)
| | - L Servato
- Vall d'Hebron Research Institute (VHIR), Barcelona, Spain
| | | | - E Rodenas
- Vall d'Hebron Research Institute (VHIR), Barcelona, Spain
| | - M Garcia
- Vall d'Hebron Research Institute (VHIR), Barcelona, Spain
| | - G Casas
- Vall d'Hebron Research Institute (VHIR), Barcelona, Spain
| | - P Jordan
- Vall d'Hebron Research Institute (VHIR), Barcelona, Spain
| | - L Herrador
- Vall d'Hebron Research Institute (VHIR), Barcelona, Spain
| | - M Bach
- Vall d'Hebron Research Institute (VHIR), Barcelona, Spain
| | - F Valente
- Vall d'Hebron Research Institute (VHIR), Barcelona, Spain
| | - L Gutierrez
- Vall d'Hebron Research Institute (VHIR), Barcelona, Spain
| | - J Baneras
- Vall d'Hebron Research Institute (VHIR), Barcelona, Spain
| | - A Evangelista
- Vall d'Hebron Research Institute (VHIR), Barcelona, Spain
| | - I Ferreira
- Vall d'Hebron Research Institute (VHIR), Barcelona, Spain
| | | |
Collapse
|
12
|
Servato ML, Lopez-Sainz A, Valente F, Fernandez-Galera R, Casas-Masnou G, Gutierrez L, Limeres J, Sao-Aviles A, Gonzalez-Alujas MT, Rodriguez-Palomares JF, Evangelista A, Teixido-Tura G. Mitral annular disjunction in patients with syndromic hereditary aorthopaties. Eur Heart J 2021. [DOI: 10.1093/eurheartj/ehab724.1993] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Background
Mitral annular disjunction (MAD) is a structural abnormality of the mitral annular fibrosus characterized by a separation between the atrial wall-mitral valve junction, and the left ventricular attachment (1). It has been associated with mitral valve prolapse (MVP) (2) but also, with arrhythmias and sudden cardiac death (SCD) (3). There is no evidence of its prevalence and clinical significance in patients with syndromic hereditary aortopathies.
Purpose
To evaluate the prevalence of MAD, PMV, and the combination of both in patients with syndromic hereditary thoracic aortic disease (HTAD) including Marfan (MFS), Loeys-Dietz (LDS) and vascular Ehlers-Danlos syndromes (vEDS), and its relationship with arrhythmias, SCD, mitral regurgitation (MR) severity and the need for mitral surgery at the follow-up.
Methods
Adult patients with syndromic HTAD seen at our specialized unit were retrospectively included. The presence of MAD, MVP, and significant MR at first echocardiogram were evaluated. Electronic medical records were reviewed to register the occurrence of arrhythmic events and the need of mitral surgery. Last echocardiogram available was also assessed to evaluate MR progression.
Results
A total of 295 patients were included (235 MFS, 42 LDS and 18 vEDS). Mean age at baseline was 39.0±14.4 and 52.9% were female. MAD was present in 87 (37.0%) of MFS, 6 (14.3%) of LDS and was not present in vEDS (p<0.001). MVP was found in 105 (44.7%) of MFS, 6 (14.3%) of LDS and 0 in vEDS (p<0.001).
In MFS, the presence of MAD was significantly associated with MVP (p≤0.001) (Table 1). However, 14 (6.0%) of patients had isolated MAD (Table 2). At baseline, significant MR was observed in 18 (24.7%) of patients with concurrent MAD and MVP and was not present in patients with isolated MAD (Table 2). MVP (OR 16.85 IC 4.43 – 64.07) but not MAD (p=0.607), was associated with significant MR in the multivariate analysis.
A second echocardiogram was available in 220 patients at ≥1 year (mean 4.1±1.4 years). Overall, 25 (11.4%) presented significant progression of MR, 0 in the isolated MAD group, 13 (19.4%) in the MAD/MVP group and 6 (20.0%) of the isolated MVP (p=0.007).
After a mean clinical follow-up of 7.5±3.2 years, 10 patients required mitral surgery (6 prosthesis, 4 valvuloplasty), 22 (9.4%) presented atrial fibrillation, flutter or supraventricular tachycardia (SVT), and 2 (0.9%) SCD.
After adjustment for the presence of MVP and time of follow-up, MAD was not associated with progression of MR (p=0.529) need for mitral surgery (p=0.096), atrial fibrillation-flutter or SVT (p=0.510) nor SCD. (p=0.997).
Conclusions
The prevalence of MAD in syndromic HTAD is high, especially in Marfan syndrome, and absent in vEDS. In this retrospective observational study, the presence of MAD in Marfan was not associated with mitral regurgitation evolution or arrhythmic events.
Funding Acknowledgement
Type of funding sources: None. Characteristics of MFS patientsPresence of significant MR by groups.
Collapse
Affiliation(s)
- M L Servato
- University Hospital Vall d'Hebron, Barcelona, Spain
| | | | - F Valente
- University Hospital Vall d'Hebron, Barcelona, Spain
| | | | | | - L Gutierrez
- University Hospital Vall d'Hebron, Barcelona, Spain
| | - J Limeres
- University Hospital Vall d'Hebron, Barcelona, Spain
| | - A Sao-Aviles
- University Hospital Vall d'Hebron, Barcelona, Spain
| | | | | | | | | |
Collapse
|
13
|
Casas G, Limeres J, Gutierrez-Garcia L, La Mura L, Guala A, Teixido G, Escalona R, Gonzalez-Del-Hoyo M, Gimeno JR, Zorio E, Garcia-Pavia P, Barriales R, Evangelista A, Ferreira-Gonzalez I, Rodriguez-Palomares JF. Prognosis of left ventricular noncompaction with preserved ejection fraction. Eur Heart J 2021. [DOI: 10.1093/eurheartj/ehab724.1758] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Introduction
Left ventricular noncompaction (LVNC) is a poorly defined entity with heterogeneous prognosis. LV ejection fraction (LVEF) is one of the main predictors of major adverse cardiovascular events (MACE). However, outcomes of LVNC patients with preserved LVEF (pEF) remain uncertain.
Purpose
The aim of our study was to determine the incidence and predictors of MACE in LVNC patients with pEF as well as to assess the evolution of LVEF throughout follow-up.
Methods
We conducted a retrospective, longitudinal, multicentre cohort study. Consecutive patients with transthoracic echocardiography (TTE) and/or cardiac magnetic resonance (CMR) diagnostic criteria for LVNC and initially pEF (LVEF≥50%) were recruited. MACE were defined as a composite of heart failure (HF), ventricular arrhythmias (VA), systemic embolisms (SE) and/or all-cause mortality. Progressive systolic dysfunction was defined as an LVEF<50% at last TTE and/or an absolute ≥10-point decrease in LVEF from first to last TTE. Lower limit of LVEF values were considered 50–53% for TTE and 50–57% for CMR, according to current recommendations.
Results
A total of 305 patients from 12 centres were included from 2000 to 2018. Age was 38±19 years, 165 (54%) were men and 185 (61%) were probands. LVEF was 62±8% and 8% had late gadolinium enhancement (LGE). During a median follow-up of 4.7 (IQR 2.1–7.4) years, MACE occurred in 40 (13%) patients with an incidence rate of 2.96 (95% CI 2.17–4.04) events per 100 person-years: 8 HF, 27 VA, 3 SE and 5 deaths. LVEF by TTE (HR 0.95, 95% CI 0.90–0.99, p=0.035) and age (HR 1.02, 95% CI 1.01–1-04, p=0.04) were the only variables independently associated with the endpoint. Patients with lower limit LVEF values showed an increased risk of MACE (Figure 1). Among probands, those with family aggregation presented a higher incidence of MACE compared to nonfamilial cases (HR 2.74, p=0.043). A positive genotype was not associated.
Sixty-one (21%) patients experienced progressive systolic dysfunction: 31 (11%) had an LVEF<50% and 48 (17%) an absolute ≥10-point decrease in LVEF at last follow-up. On multivariate analysis, LVEF by CMR was the only independent predictor (HR 0.96, 95% CI 0.92–0.99, p=0.031). Patients with lower limit LVEF values had an increased risk (Figure 2). In this subgroup, LGE was also associated with the endpoint (HR 3.52, p=0.011). Family aggregation was not associated, while a positive genotype correlated with lower risk (HR 0.52, p=0.029).
Conclusions
Patients with left ventricular noncompaction and preserved ejection fraction carry a moderate risk of major adverse cardiovascular events and progressive systolic dysfunction. LVEF remains the main predictor of outcomes in this subgroup. Patients with lower limit LVEF values are at increased risk, probably suggesting subclinical systolic dysfunction. Therefore, they should be carefully monitored.
Funding Acknowledgement
Type of funding sources: None. Figure 1Figure 2
Collapse
Affiliation(s)
- G Casas
- University Hospital Vall d'Hebron, Cardiology, Barcelona, Spain
| | - J Limeres
- University Hospital Vall d'Hebron, Cardiology, Barcelona, Spain
| | | | - L La Mura
- Federico II University Hospital, Naples, Italy
| | - A Guala
- University Hospital Vall d'Hebron, Cardiology, Barcelona, Spain
| | - G Teixido
- University Hospital Vall d'Hebron, Cardiology, Barcelona, Spain
| | - R Escalona
- University Hospital Vall d'Hebron, Cardiology, Barcelona, Spain
| | | | - J R Gimeno
- Hospital Universitario Virgen Arrixaca, Murcia, Spain
| | - E Zorio
- Hospital Universitario y Politecnico La Fe, Valencia, Spain
| | - P Garcia-Pavia
- University Hospital Puerta de Hierro Majadahonda, Madrid, Spain
| | - R Barriales
- University Hospital Complex A Coruña, A Coruña, Spain
| | - A Evangelista
- University Hospital Vall d'Hebron, Cardiology, Barcelona, Spain
| | | | | |
Collapse
|
14
|
Rodenas Alesina E, Rodriguez-Palomares J, Oller-Bach M, Jordan P, Badia C, Herrador L, Garcia-De-Acilu M, Clau-Terre F, Gonzalez-Del-Hoyo M, Fernandez-Galera R, Servato L, Casas G, Baneras J, Ferreira-Gonzalez I. Routine advanced echocardiography in the evaluation of cardiovascular sequelae of COVID19 survivors with elevated cardiovascular biomarkers. Eur Heart J 2021. [PMCID: PMC8767606 DOI: 10.1093/eurheartj/ehab724.1594] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/02/2022] Open
Abstract
Background COVID19 has been related to elevated CVB and biventricular dysfunction during hospitalization. However, it is unknown whether patients with biomarker elevation exhibit long-lasting abnormalities in cardiac function. Purpose To determine, using advanced echocardiography, the prevalence and type of cardiovascular sequelae after COVID19 infection with marked elevation of cardiovascular biomarkers (CVB), and their prognostic implications. Methods All patients admitted from March 1st to May 25th, 2020 to a tertiary referral hospital were included. Patients with cardiovascular disease antecedent, death during admission, or the first 30 days after discharge were excluded. Patients with hs-TnI >45 ng/L, NT-proBNP >300 pg/ml, and D-dimer >8000 ng/ml were separated based on each CVB elevation and matched with COVID controls (three biomarkers within the normal range) based on intensive care requirements and age. Results From a total of 2025 hospitalized COVID19 patients, 80 patients with significantly elevated CVB and 29 controls were finally included. No differences in baseline characteristics were observed among groups, but elevated CVB patients were sicker. Follow-up echocardiograms showed no differences among groups regarding LVEF or RV diameters, but TAPSE was lower if hs-TnI or D-dimer were elevated. Hs-TnI patients also had lower global myocardial work and global longitudinal strain. The presence of an abnormal echocardiogram was more frequent in the elevated CVB group compared to controls (23.8 vs 10.3%, P=0.123) but mainly associated with mild abnormalities in deformation parameters. Management did not change in any case and no major cardiovascular events except deep vein thrombosis occurred after a median follow-up of 7 months (Figure 1). Conclusions Minimal abnormalities in cardiac structure and function are observed in COVID19 survivors without previous cardiovascular diseases who presented a significant CVB rise at admission, with no impact on patient management or short-term prognosis. These results do not support a routine screening program after discharge in this population. Funding Acknowledgement Type of funding sources: None.
Figure 1 ![]()
Collapse
Affiliation(s)
| | | | - M Oller-Bach
- University Hospital Vall d'Hebron, Barcelona, Spain
| | - P Jordan
- University Hospital Vall d'Hebron, Barcelona, Spain
| | - C Badia
- University Hospital Vall d'Hebron, Barcelona, Spain
| | - L Herrador
- University Hospital Vall d'Hebron, Barcelona, Spain
| | | | - F Clau-Terre
- University Hospital Vall d'Hebron, Barcelona, Spain
| | | | | | - L Servato
- University Hospital Vall d'Hebron, Barcelona, Spain
| | - G Casas
- University Hospital Vall d'Hebron, Barcelona, Spain
| | - J Baneras
- University Hospital Vall d'Hebron, Barcelona, Spain
| | | |
Collapse
|
15
|
Fernandez Galera R, Dentamaro I, Belahnech Y, Cia X, Gutierrez L, Gonzalez-Alujas MT, Galian L, Teixido G, Casas G, Servato L, Gonzalez MT, Cuellar H, Burcet G, Guala A, Rodriguez-Palomares JF. Evaluation of myocardial strain assessed by CMR tissue-tracking to predict adverse cardiovascular events in patients with cardiac amyloidosis. Eur Heart J 2021. [DOI: 10.1093/eurheartj/ehab724.0236] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Background
Cardiac affectation in amyloidosis is presented among 50% patients what implies worse prognostic. Early diagnosis and prognostic stratification is mandatory after the appearance of new therapies that could modify the course of the disease.
Purpose
The aim of our study was to assess the prognostic value of cardiac magnetic resonance parameters, including Tissue deformation, in cardiac amyloidosis patients.
Methods
We recruited patients (p) prospectively followed in our cardiomyopathy unit, for a mean period of 10 years (from 2010 to 2020) who were diagnosed with CA. Baseline clinical, laboratory and echocardiographic data were obtained. Contrast-enhanced CMR was performed on a 1.5 T clinical scanner. Routine analysis was performed with a semi-automatic software for volumetric analysis. When late gadolinium enhancement was present, percentage of area of enhancement (LGE) was calculated.All strain parameters were measured off-line using dedicated software. Left ventricular circumferential strain (CS) measurements were obtained using mid-ventricular level short-axis cine views. Longitudinal strain (LS) derived from cine SSFP of 2-, 3-, and 4-chamber long axis views.Finally we evaluated the CMR parameters related with the combined event of mortality and heart failure in the follow-up.
Results
A total of 98 p were included, with a mean age of 67.5±16.9 years old. Mean follow-up was 42,2±32 months. 22 p (24,4%) had light-chain amyloidosis (AL), 34 p (37,8%) wild type transthyretin amyloidosis (ATTRwt) and 34 p (37,8%) familiar transthyretin amyloidosis (ATTRm). 59p (60,8%) died or present heart failure during the follow-up. Patients who died or present heart failure in the follow-uo had lower left ventricular ejection fraction (48,25±12,2% vs 56,13±11,03%, p=0,003), higher myocardial mass (156,05±54,8g vs 120,84±56,1g, p=0,007), higher LGE (8,6±6,8% vs 4,4±2%), worst GLS (−14,76±6,1% vs −18,67±6,2%) and worst GCS (−23,3±9,7% vs −30,04±9,1%). Both, GLS and GCS were independently associated with the combined event of dead or heart failure when evaluated within a multivariate analysis in a Cox regression model, but GCS was the stronger predictor of events in the follow-up over other CMR parameters like LGE an myocardial mass (p<0,001). Tertile distribution for GCS identified subgroups with different adverse events, particularly for the lowest-risk tertile: GCS <−34%, who had a combinated event in 13,6% of cases, significantly lower than patients in the mid-risk tertile (41,5%) and highest-risk tertile (53,8%) (Log-rank p=0,02)
Conclusion
Mortality and appearance of heart failure in cardiac amyloid patients is high. The assessment of myocardial strain parameters by CMR tissue-tracking in this population is useful to predict adverse outcomes in the follow-up. Particularly, GCS, stratify patients in subgroups with different risk of events, with added value to classical CMR parameters.
Funding Acknowledgement
Type of funding sources: None. Death & Heart Failure by GCS
Collapse
Affiliation(s)
| | - I Dentamaro
- University Hospital Vall d'Hebron, Barcelona, Spain
| | - Y Belahnech
- University Hospital Vall d'Hebron, Barcelona, Spain
| | - X Cia
- University Hospital Vall d'Hebron, Barcelona, Spain
| | - L Gutierrez
- University Hospital Vall d'Hebron, Barcelona, Spain
| | | | - L Galian
- University Hospital Vall d'Hebron, Barcelona, Spain
| | - G Teixido
- University Hospital Vall d'Hebron, Barcelona, Spain
| | - G Casas
- University Hospital Vall d'Hebron, Barcelona, Spain
| | - L Servato
- University Hospital Vall d'Hebron, Barcelona, Spain
| | - M T Gonzalez
- University Hospital Vall d'Hebron, Barcelona, Spain
| | - H Cuellar
- University Hospital Vall d'Hebron, Barcelona, Spain
| | - G Burcet
- University Hospital Vall d'Hebron, Barcelona, Spain
| | - A Guala
- University Hospital Vall d'Hebron, Barcelona, Spain
| | | |
Collapse
|
16
|
Valente F, Gavara J, Calvo M, Rello P, Maymi M, Barrabes J, Sao-Aviles A, Burcet G, Cuellar H, Otaegui I, Garcia-Blanco B, Ferreira I, Ortiz J, Bodi V, Rodriguez-Palomares JF. Prognostic value of baseline versus 6-month follow infarct size in patients with reperfused STEMI. Eur Heart J 2021. [DOI: 10.1093/eurheartj/ehab724.0217] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Acute infarct size is a predictor of clinical outcomes in acute ST segment elevation myocardial infarction (STEMI) patients, although its prognostic value has differed between studies. In acute STEMI, infarct size is often overestimated due to the presence of extensive myocardial oedema, a confounder that is no longer present at a 6-month follow-up study. It was our purpose to assess whether infarct size in the acute phase or at 6-months follow-up provided superior prognostic information in STEMI patients.
Methods
STEMI patients who underwent successful primary percutaneous revascularization were included and a cardiac magnetic resonance (CMR) was performed between 5–7 days after STEMI and at 6 months to study infarct size (as a % of myocardial mass). The primary endpoint was a composite of cardiovascular mortality, hospitalization for heart failure and ventricular arrhythmia.
Results
A total of 796 patients were included (mean age 58.3±11.5 years, 82.4% male, 52.3% anterior infarction). During a mean follow-up of 59 months, 59 patients (7.4%) presented with the primary end-point (cardiovascular death n=7, hospitalization for heart failure n=52, ventricular arrhythmia n=1). ROC curve analysis (figure 1) showed a non-significant difference between baseline and 6-month infarct size for the prediction of the primary endpoint (baseline AUC 0.685 95% CI 0.610–0.760, 6-month AUC 0.713 95% CI 0.643–0.782, p=0.60). Optimal cut-off values for baseline and 6-months follow-up infarct size for prediction of outcomes, respectively 22% and 17.5%, were used for Kaplan-Meier curve analysis (figure 2).
Conclusion
Infarct size estimated during the first week after STEMI and at 6-months follow-up showed similar predictive value and with similar cut-off values. Therefore, the prognostic information provided by infarct size can be obtained during initial STEMI admission and does not require a waiting period for infarct size stabilization.
Funding Acknowledgement
Type of funding sources: None. ROC curve analysisKaplan-Meier analysis
Collapse
Affiliation(s)
- F Valente
- University Hospital Vall d'Hebron, Barcelona, Spain
| | - J Gavara
- Research Foundation Hospital of Valencia (INCLIVA), Valencia, Spain
| | - M Calvo
- Barcelona Hospital Clinic, Cardiology, Barcelona, Spain
| | - P Rello
- University Hospital Vall d'Hebron, Barcelona, Spain
| | - M Maymi
- University Hospital Vall d'Hebron, Barcelona, Spain
| | - J Barrabes
- University Hospital Vall d'Hebron, Barcelona, Spain
| | - A Sao-Aviles
- University Hospital Vall d'Hebron, Barcelona, Spain
| | - G Burcet
- University Hospital Vall d'Hebron, Barcelona, Spain
| | - H Cuellar
- University Hospital Vall d'Hebron, Barcelona, Spain
| | - I Otaegui
- University Hospital Vall d'Hebron, Barcelona, Spain
| | | | - I Ferreira
- University Hospital Vall d'Hebron, Barcelona, Spain
| | - J Ortiz
- Barcelona Hospital Clinic, Cardiology, Barcelona, Spain
| | - V Bodi
- Research Foundation Hospital of Valencia (INCLIVA), Valencia, Spain
| | | |
Collapse
|
17
|
Ruiz Munoz A, Guala A, Dux-Santoy L, Teixido-Tura G, Casas G, Valente F, Servato ML, Fernandez-Galera R, Galian-Gay L, Gutierrez L, Gonzalez-Alujas T, Ferreira-Gonzalez I, Evangelista A, Rodriguez-Palomares JF. Do morphological, haemodynamic and biomechanical parameters relate to aortic growth rate in chronic type B aortic dissection? A 4D flow CMR study. Eur Heart J 2021. [DOI: 10.1093/eurheartj/ehab724.2014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Aortic dissection (AD) is the most devastating complication of thoracic aortic disease (1). In the chronic phase, yearly clinical and imaging follow-up of the maximum aortic diameter is recommended, since indication for thoracic endovascular aortic repair or surgery is suggested by guidelines in case of thoracic aortic enlargement or false lumen (FL) aneurysms (2). Most of the reported parameters related adverse events in chronic AD are focused on morphological variables (3) and not on the haemodynamics and biomechanics of the FL.
Purpose
To evaluate the relationship between aortic growth rate and anatomical variables, flow patterns and aortic stiffness in patients with chronic type B AD.
Methods
Forty-one patients with chronic type B aortic dissection, no connective tissue disorders and with an imaging follow-up including two computed tomography angiograms (CTA) acquired at least 3 years apart underwent contrast-enhanced 4D-flow CMR and MR angiography (MRA). The FL volume was segmented from MRA, and velocity data inside the 3D volume of the FL was extracted from 4D-flow CMR and used for parameter quantification. Retrograde systolic and diastolic flow, wall shear stress (WSS) and in-plane rotational flow (IRF) were calculated at 8 equidistant planes in the distal descending aorta (DAo), from the pulmonary bifurcation to the diaphragmatic level, and averaged values were used [4]. Aortic stiffness in the FL was assessed in terms of pulse wave velocity (PWV), which was calculated from the third supraortic trunk to the diaphragmatic level on 4D-flow CMR [5]. The percentage of thrombus in the FL was calculated as the ratio of thrombus and FL volumes on MRA. Dominant entry tear area was quantified on the baseline CTA (Figure 1). Aortic growth rate (GR) was defined as the difference between final and baseline aortic diameters as measured on CTA divided by follow-up duration.
Results
Anatomical, haemodynamic and biomechanical parameters are shown in Table. Twenty-five patients have repaired type A AD with residual entry tear and 16 have type B AD. Mean follow-up duration was of 4.9±2.7 years. In bivariate analysis, WSS, IRF and PWV were positively related to GR, whereas dominant entry tear area and percentage of thrombus in the FL showed a positive tendency with GR (Table) (Figure). In multivariate analysis IRF, PWV, dominant entry tear area and thrombus in the FL were positively and independently associated with GR (Table). Retrograde systolic and diastolic flow were not related to GR while WSS tended to statistical significance.
Conclusions
In-plane rotational flow, regional aortic stiffness, dominant entry tear area and percentage of thrombus in the false lumen are positively and independently related to aortic growth rate in patients with chronic type B aortic dissection. Further prospective studies are needed to confirm if the assessment of these parameters may help to identify patients at higher risk of adverse clinical events.
Funding Acknowledgement
Type of funding sources: None. Table 1Figure 1
Collapse
Affiliation(s)
- A Ruiz Munoz
- University Hospital Vall d'Hebron, Cardiology, Barcelona, Spain
| | - A Guala
- University Hospital Vall d'Hebron, Cardiology, Barcelona, Spain
| | - L Dux-Santoy
- University Hospital Vall d'Hebron, Cardiology, Barcelona, Spain
| | - G Teixido-Tura
- University Hospital Vall d'Hebron, Cardiology, Barcelona, Spain
| | - G Casas
- University Hospital Vall d'Hebron, Cardiology, Barcelona, Spain
| | - F Valente
- University Hospital Vall d'Hebron, Cardiology, Barcelona, Spain
| | - M L Servato
- University Hospital Vall d'Hebron, Cardiology, Barcelona, Spain
| | | | - L Galian-Gay
- University Hospital Vall d'Hebron, Cardiology, Barcelona, Spain
| | - L Gutierrez
- University Hospital Vall d'Hebron, Cardiology, Barcelona, Spain
| | | | | | - A Evangelista
- University Hospital Vall d'Hebron, Cardiology, Barcelona, Spain
| | | |
Collapse
|
18
|
Aviles J, Maso Talou G, Camara O, Mejia Cordova M, Ferdian E, Kat G, Young A, Dux-Santoy L, Ruiz-Munoz A, Teixido-Tura G, Rodriguez-Palomares J, Guala A. Automatic segmentation of the aorta on multi-center and multi-vendor phase-contrast enhanced magnetic resonance angiographies and the advantages of transfer learning. Eur Heart J Cardiovasc Imaging 2021. [DOI: 10.1093/ehjci/jeab090.121] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: Public grant(s) – National budget only. Main funding source(s): Guala A. received funding from the Spanish Ministry of Science, Innovation and Universities
Background
Phase-contrast (PC) enhanced magnetic resonance (MR) angiography (MRA) is a class of angiogram exploiting velocity data to increase the signal-to-noise ratio, thus avoiding the administration of external contrast agent, normally used to segment 4D flow MR data. To train deep-learning algorithms to segment PC-MRA a large amount of manually annotated data is needed: however, the relatively novelty of the sequence, its rapid evolution and the extensive time needed to manually segment data limit its availability.
Purpose
The aim of this study was to test a deep learning algorithm in the segmentation of multi-center and multi-vendor PC-MRA and to test if transfer learning (TL) improves performance.
Methods
A large dataset (LD) of 262 and a small one (SD) of 22 PC-MRA, acquired without contrast agent at 1.5 T in a General Electric and a Siemens scanner, respectively, were manually annotated and divided into training (232 and 15 cases) and testing (30 and 7) sets. They both included PC-MRA of healthy subjects and patients with aortic diseases (excluding dissections) and native aorta. A convolutional neural networks (CNN) based on nnU-Net framework [1] was trained in the LD and another in the SD. The left ventricle was removed semi-automatically from the DL segmentations of the LD as it was not relevant for this application. Networks were then tested on the test sets of the dataset there were trained and the other dataset to assess generalizability. Finally, a fine-tuning transfer learning approach was applied to LD network and the performance on both test sets were tested. Dice score, Hausdorff distance, Jaccard score and Average Symmetrical Surface Distance were used as segmentation quality metrics.
Results
LD network achieved good performance in LD test set, with a DS of 0.904, ASSD of 1.47, J of 0.827 and HD of 6.35, which further improve after removing the left ventricle in the post-processing to a DS of 0.942, ASSD of 0.93, J of 0.892 and HD of 3.32. SD network results in an average DS of 0.895, ASSD of 0.59, J of 0.812 and HD of 2.05. Once tested on the testing set of the other dataset, LD network resulted in a DS of 0.612 while SD network in DS of 0.375, thus showing limited generalizability. However, the application of transfer learning to LD network resulted in the improvement of the evaluation metrics on the SD from a DS of 0.612 to 0.858, while slightly worsening in the first one without post-processing to 0.882.
Conclusions
nnU-net framework is effective for fast automatic segmentation of the aorta from multi-center and multi-vendor PC-MRA, showing performance comparable with the state of the art. The application of transfer learning allows for increased generalization to data from center not included in the original training. These results unlock the possibility for fully-automatic analysis of multi-vendor multi-center 4D flow MR.
Collapse
Affiliation(s)
- J Aviles
- University Hospital Vall d"Hebron, Barcelona, Spain
| | - G Maso Talou
- The University of Auckland, Auckland Bioengineering Institute, Auckland, New Zealand
| | - O Camara
- University Pompeu Fabra, Physense, BCN Medtech, Department of Information and Communications Technologies, Barcelona, Spain
| | - M Mejia Cordova
- University Pompeu Fabra, Physense, BCN Medtech, Department of Information and Communications Technologies, Barcelona, Spain
| | - E Ferdian
- The University of Auckland, Faculty of Medical and Health Sciences, Auckland, New Zealand
| | - G Kat
- The University of Auckland, Auckland Bioengineering Institute, Auckland, New Zealand
| | - A Young
- The University of Auckland, Faculty of Medical and Health Sciences, Auckland, New Zealand
| | - L Dux-Santoy
- University Hospital Vall d"Hebron, Barcelona, Spain
| | - A Ruiz-Munoz
- University Hospital Vall d"Hebron, Barcelona, Spain
| | | | | | - A Guala
- University Hospital Vall d"Hebron, Barcelona, Spain
| |
Collapse
|
19
|
Guala A, Mejia Cordova M, Morales X, Jimenez-Perez G, Dux-Santoy L, Aviles J, Ruiz-Munoz A, Teixido-Tura G, Ferreira-Gonzalez I, Camara O, Rodriguez-Palomares J. Machine learning to automatically detect anatomical landmarks on phase-contrast enhanced magnetic resonance angiography. Eur Heart J Cardiovasc Imaging 2021. [DOI: 10.1093/ehjci/jeab090.122] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: Public grant(s) – National budget only. Main funding source(s): Guala A. received funding from the Spanish Ministry of Science, Innovation and Universities
Introduction
The heterogeneous characteristic of the thoracic aorta implies that all biomarkers with potential for risk stratification need to be references to a specific location. This is the case, for example, of diameter [1], stiffness [2] and wall shear stress [3]. This is normally achieved by the manual identification of a limited number of key anatomic landmarks [4], which is a time-demanding task and may impact biomarkers accuracy and reproducibility. Automatic identification of these anatomic landmarks may speed-up the analysis and allow for the creation of fully automatic image analysis pipelines. Machine learning (ML) algorithms might be suitable for this task.
Purpose
The aim of this study was to test the performance of a ML algorithm in localizing key thoracic anatomical landmarks on phase-contrast enhanced magnetic resonance angiograms (PC-MRA).
Methods
PC-MRA of 323 patients with native aorta and aortic valve and a variety of aortic conditions (141 bicuspid aortic valve patients, 60 patients with degenerative aortic aneurysms, 82 patients with genetic aortopathy and 40 healthy volunteers) were included in this study. Four anatomical landmarks were manually identified on PC-MRA by an experienced researcher: sinotubular junction, the pulmonary artery bifurcation and the first and third supra-aortic vessel braches. A reinforcement learning algorithm (DQN), combining Q-learning with deep neural networks, was trained. The algorithm was tested in a separate set of 30 PC-MRA with similar distribution of aortic conditions in which human intra-observer reproducibility was quantified. The distance between points was used as quality metric and human annotation was considered as ground-truth. Repeated-measures ANOVA was used for statistical testing.
Results
ML algorithm resulted in performance similar to the intra-observer variability obtained by the experienced human reader in the identification of the sinotubular junction (11.1 ± 8.6 vs 11.0 ± 8.1 mm, p = 0.949) and first (6.8 ± 5.6 vs 6.6 ± 3.9 mm, p = 0.886) and third (8.4 ± 7.4 vs 6.8 ± 4.0 mm, p = 0.161) supra-aortic vessels branches. However, the algorithm did not reach human-level performance in the localization of the pulmonary artery bifurcation (15.2 ± 13.1 vs 10.2 ± 7.0 mm, p = 0.008). The time needed to the ML algorithm to locate all points ranged between 0.8 and 1.6 seconds on a standard computer while manual annotation required around two minutes to be performed.
Conclusions
The rapid identification of key aortic anatomical landmarks by a reinforced learning algorithm is feasible with human-level performance. This approach may thus be used for the design of fully-automatic pipeline for 4D flow CMR analysis.
Collapse
Affiliation(s)
- A Guala
- University Hospital Vall d"Hebron, Barcelona, Spain
| | - M Mejia Cordova
- University Pompeu Fabra, Physense, BCN Medtech, Department of Information and Communications Technologies, Barcelona, Spain
| | - X Morales
- University Pompeu Fabra, Physense, BCN Medtech, Department of Information and Communications Technologies, Barcelona, Spain
| | - G Jimenez-Perez
- University Pompeu Fabra, Physense, BCN Medtech, Department of Information and Communications Technologies, Barcelona, Spain
| | - L Dux-Santoy
- University Hospital Vall d"Hebron, Barcelona, Spain
| | - J Aviles
- University Pompeu Fabra, Physense, BCN Medtech, Department of Information and Communications Technologies, Barcelona, Spain
| | - A Ruiz-Munoz
- University Hospital Vall d"Hebron, Barcelona, Spain
| | | | | | - O Camara
- University Pompeu Fabra, Physense, BCN Medtech, Department of Information and Communications Technologies, Barcelona, Spain
| | | |
Collapse
|
20
|
Guala A, Teixido-Tura G, Dux-Santoy L, Ruiz-Munoz A, Valente F, Galian L, Gutierrez L, Gonzalez-Alujas T, Johnson K, Wieben O, Sao-Aviles A, Ferreira-Gonzalez I, Evangelista A, Rodriguez-Palomares J. Bicuspid aortic valve fusion length correlates with maximum aortic diameter and heamodynamic abnormalities: a 4D flow CMR study. Eur Heart J Cardiovasc Imaging 2021. [DOI: 10.1093/ehjci/jeab090.106] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: Public grant(s) – National budget only. Main funding source(s): Guala A. received funding from the Spanish Ministry of Science, Innovation and Universities.
Background
Bicuspid aortic valve (BAV), a congenital heart defect, is associated with ascending aorta dilation, possibly via alteration of aortic blood flow [1]. In BAV abnormal flow condition have been associated with aortic extracellular matrix dysregulation and elastic fiber degeneration [2]. Current morphological classification of BAV patients with aortic valve with a single fusion between two adjacent leaflets does not allow for risk stratification.
Purpose
This research work tested whether the extent of fusion between leaflets is related to AAo diameter and flow alterations.
Methods
Ninety BAV patients free from moderate and severe aortic valve disease and with no previous aortic or aortic valve surgery or replacement were prospectively enrolled. A comprehensive magnetic resonance protocol comprised a stack of double-oblique 2D balanced steady-state free-precession (bSSFP) cine CMR of the aortic valve, which was used to measure the length of the fusion between leaflets, a cine CMR at the level of the pulmonary bifurcation to assess aortic diameter and 4D flow MRI sequence to assess flow characteristics and regional stiffness [3]. Jet angle and flow radial displacement, quantifying the extent of flow eccentricity, and systolic flow reversal ratio (SFRR), assessing the relative amount of backward flow during systole, were computed at 8 equidistant planes in the ascending aorta and 4 equidistant planes in the aortic arch [4]. A two-tailed p-value < 0.05 was considered statistically significant.
Results
The length of leaflet fusion varied widely (median 7.7 mm, inter-quartile range [5.5; 10.2]), Table 1). In bivariate analysis, fusion length was also associated to ascending aortic diameter (R = 0.391, p < 0.001), age (R = 0.313, p = 0.005) and body surface area (R = 0.396, p < 0.001). It was also positively related to flow abnormalities: like displacement in the proximal and distal ascending aorta, jet angle in the mid ascending aorta, and SFRR in the ascending aorta and the aortic arch (see Figure 1). The association between fusion length and ascending aorta diameter persisted in multivariate analysis after correction for age (p = 0.006).
Conclusions
Bicuspid aortic valve fusion extent varies greatly and it is associated with aortic diameter, possibly through flow alterations. Prospective longitudinal studies are needed to establish whether fusion length may allow for risk stratification in bicuspid aortic valve patients.
Collapse
Affiliation(s)
- A Guala
- University Hospital Vall d"Hebron, Barcelona, Spain
| | | | - L Dux-Santoy
- University Hospital Vall d"Hebron, Barcelona, Spain
| | - A Ruiz-Munoz
- University Hospital Vall d"Hebron, Barcelona, Spain
| | - F Valente
- University Hospital Vall d"Hebron, Barcelona, Spain
| | - L Galian
- University Hospital Vall d"Hebron, Barcelona, Spain
| | - L Gutierrez
- University Hospital Vall d"Hebron, Barcelona, Spain
| | | | - K Johnson
- University of Wisconsin-Madison, Departments of Medical Physics & Radiology, Madison, United States of America
| | - O Wieben
- University of Wisconsin-Madison, Departments of Medical Physics & Radiology, Madison, United States of America
| | - A Sao-Aviles
- University Hospital Vall d"Hebron, Barcelona, Spain
| | | | | | | |
Collapse
|
21
|
Ruiz Munoz A, Guala A, Rodriguez-Palomares JF, Dux-Santoy L, Servato L, Lopez-Sainz A, La Mura L, Gonzalez-Alujas T, Galian-Gay L, Gutierrez L, Johnson K, Wieben O, Ferreira I, Evangelista A, Teixido-Tura G. Aortic rotational flow patterns and stiffness by 4D flow CMR in patients with Loeys-Dietz syndrome compared to healthy volunteers and patients with Marfan syndrome. Eur Heart J Cardiovasc Imaging 2021. [DOI: 10.1093/ehjci/jeab090.078] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: Public grant(s) – National budget only. Main funding source(s): La Marató de TV3, Instituto de Salud Carlos III through the project and Spanish Ministry of Science, Innovation and Universities.
BACKGROUND
Loeys-Dietz (LDS) and Marfan (MFS) syndromes are rare genetic connective tissue disorders associated with progressive aortic dilation, however, aortic dissections have been observed at lower aortic root diameters in LDS than in MFS. Recent CMR studies in MFS patients reported increased aortic stiffness (1–3) and altered rotational flow (4), but research on aortic flow dynamics and biomechanics in LDS is lacking.
PURPOSE
The aim of this study was to assess rotational aortic flow and aortic stiffness in LDS compared to healthy volunteers (HV) and MFS patients, using 4Dflow CMR.
METHODS
Twenty-one LDS and 44 MFS patients, without previous aortic dissection or surgery, and 43 HV underwent a non-contrast-enhanced 4D flow CMR. Aortic stiffness was quantified at the AAo and DAo using pulse wave velocity (PWV). In-plane rotational flow (IRF), systolic flow reversal ratio (SFRR) (5) and local aortic diameters were obtained at 20 equidistant planes from the ascending (AAo) to the proximal descending aorta (DAo).
RESULTS
LDS patients had lower IRF at the distal AAo and proximal DAo compared to HV (p = 0.053 and 0.004, respectively), once adjusted for age, stroke volume and local aortic diameter; but no differences were found with respect to MFS (Figure). Although SFRR at the proximal DAo was increased in LDS patients compared to both HV (p = 0.037) and MFS populations (p = 0.015), once adjusted for age and aortic diameter, the difference in magnitude was small (Figure). On the other hand, AAo and DAo PWV revealed stiffer aortas in LDS patients compared to HV but no differences versus MFS patients (Table).
CONCLUSIONS
Patients with Loeys-Dietz syndrome showed decreased in-plane rotational flow and abnormally-high regional aortic stiffness compared to healthy controls, and similar hemodynamics and aortic stiffness with respect to patients with Marfan syndrome.
Collapse
Affiliation(s)
- A Ruiz Munoz
- University Hospital Vall d"Hebron, Cardiology, Barcelona, Spain
| | - A Guala
- University Hospital Vall d"Hebron, Cardiology, Barcelona, Spain
| | | | - L Dux-Santoy
- University Hospital Vall d"Hebron, Cardiology, Barcelona, Spain
| | - L Servato
- University Hospital Vall d"Hebron, Cardiology, Barcelona, Spain
| | - A Lopez-Sainz
- University Hospital Vall d"Hebron, Cardiology, Barcelona, Spain
| | - L La Mura
- University Hospital Vall d"Hebron, Cardiology, Barcelona, Spain
| | | | - L Galian-Gay
- University Hospital Vall d"Hebron, Cardiology, Barcelona, Spain
| | - L Gutierrez
- University Hospital Vall d"Hebron, Cardiology, Barcelona, Spain
| | - K Johnson
- University of Wisconsin, Wisconsin, United States of America
| | - O Wieben
- University of Wisconsin, Wisconsin, United States of America
| | - I Ferreira
- University Hospital Vall d"Hebron, Cardiology, Barcelona, Spain
| | - A Evangelista
- University Hospital Vall d"Hebron, Cardiology, Barcelona, Spain
| | - G Teixido-Tura
- University Hospital Vall d"Hebron, Cardiology, Barcelona, Spain
| |
Collapse
|
22
|
Casas G, Limeres J, Barriales-Villa R, Garcia-Pavia P, Zorio E, Gimeno-Blanes JR, Palomino-Doza J, Garcia-Pinilla JM, Bayes-Genis A, Ripoll-Vera T, Jimenez-Jaimez J, Villacorta E, Evangelista A, Ferreira-Gonzales I, Rodriguez-Palomares JF. Prognostic role of cardiac magnetic resonance in left ventricular noncompaction. Eur Heart J Cardiovasc Imaging 2021. [DOI: 10.1093/ehjci/jeab090.111] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: None.
Background
Left ventricular noncompaction (LVNC) is a heterogeneous entity with a wide phenotypic expression. Risk factors have not been well established and prognostic stratification remains challenging.
Purpose
Describe prognostic role of CMR on long term outcomes of LVNC patients.
Methods
Retrospective multicentric longitudinal cohort study of consecutive patients fulfilling imaging diagnostic criteria for LVNC (Jenni echo criteria and Petersen and Jacquier CMR criteria). Demographic, ECG, genetic, family and treatment variables were recorded. Baseline CMR was used for the analysis. LV ejection fraction (LVEF) was categorized according to heart failure (HF) guidelines and late gadolinium enhancement (LGE) was visually assessed in a binary way. End points were HF, ventricular arrhythmias (VA), systemic embolisms (SE) and all-cause death. Major adverse cardiovascular events (MACE) were the combination of the four previous end points. In patients with initially preserved LVEF (≥ 50%), LV adverse remodelling (LVAR) was defined as an LVEF < 50% and/or absolute decrease of ≥10% in LVEF at last follow-up.
Results
585 patients from 12 referral centres were included from 2000 to 2018. Age at diagnosis was 45 ± 20 years, 334 (57%) were male, baseline LVEF was 48 ± 17% and 18% presented LGE. During a median follow-up of 5.1 years (IQR 2.3-8.1), 110 (19%) patients presented HF, 87 (15%) VA, 18 (3%) SE and 34 (6%) died. MACE occurred in 223 (38%) patients.
LVEF was independently associated with HF, VA, SE and MACE: HR were 1.08, 1.02, 1.04 and 1.02 respectively (all p < 0.05). LGE was more frequent in patients with reduced LVEF (39 Vs 53%, p < 0.001) and was associated with higher HF and VA risk in patients with an LVEF > 35% (HR 2.69 and 2.48 respectively, p < 0.05) (Figure 1). No MACE (0%) occurred during long-term follow-up in patients with preserved LVEF, no LGE as well as no ECG abnormalities and no family aggregation.
305 (52%) patients presented with initially preserved LVEF, and 230 (75%) of those had LVEF available at last follow-up. LVAR occurred in 50 (22%) patients: 22 (10%) had an LVEF < 50% and 41 (18%) an absolute ≥ 10% decrease in LVEF. LGE was independently associated with LVAR (HR 3.51, p = 0.045) (Figure 2).
Conclusions
Cardiac magnetic resonance has an important prognostic role in LVNC. LVEF is the most powerful predictor of events. Myocardial fibrosis is associated with worse outcomes in patients without severe systolic dysfunction, as well as with left ventricular adverse remodelling in those with initially preserved LVEF. Besides, CMR may identify a low-risk subgroup of LVNC patients. Therefore, CMR should be used in risk stratification in LVNC.
Collapse
Affiliation(s)
- G Casas
- University Hospital Vall d"Hebron, Cardiology, Barcelona, Spain
| | - J Limeres
- University Hospital Vall d"Hebron, Cardiology, Barcelona, Spain
| | | | - P Garcia-Pavia
- University Hospital Puerta de Hierro Majadahonda, Madrid, Spain
| | - E Zorio
- Hospital Universitario y Politecnico La Fe, Valencia, Spain
| | | | | | | | | | | | | | - E Villacorta
- University Hospital of Salamanca, Salamanca, Spain
| | - A Evangelista
- University Hospital Vall d"Hebron, Cardiology, Barcelona, Spain
| | | | | |
Collapse
|
23
|
Gavara J, Marcos-Garces V, Rios-Navarro C, Lopez-Lereu MP, Monmeneu JV, Bonanad Lozano C, Moratal D, Chorro FJ, Valente F, Lorenzatti D, Rodriguez-Palomares JF, Ortiz-Perez JT, Bodi V. Sequential cardiovascular magnetic resonance assessment of left ventricular ejection fraction for prediction of subsequent events in a large multicenter STEMI registry. Eur Heart J Cardiovasc Imaging 2021. [DOI: 10.1093/ehjci/jeab090.042] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: Public grant(s) – EU funding. Main funding source(s): This work was supported by “Instituto de Salud Carlos III” and “Fondos Europeos de Desarrollo Regional FEDER”
Background. Cardiovascular magnetic resonance (CMR) is the best tool for left ventricular ejection fraction (LVEF) quantification, but as yet the prognostic value of sequential LVEF assessment for major adverse cardiac event (MACE) prediction after ST-segment elevation myocardial infarction (STEMI) is uncertain.
Purpose. We explored the prognostic impact of sequential assessment of CMR-derived LVEF after STEMI to predict subsequent MACE.
Methods. We recruited 1036 STEMI patients in a large multicenter registry. LVEF (reduced [r]: <40%; mid-range [mr]: 40-49%; preserved [p]: ≥50%) was sequentially quantified by CMR at 1 week and after >3 months of follow-up. MACE was regarded as cardiovascular death or re-admission for acute heart failure after follow-up CMR.
Results. During a 5.7-year mean follow-up, 82 MACE (8%) were registered. The MACE rate was higher only in patients with LVEF < 40% at follow-up CMR (r-LVEF 22%, mr-LVEF 7%, p-LVEF 6%; p-value < 0.001). Based on LVEF dynamics from 1-week to follow-up CMR, incidence of MACE was 5% for sustained LVEF³40% (n = 783), 13% for improved LVEF (from <40 to ³40%, n = 96), 21% for worsened LVEF (from ³40% to <40%, n = 34) and 22% for sustained LVEF <40% (n = 100), p-value < 0.001. Using a Markov approach that considered all studies performed, transitions towards improved LVEF predominated and only r-LVEF (at any time assessed) was significantly related to higher incidence of subsequent MACE.
Conclusions. LVEF constitutes a pivotal CMR index for simple and dynamic post-STEMI risk stratification. Detection of reduced LVEF (<40%) by CMR at any time during follow-up identifies a small subset of patients at high risk of subsequent events.
Collapse
Affiliation(s)
- J Gavara
- University Hospital Clinic of Valencia, Cardiology. INCLIVA. University of Valencia., Valencia, Spain
| | - V Marcos-Garces
- University Hospital Clinic, Department of Cardiology, Valencia, Spain
| | - C Rios-Navarro
- University Hospital Clinic of Valencia, Cardiology. INCLIVA. University of Valencia., Valencia, Spain
| | - MP Lopez-Lereu
- University Hospital Clinic, Imaging Unit-ERESA, Valencia, Spain
| | - JV Monmeneu
- University Hospital Clinic, Imaging Unit-ERESA, Valencia, Spain
| | - C Bonanad Lozano
- University Hospital Clinic, Department of Cardiology, Valencia, Spain
| | - D Moratal
- Polytechnic University of Valencia, Center for Biomaterials and Tissue Engineering, Valencia, Spain
| | - FJ Chorro
- University Hospital Clinic of Valencia, Cardiology. INCLIVA. University of Valencia., Valencia, Spain
| | - F Valente
- University Hospital Vall d"Hebron, Department of Cardiology, Barcelona, Spain
| | - D Lorenzatti
- Barcelona Hospital Clinic, Cardiovascular Institute, Barcelona, Spain
| | | | - JT Ortiz-Perez
- Barcelona Hospital Clinic, Cardiovascular Institute, Barcelona, Spain
| | - V Bodi
- University Hospital Clinic of Valencia, Cardiology. INCLIVA. University of Valencia., Valencia, Spain
| |
Collapse
|
24
|
Casas G, Limeres J, Oristrell G, Gutierrez L, Barriales R, Garcia-Pavia P, Zorio E, Gimeno JR, Villacorta E, Jimenez-Jaimez J, Ripoll T, Bayes A, Ferreira I, Rodriguez-Palomares JF. Long term outcomes in left ventricular noncompaction. Eur Heart J Cardiovasc Imaging 2021. [DOI: 10.1093/ehjci/jeaa356.305] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: None.
Background
Left ventricular noncompaction (LVNC) is a heterogeneous entity with a wide phenotypic expression. Risk factors have not been well established and prognostic stratification remains challenging.
Objectives
Describe long term outcomes of LVNC patients and determine predictors of cardiovascular events.
Methods
Prospective multicentric study of consecutive patients fulfilling imaging diangostic criteria for LVNC (Jenni echo criteria and Petersen CMR criteria). Demographic, ECG, imaging and genetic variables were collected. End points were heart failure (HF), ventricular arrhythmias (VA), systemic embolisms (SE) and all-cause death. Major adverse cardiovascular events (MACE) was the combination of the four previous end points.
Results
585 patients from 12 referral centres were included from 2000 to 2018. Age at diagnosis was 45 ± 20 years, 334 (57%) were male, baseline LVEF was 48 ± 17% and 18% presented late gadolinium enhancement (LGE). During a median follow-up of 5.1 years (IQR 2.3-8.1), 110 (19%) patients presented HF, 87 (15%) VA, 18 (3%) SE and 34 (6%) died. MACE occurred in 223 (38%) patients.
LVEF was independently associated with HF, VA, SE and MACE: HR were 1.08, 1.02, 1.04 and 1.02 respectively (all p < 0.05). LGE was more frequent in patients with reduced LVEF (39 Vs 53%, p < 0.001) and was associated with higher HF and VA risk in patients with LVEF > 35% (HR 2.69 and 2.48 respectively, p < 0.05) (Figure 1). Patients with a normal ECG, LVEF≥50%, no LGE and no family aggregation presented no MACE (0%) at long term follow-up.
Among patients who underwent genetic testing (354, 61%), TTN variants and complex genotype (more than one variant) presented lower LVEF and higher HF risk. ACTC1 variants were associated with VA.
Conclusions
LVNC carries a high long term risk of heart faliure and ventricular arrhythmias. LVEF is the most important predictor and myocardial fibrosis is associated with increased risk in patients without severe systolic dysfunction. Genotype is a modifier of outcomes. These factors might be used to risk stratify LVNC patients.
Abstract Figure. Kaplan Meier survival curves
Collapse
Affiliation(s)
- G Casas
- University Hospital Vall d"Hebron, Cardiology, Barcelona, Spain
| | - J Limeres
- University Hospital Vall d"Hebron, Cardiology, Barcelona, Spain
| | - G Oristrell
- University Hospital Vall d"Hebron, Cardiology, Barcelona, Spain
| | - L Gutierrez
- University Hospital Vall d"Hebron, Cardiology, Barcelona, Spain
| | - R Barriales
- University Hospital Complex A Coru??a, A Coruna, Spain
| | - P Garcia-Pavia
- University Hospital Puerta de Hierro Majadahonda, Madrid, Spain
| | - E Zorio
- Hospital Universitario y Politecnico La Fe, Valencia, Spain
| | - JR Gimeno
- Hospital Universitario Virgen Arrixaca, Murcia, Spain
| | - E Villacorta
- Complejo Asistencial Universitario de Salamanca, Salamanca, Spain
| | | | - T Ripoll
- Hospital Son Llatzer, Palma de Mallorca, Spain
| | - A Bayes
- Germans Trias i Pujol Hospital, Badalona, Spain
| | - I Ferreira
- University Hospital Vall d"Hebron, Cardiology, Barcelona, Spain
| | | |
Collapse
|
25
|
Guala A, Pons MI, Ruiz-Munoz A, Dux-Santoy L, Madrenas L, Valente F, Lopez-Sainz A, Galian L, Gutierrez L, Sao-Aviles A, Gonzalez-Alujas T, Ferreira I, Evangelista A, Rodriguez-Palomares J, Teixido-Tura G. Aortic root longitudinal strain by speckle-tracking echocardiography predicts progressive aortic root dilation in Marfan syndrome patients. Eur Heart J Cardiovasc Imaging 2021. [DOI: 10.1093/ehjci/jeaa356.177] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: Public grant(s) – National budget only. Main funding source(s): Spanish Ministry of Science, Innovation and Universities; Instituto de Salud Carlos III
Introduction
In Marfan syndrome (MFS) patients reduced longitudinal strain of the ascending aorta (AAo) as measured by applying feature-tracking on cine cardiac magnetic resonance (CMR) images predicts aortic root dilation and aortic events during the follow-up. Speckle-tracking is well established for cardiac deformation assessment but proximal aorta applications are challenging due to limited wall thickness and substantial cardiac motion. Moreover, echocardiography is widely used in the clinical assessment aortic diseases.
Purpose
We aimed to test a speckle-tracking tool for root longitudinal strain analysis in terms of comparison with CMR-derived AAo longitudinal strain and reproducibility and as predictor of dilation in MFS patients.
Methods
Thirty-five MFS patients diagnosed by original GHENT criteria, with maximum aortic root diameter of 45 mm and free from previous aortic dissection or cardiac/aortic surgery and non-severe aortic regurgitation were consecutive enrolled and followed-up. CMR and echocardiography were performed less than 2 months apart. Baseline and final aortic root diameter were measured on CMR images. To quantify aortic root cyclic elongation by echocardiography, two regions of interests were manually created covering both walls in a parasternal long-axis view and tracked along the cardiac cycle (Figure 1). Longitudinal strain was computed as the average of maximum increase in relative distance of several sub-regions covering both walls. CMR-derived AAo longitudinal strain was available in 29 patients. Intra-observer reproducibility was tested in 15 patients via intraclass correlation coefficient (ICC) for single-rater absolute agreement.
Results
Aortic root longitudinal strain by echocardiography was mildly related to CMR-derived AAo longitudinal strain (R = 0.27) and was larger compared to CMR-derived values (16.2 ± 6.0 vs 11.3 ± 4.3). Reproducibility was high, with ICC of 0.811, R = 0.802, p < 0.001. After a mean follow up of 76 ± 13 months, aortic root diameter grew in 20 patients with a rate of 0.29± 0.24 mm/year. Overall mean growth-rate was 0.87 ± 0.33 mm/year. In multivariable analysis corrected for age and baseline aortic root diameter, baseline longitudinal strain by echocardiography was independently and inversely related to progressive dilation (p = 0.033).
Conclusions
The measurement of aortic root longitudinal strain by speckle-tracking echocardiography is feasible. Aortic root longitudinal strain is an independent predictor of progressive dilation in MFS patients. This may permit the improvement of risk-stratification in aortic diseases in large scale studies.
Abstract Figure 1
Collapse
Affiliation(s)
- A Guala
- University Hospital Vall d"Hebron, Barcelona, Spain
| | - MI Pons
- University Hospital Vall d"Hebron, Barcelona, Spain
| | - A Ruiz-Munoz
- University Hospital Vall d"Hebron, Barcelona, Spain
| | - L Dux-Santoy
- University Hospital Vall d"Hebron, Barcelona, Spain
| | - L Madrenas
- University Hospital Vall d"Hebron, Barcelona, Spain
| | - F Valente
- University Hospital Vall d"Hebron, Barcelona, Spain
| | | | - L Galian
- University Hospital Vall d"Hebron, Barcelona, Spain
| | - L Gutierrez
- University Hospital Vall d"Hebron, Barcelona, Spain
| | - A Sao-Aviles
- University Hospital Vall d"Hebron, Barcelona, Spain
| | | | - I Ferreira
- University Hospital Vall d"Hebron, Barcelona, Spain
| | | | | | | |
Collapse
|
26
|
Guala A, Evangelista A, La Mura L, Teixido-Tura G, Dux-Santoy L, Ruiz-Munoz A, Cinque A, Valente F, Lopez-Sainz A, Galian-Gay L, Gutierrez L, Gonzalez-Alujas T, Sao-Aviles A, Ferreira I, Rodriguez-Palomares JF. Leaflets fusion length in bicuspid aortic valve is related to ascending and aortic root dilation and ascending aorta wall shear stress. Eur Heart J Cardiovasc Imaging 2021. [DOI: 10.1093/ehjci/jeaa356.285] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: Public Institution(s). Main funding source(s): Spanish Ministry of Science, Innovation and Universities, Instituto de Salud Carlos III
Background
Bicuspid aortic valve (BAV) is the most common congenital heart defect, consisting in the fusion of two aortic valve leaflets. Altered flow patterns have been related to aortic wall degeneration in BAV patients and may be responsible for the high prevalence of aortic disease in these patients. A number of studies on excised BAV or using advanced imaging modalities reported a wide variability of fusion extent between leaflet, but no previous study assessed whether leaflet fusion length may be used to stratify BAV patients.
Purpose
We aimed to test whether leaflet fusion extent can be quantified by cardiac magnetic resonance imaging (CMR) and whether it is related to aortic dilation and flow abnormalities in non-dysfunctional BAV.
Methods
One hundred and twenty BAV adults with no previous aortic or aortic valve surgery or significant valvular disease were consecutively enrolled. Patients with two sinuses of Valsalva (true BAV) or fusion of the left and non-coronary cusps, both being rare forms of BAV, were excluded. Twenty-eight healthy volunteers were also included for comparison. A 4D flow CMR sequence was acquired and circumferential wall shear stress and pulse wave velocity were assessed in the ascending aorta. A stack of double-oblique cine images of the aortic valve were used to quantify the length of the fusion between leaflets.
Results
The length of the fusion between leaflets was effectively measured in 112/120 patients (93%). Reproducibility was good (ICC = 0.826). Fusion length varied greatly (range 2.3 – 15.4 mm, 7.8 ± 3.2 mm, tertiles cut-off points were 6 and 9.3 mm). After correction for age, BSA, stroke volume and BAV fusion morphotype, fusion length was independently associated with diameter at the sinus of Valsalva (p = 0.002). Moreover, once corrected for age, stroke volume and ascending aorta pulse wave velocity, fusion length was positively related to ascending aorta diameter (p = 0.028). The comparison of maps of circumferential peak-systolic WSS in healthy volunteers (left) and BAV patients pertaining to the three leaflet fusion length tertiles is shown in Figure 1. Circumferential WSS progressively increase with larger fusion length. This trend was statistically significant (p < 0.05) in the right and outer regions of the proximal and mid ascending aorta.
Conclusions
Bicuspid aortic leaflet fusion length varies considerably and it is independently associated with ascending aorta and aortic root dilation, possibly through flow alterations.
Abstract Figure 1
Collapse
Affiliation(s)
- A Guala
- University Hospital Vall d"Hebron, Cardiology, Barcelona, Spain
| | - A Evangelista
- University Hospital Vall d"Hebron, Cardiology, Barcelona, Spain
| | - L La Mura
- University Hospital Vall d"Hebron, Cardiology, Barcelona, Spain
| | - G Teixido-Tura
- University Hospital Vall d"Hebron, Cardiology, Barcelona, Spain
| | - L Dux-Santoy
- University Hospital Vall d"Hebron, Cardiology, Barcelona, Spain
| | - A Ruiz-Munoz
- University Hospital Vall d"Hebron, Cardiology, Barcelona, Spain
| | - A Cinque
- University Hospital Vall d"Hebron, Cardiology, Barcelona, Spain
| | - F Valente
- University Hospital Vall d"Hebron, Cardiology, Barcelona, Spain
| | - A Lopez-Sainz
- University Hospital Vall d"Hebron, Cardiology, Barcelona, Spain
| | - L Galian-Gay
- University Hospital Vall d"Hebron, Cardiology, Barcelona, Spain
| | - L Gutierrez
- University Hospital Vall d"Hebron, Cardiology, Barcelona, Spain
| | | | - A Sao-Aviles
- University Hospital Vall d"Hebron, Cardiology, Barcelona, Spain
| | - I Ferreira
- University Hospital Vall d"Hebron, Cardiology, Barcelona, Spain
| | | |
Collapse
|
27
|
Guala A, Dux-Santoy L, Teixido-Tura G, Ruiz-Munoz A, Lopez-Sainz A, La Mora L, Galian L, Gutierrez L, Valente F, Gonzalez-Alujas T, Johnson K, Wieben O, Ferreira I, Evangelista A, Rodriguez-Palomares J. Regional curvature in thoracic aortic aneurysms of different aetiologies and its relationship with established risk factors. Eur Heart J Cardiovasc Imaging 2021. [DOI: 10.1093/ehjci/jeaa356.320] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: Public grant(s) – National budget only. Main funding source(s): Spanish Ministry of Science, Innovation and Universities ; Instituto de Salud Carlos III
Introduction
The aorta is a 3D hollow, curvilinear elastic structure whose diseases have life-threatening consequences. Despite much effort has been paid to study aortic diameter, diameter is a poor predictor of events. Conversely, much less is known about aortic curvature, its distribution in the thoracic aorta and the potential impact of risk factors in aneurysms associated with different conditions. Currently, 4D flow magnetic resonance imaging (4D flow CMR) allows to obtain 3D geometry, 4D flow data and regional aortic stiffness.
Purpose
We aim to study regional aortic curvature in thoracic aorta aneurysms of different aetiologies and define its relationship with established risk factors.
Methods
One-hundred twenty patients (40 for each group, selected out of prospective cohorts of 156 bicuspid aortic valve – BAV-, 77 Marfan –MFS- and 67 patients with a degenerative aneurysm – TAVdeg-) were matched for age, sex and BSA via propensity score with 40 healthy volunteers (HV). The thoracic aorta was semi-automatically segmented from angiograms and the centreline was computed. Local curvature was assessed at 20 planes covering the thoracic aorta from the sinotubular junction to the proximal descending aorta (DAo) at the level of the pulmonary artery bifurcation. Local curvature was normalized by subject mean thoracic aorta curvature. Length was measured as centreline length. Aortic stiffness was measured in the DAo by pulse wave velocity (PWV). Aneurysm was defined by z-score ≥ 2 using diameters measured by double-oblique cine CMR.
Results
Matching was successful in all groups with the exception of a residual age difference between HV and TAVdeg. Curvature in HV showed a fairly smooth transition between the straighter ascending aorta (AAo) and DAo to a more curved aortic arch, with a peak in the mid aortic arch (Figure 1A). Conversely, all patients’ groups presented a peak in curvature in the proximal DAo and a decreased local curvature in the aortic arch and mid DAo close to the level of the pulmonary artery. BAV and TAVdeg patients showed also increased curvature in the mid AAo, were dilation is prevalent. Conversely, in the same area MFS showed a reduced curvature and limited prevalence of aneurysm. In the overall population, age, AAo and root diameters, mean blood pressure, DAo PWV and aortic length, all established risk factors for aortic events, were inversely related to curvature in the distal AAo and aortic arch (Figure 1B).
Conclusions
Aneurysms related to different aetiologies show similar abnormalities in aortic curvature, with limited curvature in the aortic arch and a peak soon after the third supra-aortic vessel. Age, aortic diameter, length, stiffness and blood pressure, all known risk factors, are all related to reduced curvature in the distal ascending aorta and aortic arch.
Abstract Figure.
Collapse
Affiliation(s)
- A Guala
- University Hospital Vall d"Hebron, Barcelona, Spain
| | - L Dux-Santoy
- University Hospital Vall d"Hebron, Barcelona, Spain
| | | | - A Ruiz-Munoz
- University Hospital Vall d"Hebron, Barcelona, Spain
| | | | - L La Mora
- University Hospital Vall d"Hebron, Barcelona, Spain
| | - L Galian
- University Hospital Vall d"Hebron, Barcelona, Spain
| | - L Gutierrez
- University Hospital Vall d"Hebron, Barcelona, Spain
| | - F Valente
- University Hospital Vall d"Hebron, Barcelona, Spain
| | | | - K Johnson
- University of Wisconsin-Madison, Departments of Medical Physics & Radiology, Madison, United States of America
| | - O Wieben
- University of Wisconsin-Madison, Departments of Medical Physics & Radiology, Madison, United States of America
| | - I Ferreira
- University Hospital Vall d"Hebron, Barcelona, Spain
| | | | | |
Collapse
|
28
|
Mejia Cordova M, Guala A, Morales X, Jimenez-Perez G, Dux-Santoy L, Ruiz-Munoz A, Teixido-Tura G, Ferreira I, Evangelista A, Rodriguez-Palomares J, Camara O. Reinforcement machine learning-based aortic anatomical landmarks detection from phase-contrast enhanced magnetic resonance angiography. Eur Heart J Cardiovasc Imaging 2021. [DOI: 10.1093/ehjci/jeaa356.286] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: Public grant(s) – National budget only. Main funding source(s): Spanish Ministry of Science, Innovation and Universities; La Marató de TV3
Introduction
Automatic analysis of medical imaging data may improve their clinical impact by reducing analysis time and improving reproducibility. Many medical imaging data, like 4D-flow magnetic resonance imaging (MRI), are often quantified regionally, implying the need for anatomical landmark identification to locate correspondences in the extracted data and compare among patients. Machine learning (ML) techniques hold potential for automatic analysis of medical imaging. Phase-contrast enhanced magnetic resonance angiography (PC-MRA) is a class of angiograms not requiring the administration of contrast agents.
Purpose
We aimed to test whether a machine learning algorithm can be trained to identify key anatomical cardiovascular landmarks on PC-MRA images and compare its performance with humans.
Methods
Three-hundred twenty-three aortic PC-MRA were manually annotated with the location of 4 landmarks: sinotubular junction, pulmonary artery bifurcation and first and third supra-aortic vessels (Figure 1), often used to separate the aorta in sub-regions. Patients included in the training dataset comprised healthy volunteers (40), bicuspid aortic valve patients (141), patients with degenerative aortic disease (60) and patients with genetically-triggered aortic disease (82), all without previous aortic surgery and with native aortic valve. PC-MRA images and manual annotations were used to train a DQN, a reinforcement learning algorithm that combines Q-learning with deep neural networks. The agents can navigate the images and optimally find the landmarks by following the policies learned during training. Data from thirty patients, distributed in terms of aortic condition as the training set, unseen by the algorithm in the training phase, were used to quantify intra-observer reproducibility and to assess ML algorithm performance. Distance between points was used as metric for comparisons, original human annotation was used as ground-truth and repeated-measures ANOVA was used for statistical testing.
Results
Human and machine learning performed similarly in the identification of the sinotubular junction (distance between points of 11.0 ± 8.1 vs. 11.1 ± 8.6 mm, respectively, p = 0.949) and first (6.6 ± 3.9 vs. 6.8 ± 5.6 mm, p = 0.886) and third (6.8 ± 4.0 vs. 8.4 ± 7.4 mm, p = 0.161) supra-aortic vessels branches but human annotation outperformed ML landmark detection in the identification of the pulmonary artery bifurcation (10.2 ± 7.0 vs. 15.2 ± 13.1 mm, p = 0.008). Computation time for landmark detection by ML was between 0.8 and 1.6 seconds on a standard computer while human annotation took approximatively two minutes.
Conclusions
ML-based aortic landmarks detection from phase-contrast enhanced magnetic resonance angiography is feasible and fast and performs similarly to human. Reinforced learning anatomical landmark identification unlock automatic extraction of a variety of regional aortic data, including complex 4D flow parameters.
Abstract Figure
Collapse
Affiliation(s)
- M Mejia Cordova
- University Pompeu Fabra, Physense, BCN Medtech, Department of Information and Communications Technologies, Barcelona, Spain
| | - A Guala
- University Hospital Vall d"Hebron, Barcelona, Spain
| | - X Morales
- University Pompeu Fabra, Physense, BCN Medtech, Department of Information and Communications Technologies, Barcelona, Spain
| | - G Jimenez-Perez
- University Pompeu Fabra, Physense, BCN Medtech, Department of Information and Communications Technologies, Barcelona, Spain
| | - L Dux-Santoy
- University Hospital Vall d"Hebron, Barcelona, Spain
| | - A Ruiz-Munoz
- University Hospital Vall d"Hebron, Barcelona, Spain
| | | | - I Ferreira
- University Hospital Vall d"Hebron, Barcelona, Spain
| | | | | | - O Camara
- University Pompeu Fabra, Physense, BCN Medtech, Department of Information and Communications Technologies, Barcelona, Spain
| |
Collapse
|
29
|
Dux-Santoy L, Teixido-Tura G, Ruiz-Munoz A, La Mura L, Valente F, Lopez-Sainz A, Galian L, Gutierrez L, Gonzalez-Alujas T, Sao-Aviles A, Ferreira Gonzalez I, Evangelista A, Rodriguez-Palomares JF, Guala A. Semi-automatic quantification of aortic root progressive dilation by automatic co-registration of computed tomography angiograms: a preliminary comparison with manual assessment in Marfan patients. Eur Heart J Cardiovasc Imaging 2021. [DOI: 10.1093/ehjci/jeaa356.224] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: Public Institution(s). Main funding source(s): Spanish Ministry of Science, Innovation and Universities Instituto de Salud Carlos III
Background. Dilation of the aortic root is a key feature of Marfan syndrome and it is related to the occurrence of aortic events and death. On top of maximum diameter, rapid annual growth rate is suggested by guidelines for indication of aortic root replacement. Current gold-standard for aortic root diameter assessment is manual quantification on multiplanar reformatted 3D computed tomography (CT) or magnetic resonance angiogram. However, inter- and intra-observer reproducibility are limited and different measurement methods, i.e. cusp-to-cusp and cusp-to-commissure, may be used in different clinical centres, leading to difficulties in the clinical assessment of progressive dilation.
Purpose. We aimed to test whether aortic root growth rate during follow-up can be reliably quantified by semi-automatic co-registration of two CT angiograms.
Methods. Seven Marfan syndrome patients, free from previous aortic surgery, with a total of 11 pairs of CT were identified. Manual assessment of six aortic root diameters (right-non coronary -RN- , right-left -RL- and left-non coronary -LN- cusp-to-cusp and R, L and N cusp-to-commissure) was obtained from all CTs by an experienced researcher blind to semi-automatic results. The thoracic aorta and the outflow tract were semi-automatically segmented in the baseline CT and commissure and cusps were manually located. A 10 mm-thick region of interest containing the aortic wall was automatically generated from segmentation boundary. Co-registration was obtained with three, fully-automatic steps. Firstly, baseline and follow-up CT scans were aligned by means of a rigid registration. Then, scans were co-registered with multi-resolution affine followed by b-spline non-rigid registrations based on mutual information metric. The transformation pertaining to the location of baseline commissure and cusps points was used to locate the same points in the follow-up scan (Fig. 1 top).
Results. Follow-up duration was 35 ± 22 (range 12-70.3) months. Automatic quantification of diameter growth during the follow-up was obtained in 62 out of 66 (94%) diameter comparisons. High Pearson correlation coefficients (R) and ICC were found between manual and semi-automatic assessment of growth rate, both for cusp-to-cusp and cusp-to-commissure diameters: R = 0.727 and ICC = 0.678 for RN; R = 0.822 and ICC = 0.602 for RL; R = 0.648 and ICC = 0.668 for LN; R = 0.726 and ICC = 0.711 for R; R = 0.911 and ICC = 0.895 for L and R = 0.553 and ICC = 0.482 for N. Scatter and Bland-Altman plots for all growth rates (Fig. 1) confirmed very good correlation (R = 0.810) but a slight tendency (R=-0.270) for underestimation at high growth rate. No correlation was found between follow-up duration and difference between techniques (R = 0.06).
Conclusions. Semi-automatic quantification of aortic root growth rate by co-registration of pairs of CT angiograms is feasible for follow-up as short as one year. Larger studies are needed to confirm these preliminary data.
Abstract Figure. CT measurements. Automatic vs manual.
Collapse
Affiliation(s)
- L Dux-Santoy
- UNIVERSITY HOSPITAL VALL D" HEBRON, VHIR, UNIVERSTITAT AUTONOMA DE BARCELONA, Barcelona, Spain
| | - G Teixido-Tura
- UNIVERSITY HOSPITAL VALL D" HEBRON, VHIR, UNIVERSTITAT AUTONOMA DE BARCELONA, Barcelona, Spain
| | - A Ruiz-Munoz
- UNIVERSITY HOSPITAL VALL D" HEBRON, VHIR, UNIVERSTITAT AUTONOMA DE BARCELONA, Barcelona, Spain
| | - L La Mura
- Federico II University, Department of Advanced Biomedical Sciences, Napoli, Italy
| | - F Valente
- UNIVERSITY HOSPITAL VALL D" HEBRON, VHIR, UNIVERSTITAT AUTONOMA DE BARCELONA, Barcelona, Spain
| | - A Lopez-Sainz
- UNIVERSITY HOSPITAL VALL D" HEBRON, VHIR, UNIVERSTITAT AUTONOMA DE BARCELONA, Barcelona, Spain
| | - L Galian
- UNIVERSITY HOSPITAL VALL D" HEBRON, VHIR, UNIVERSTITAT AUTONOMA DE BARCELONA, Barcelona, Spain
| | - L Gutierrez
- UNIVERSITY HOSPITAL VALL D" HEBRON, VHIR, UNIVERSTITAT AUTONOMA DE BARCELONA, Barcelona, Spain
| | - T Gonzalez-Alujas
- UNIVERSITY HOSPITAL VALL D" HEBRON, VHIR, UNIVERSTITAT AUTONOMA DE BARCELONA, Barcelona, Spain
| | - A Sao-Aviles
- UNIVERSITY HOSPITAL VALL D" HEBRON, VHIR, UNIVERSTITAT AUTONOMA DE BARCELONA, Barcelona, Spain
| | - I Ferreira Gonzalez
- UNIVERSITY HOSPITAL VALL D" HEBRON, VHIR, UNIVERSTITAT AUTONOMA DE BARCELONA, Barcelona, Spain
| | - A Evangelista
- UNIVERSITY HOSPITAL VALL D" HEBRON, VHIR, UNIVERSTITAT AUTONOMA DE BARCELONA, Barcelona, Spain
| | - JF Rodriguez-Palomares
- UNIVERSITY HOSPITAL VALL D" HEBRON, VHIR, UNIVERSTITAT AUTONOMA DE BARCELONA, Barcelona, Spain
| | - A Guala
- UNIVERSITY HOSPITAL VALL D" HEBRON, VHIR, UNIVERSTITAT AUTONOMA DE BARCELONA, Barcelona, Spain
| |
Collapse
|
30
|
Garcia-Vives E, Rodriguez-Palomares JF, Harty L, Solans-Laque R, Jayne D. Heart Disease in Eosinophilic Granulomatosis with Polyangiitis (EGPA) Patients: a screening approach proposal. Rheumatology (Oxford) 2021; 60:4538-4547. [PMID: 33493294 DOI: 10.1093/rheumatology/keab027] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/07/2020] [Accepted: 12/11/2020] [Indexed: 11/13/2022] Open
Abstract
OBJECTIVE To define the pattern of cardiac involvement in eosinophilic granulomatosis and polyangiitis (EGPA) and propose an algorithm for heart disease screening. METHODS Retrospective study of EGPA patients attending a specialized vasculitis clinic (1989-2016). Clinical characteristics and cardiovascular evaluation (CE) results (serum troponin, ECG, echocardiography and cardiac magnetic resonance) were collected and compared according to symptoms and inflammatory cardiac disease (ICD). RESULTS 131 EGPA patients were included, of whom 96 (73%) had undergone CE. The median age was 50 [IQR 38-58] years and 36% showed ANCA+. Asthma preceded diagnosis by a median of 97 [36-240] months. Among the 96 patients who underwent CE, 43% were symptomatic, being dyspnea (47%) and chest pain (29%) the predominant symptoms. In asymptomatic patients, CE reported abnormalities in 45% of cases with a subsequent earlier diagnosis (4 vs 11 months). Overall, 27 patients had EGPA-related ICD (rICD) that was already present at diagnosis in 20 cases, preceded it in 2 cases and developed later in 5. EGPA-rICD patients were younger (46 vs 50 years; p= 0.04), had more frequently abnormal ECG (30.8% vs 2.1%; p< 0.001), negative ANCA (85% vs 69%; NS), higher BVAS score (3 vs 1; p= 0.005), higher eosinophil count (5.60 vs 1.60x109/l; p= 0.029) and higher C reactive protein (52 vs 15 mg/l; p= 0.017). Overall, 11% of cases with EGPA-rICD were asymptomatic. CONCLUSION In our study, 45% of asymptomatic patients had an abnormal baseline cardiac evaluation, which allowed an earlier diagnosis of cardiac disease. We recommend prompt cardiac screening in all EGPA patients, instead of a symptoms-guided algorithm.
Collapse
Affiliation(s)
- Eloi Garcia-Vives
- Autoimmune Systemic Diseases Unit, Internal Medicine Department, Hospital Universitari Vall d'Hebrón, Barcelona, Spain
| | - J F Rodriguez-Palomares
- Department of Cardiology, Hospital Universitari Vall d'Hebrón, CIBER-CV, Vall d'Hebrón Institut de recerca (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain
| | - Len Harty
- Rheumatology Department, Addenbrooke's Hospital, Cambridge, United Kingdom
| | - Roser Solans-Laque
- Autoimmune Systemic Diseases Unit, Internal Medicine Department, Hospital Universitari Vall d'Hebrón, Barcelona, Spain
| | - David Jayne
- Nephrology Department, Addenbrooke's Hospital, Cambridge, United Kingdom
| |
Collapse
|
31
|
Barrabes J, Aluja D, Castellote L, Rodriguez A, Otaegi I, Pineda V, Mila A, Baneras J, Lidon R, Sambola A, Rodriguez-Palomares J, Valente F, Beneitez D, Ferreira-Gonzalez I, Inserte J. Iron deficiency is associated with larger infarcts and with adverse remodeling in STEMI patients and reduces myocardial tolerance to ischemia/reperfusion by inhibiting the eNOS/sGC/PKG pathway in mice. Eur Heart J 2020. [DOI: 10.1093/ehjci/ehaa946.1578] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Iron deficiency (ID) interferes with the cardioprotective pathway endothelial nitric oxide synthase/soluble guanylate cyclase/protein kinase G (eNOS/sGC/PKG), but its role in acute myocardial infarction remains unclear.
Methods
Patients (n=125) with a first anterior STEMI treated with PCI underwent magnetic resonance imaging in the acute phase and at 6 months. We assessed whether ID (ferritin level <100 μg/L or <300 μg/L if transferrin saturation was <20%) was associated with infarct size acutely or with adverse left ventricular (LV) remodeling (LV end-diastolic volume increase at 6 months >20%, n=105). C57BL6/N mice were fed with standard diet or iron-deficient diet for 4 weeks before undergoing 45-min coronary occlusion/24-h reperfusion.
Results
Patients with ID (43.2%) had larger infarcts (22.8±10.2 vs 16.8±9.8% of LV mass, P=0.002) and more frequent microvascular obstruction (70.0 vs 43.3%, P=0.004) in the initial exam than the rest. They also developed adverse LV remodeling more often (38.6 vs 14.8%, P=0.005), even after adjusting by infarct size and final TIMI flow grade (OR 3.1, 95% CI 1.1–8.6, P=0.027). In mice, ID diet reduced myocardial iron content, serum ferritin and hemoglobin levels without reaching anemic values and without inducing echocardiographic alterations. ID diet reduced myocardial eNOS protein content, its dimeric form, and nitrites/nitrates and cGMP levels. eNOS decrease was associated with reduced HSP90 levels and increased eNOS ubiquitination in correlation with oxidative and nitrosative stress. Weekly iv administration of iron sucrose effectively reverted the ID-diet effects. Infarct size was larger in the ID group than in controls (58.8±3.0 vs. 40.3±3.6%, P=0.03) but was not increased in ID-diet animals treated with iron sucrose (36.3±4.0%) or receiving the sGC activator ataciguat before ischemia (31.0±2.5%).
Conclusions
ID is associated with larger infarcts and with more frequent adverse LV remodeling in patients with STEMI and reduces myocardial tolerance to ischemia/reperfusion in mice by attenuating eNOS/sGC/PKG pathway activity. Iron sucrose treatment and sGC activation reverted these deleterious effects of ID in mice. Iron supplementation might be beneficial in STEMI patients with ID.
Funding Acknowledgement
Type of funding source: Public grant(s) – National budget only. Main funding source(s): CIBER-CV. Instituto de Salud Carlos III (PI16/00232), co-financed by the ERDF
Collapse
Affiliation(s)
- J.A Barrabes
- Hospital Universitari Vall d'Hebron, Barcelona, Spain
| | - D Aluja
- Hospital Universitari Vall d'Hebron, Barcelona, Spain
| | - L Castellote
- Hospital Universitari Vall d'Hebron, Barcelona, Spain
| | - A Rodriguez
- Hospital Universitari Vall d'Hebron, Barcelona, Spain
| | - I Otaegi
- Hospital Universitari Vall d'Hebron, Barcelona, Spain
| | - V Pineda
- Hospital Universitari Vall d'Hebron, Barcelona, Spain
| | - A Mila
- Hospital Universitari Vall d'Hebron, Barcelona, Spain
| | - J Baneras
- Hospital Universitari Vall d'Hebron, Barcelona, Spain
| | - R.M Lidon
- Hospital Universitari Vall d'Hebron, Barcelona, Spain
| | - A Sambola
- Hospital Universitari Vall d'Hebron, Barcelona, Spain
| | | | - F Valente
- Hospital Universitari Vall d'Hebron, Barcelona, Spain
| | - D Beneitez
- Hospital Universitari Vall d'Hebron, Barcelona, Spain
| | | | - J Inserte
- Hospital Universitari Vall d'Hebron, Barcelona, Spain
| |
Collapse
|
32
|
Casas G, Oristrell G, Limeres J, Barriales R, Gimeno JR, Garcia Pavia P, Zorio E, Villacorta E, Jimenez Jaimez J, Bayes A, Garcia Pinilla JM, Palomino AJ, Evangelista A, Ferreira I, Rodriguez-Palomares JF. P1441 Predictors of systemic embolisms in a large cohort of left ventricular noncompaction patients. Eur Heart J Cardiovasc Imaging 2020. [DOI: 10.1093/ehjci/jez319.869] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
BACKGROUND
Left ventricular noncompaction (LVNC) is associated with an increased risk of systemic embolisms (SE). However, incidence and risk factors are not well established.
PURPOSE
To evaluate the rate of SE in LVNC and describe risk factors.
METHODS
LNVC patients were included in a multicentric registry. Those with SE were considered for the analysis.
RESULTS
514 patients with LVNC from 10 Spanish centres were recruited from 2000 to 2018. During a median follow-up of 4.2 years (IQR 1.9-7.1), 23 patients (4.5%) had a SE. Patients with SE (Table 1) were older at diagnosis, with no differences in gender and had similar cardiovascular risk factors. They were more frequently under oral anticoagulation (OAC). Besides, they had a more reduced LVEF, and more dilated LV and left atrium (LA). Late gadolinium enhancement (LGE) was more frequent, altogether suggesting a more severe phenotype.
Patients with SE had non-significantly higher rates of hospitalization for heart failure (33% Vs 24%, p = 0.31) and atrial fibrillation (35% Vs 19%, p = 0.10). In multivariate analysis, only LA diameter was an independent predictor of SE (OR 1.04, p = 0.04). A LA diameter > 45 mm had an independent 3 fold increased risk of SE (OR 3.04, p = 0.02) (Image 1).
CONCLUSIONS
LVNC carries a moderate mid-term risk of SE, which appears to be irrespective of atrial fibrillation and associated with age, LV dilatation and systolic dysfunction and mainly LA dilatation. This subgroup of patients should be considered for oral anticoagulation in primary prevention.
Table 1 Systemic embolisms (n = 23) No systemic embolisms (n = 491) p Men, n (%) 15 (65) 289 (56) 0.52 Median age at diagnosis (IQR) - yr 60 (48-76) 48 (30-64) 0.02 Median follow up (IQR) - yr 5.9 (3.1-7.8) 4.2 (1.8-7.1) 0.18 OAC, n (%) 19 (83) 118 (24) 0.01 LVEF (SD) - % 37 (15) 48 (17) 0.01 LVEDD (SD) - mm 58 (11) 54 (10) 0.04 LA diameter (SD) - mm 46 (9) 39 (9) 0.01 Characteristics of patients with and without systemic embolisms
Abstract P1441 Figure. Image 1
Collapse
Affiliation(s)
- G Casas
- University Hospital Vall d"Hebron, Cardiology, Barcelona, Spain
| | - G Oristrell
- University Hospital Vall d"Hebron, Cardiology, Barcelona, Spain
| | - J Limeres
- University Hospital Vall d"Hebron, Cardiology, Barcelona, Spain
| | - R Barriales
- University Hospital Complex A Coru??a, A Coruna, Spain
| | - J R Gimeno
- Hospital Universitario Virgen Arrixaca, Murcia, Spain
| | - P Garcia Pavia
- University Hospital Puerta de Hierro Majadahonda, Madrid, Spain
| | - E Zorio
- University Hospital La Fe, Valencia, Spain
| | - E Villacorta
- Hospital Clinico Universitario, Salamanca, Spain
| | | | - A Bayes
- Germans Trias i Pujol Hospital, Badalona, Spain
| | | | - A J Palomino
- University Hospital 12 de Octubre, Madrid, Spain
| | - A Evangelista
- University Hospital Vall d"Hebron, Cardiology, Barcelona, Spain
| | - I Ferreira
- University Hospital Vall d"Hebron, Cardiology, Barcelona, Spain
| | | |
Collapse
|
33
|
Ruiz Munoz A, Guala A, Rodriguez-Palomares JF, Lopez-Sainz A, Granato C, Valente F, Gutierrez L, Galian L, La Mura L, Gonzalez-Alujas T, Servato L, Sao-Aviles A, Ferreira I, Evangelista A, Teixido-Tura G. P372 Aortic stiffness in Loeys-Dietz syndrome: a comparison with Marfan syndrome patients and healthy volunteers. Eur Heart J Cardiovasc Imaging 2020. [DOI: 10.1093/ehjci/jez319.220] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Funding Acknowledgements
ISCIII PI14/0106 and PI17/00381, La Marató de TV3 (20151330), Eur FP7/People 267128 and CIBERCV
BACKGROUND
Genetic syndromic aortic diseases are rare, with Marfan syndrome (MFS) being the most common. However, less is known of Loeys-Dietz syndrome (LDS) which has much lower prevalence and presumed worse prognosis. Increased aortic stiffness in MFS has been previously described but no studies have evaluated aortic biomechanics in LDS. Pulse wave velocity (PWV) is the gold standard measure for arterial stiffness and can be quantified by 4D flow MRI. We aim to evaluate regional aortic PWV by 4D flow MRI in LDS compared to MFS and healthy volunteers.
METHODS
Sixteen LDS patients with a pathogenic mutation, 76 MFS and 49 healthy volunteers were prospectively and consecutively included. No patient had previous aortic dissection or surgery. All underwent a 4D flow MRI study in a 1.5 T clinical scanner. Ascending (AAo) and descending (DAo) aorta PWV were computed using wavelet analysis of the systolic upslope for transit time calculation (Figure). Statistical comparison was made with non-parametric analysis to account for the non-normality of data and multivariate analysis was evaluated separately for AAo and DAo PWV.
RESULTS
Ascending and descending aortic PWV revealed stiffer aortas in LDS patients than in healthy volunteers, even after adjustment for diameter of sinus of Valsalva (SoV) and sex. Conversely, no differences in aortic stiffness were found between LDS and MFS patients (Table).
CONCLUSIONS
Abnormally high regional aortic stiffness was observed in LDS patients when compared with controls. The severity of increased regional aortic stiffness was found similar to the one affecting MFS patients.
Table Controls (N = 49) LDS (N = 16) MFS (N = 76) LDS vs. HV LDS vs. MFN Parameter Unadjusted p-value Adjusted p-value Unadjusted p-value Adjusted p-value Age [years] 39 ± 12 39 ± 16 36 ± 12 0.903 0.599 Men 32 (65%) 6 (37%) 34 (45%) 0.079 0.782 Weight [kg] 72 ± 11 69 ± 13 74 ± 16 0.288 0.194 Height [cm] 172 ± 8 172 ±12 181 ± 11 0.834 0.008 Systolic BP [mmHg] 126 ± 18 125 ± 14 127 ± 17 0.957 0.523 Diastolic BP [mmHg] 70 ± 11 77 ± 6 75 ± 12 0.011 0.318 SoV diameter [mm] 30.6 ± 3.9 35.4 ± 4.6 38.1 ± 5.9 0.001 0.060 AAo diameter [mm] 27.7 ± 3.8 29,0 ± 5.0 29.7 ± 5.4 0.458 0.579 DAo diameter [mm] 20.0 ± 2.0 21.3 ± 3.6 22.9 ± 3.8 0.546 0.124 AAo PWV [m/s] 5.2 ± 1.9 7.6 ± 2.4 7.3 ± 2.8 0.001 0.050* 0.534 NS DAo PWV [m/s] 7.1 ± 2.2 9.4 ± 2.6 10.7 ± 4.6 0.003 0.025** 0.493 NS
Abstract P372 Figure
Collapse
Affiliation(s)
- A Ruiz Munoz
- University Hospital Vall d"Hebron, Cardiology, Barcelona, Spain
| | - A Guala
- University Hospital Vall d"Hebron, Cardiology, Barcelona, Spain
| | | | - A Lopez-Sainz
- University Hospital Vall d"Hebron, Cardiology, Barcelona, Spain
| | - C Granato
- University Hospital Vall d"Hebron, Cardiology, Barcelona, Spain
| | - F Valente
- University Hospital Vall d"Hebron, Cardiology, Barcelona, Spain
| | - L Gutierrez
- University Hospital Vall d"Hebron, Cardiology, Barcelona, Spain
| | - L Galian
- University Hospital Vall d"Hebron, Cardiology, Barcelona, Spain
| | - L La Mura
- University Hospital Vall d"Hebron, Cardiology, Barcelona, Spain
| | | | - L Servato
- University Hospital Vall d"Hebron, Cardiology, Barcelona, Spain
| | - A Sao-Aviles
- University Hospital Vall d"Hebron, Cardiology, Barcelona, Spain
| | - I Ferreira
- University Hospital Vall d"Hebron, Cardiology, Barcelona, Spain
| | - A Evangelista
- University Hospital Vall d"Hebron, Cardiology, Barcelona, Spain
| | - G Teixido-Tura
- University Hospital Vall d"Hebron, Cardiology, Barcelona, Spain
| |
Collapse
|
34
|
Ruiz Munoz A, Guala A, Teixido-Tura G, Dux-Santoy L, Sao-Aviles A, Lopez-Sainz A, Granato C, Servato L, Casas G, Gonzalez-Alujas T, La Mura L, Galian L, Ferreira I, Evangelista A, Rodriguez-Palomares JF. P1600 Aortic dilatation in patients with chronic descending aorta dissection is related to maximum false-lumen systolic flow deceleration rate as evaluated by 4D-flow MRI. Eur Heart J Cardiovasc Imaging 2020. [DOI: 10.1093/ehjci/jez319.1018] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Due to improved surgical strategies a growing number of patients survive acute aortic dissection. Patent false lumen (FL) is common in chronic dissection and it has been associated with poor prognosis, which is mainly driven by FL expansion. Several variables indirectly related to flow characteristics have been associated with progressive aortic dilation. We aimed to evaluate whether the maximum systolic flow deceleration rate (MSDR) in the FL, quantified by 4D-flow MR, is related to FL dilation in chronic type B aortic dissection.
Methods
Twenty-nine patients with a patent FL after aortic dissection and a prior follow-up of at least 3 years underwent contrast-enhanced 4D-flow MR. Marfan patients were excluded. Time-resolved FL flow acceleration was calculated in a 5 cm-long volume of the descending aorta around the level of the pulmonary bifurcation. MSDR was determined as the maximum minus the minimum acceleration in systole over the corresponding time interval (Figure 1a). Aortic growth rate (GR) was measured as the difference between final and initial maximum FL diameters obtained by angio-CT divided by follow-up duration. Population was divided into tertiles based on GR.
Results
Demographic and clinical variables were similar among GR tertiles (Table). MSDR was lower in patients with a GR <1mm/year (group 1) compared to both the other two patient groups (p = 0.009 and 0.003 for groups 2 and 3, respectively) (Figure 1c). MSDR showed a marked positive linear correlation with GR (R = 0.481, p = 0.008) (Figure 1b).
Conclusions
The MSDR in the FL of chronic type B aortic dissection is linearly related to FL growth rate and discriminated between tertiles of aortic dilation. Prospective longitudinal studies are need to unveil possible prognostic value of this parameter.
Table Group 1 (n = 9) Group 2 (n = 10) Group 3 (n = 10) p-value Age (years) 63.44 ±13.54 62.50 ± 13.60 64.56 ± 6.67 0.902 BSA (m2) 2.00 ± 0.18 1.77 ± 0.20 1.94 ± 0.12 0.213 Men 6 (86%) 4 (57%) 4 (100%) 0.210 Hypertension 4 (66%) 5 (71%) 4 (100%) 0.438 Atheroclerosis 1 (17%) 1 (14%) 0 (0%) 0.699 Initial Diameter (mm) 45.00 ± 7.69 36.00 ± 4.20 37.00 ± 6.48 0.078 Final Diameter (mm) 49.50 ± 6.74 44.86 ± 5.70 59.25 ± 9.84 0.049 Follow-up (year) 11.83 ± 8.79 7.82 ± 3.34 8.08 ± 4.05 0.921 GR (mm/year) 0.27 ± 0.29 1.18 ± 0.26 2.64 ± 0.97 <0.001 MSDR (cm/s3) 1212.18 ± 467.61 2410.54 ± 1034.30 2558.16 ± 1098.06 0.005
Abstract P1600 Figure 1
Collapse
Affiliation(s)
- A Ruiz Munoz
- University Hospital Vall d"Hebron, Cardiology, Barcelona, Spain
| | - A Guala
- University Hospital Vall d"Hebron, Cardiology, Barcelona, Spain
| | - G Teixido-Tura
- University Hospital Vall d"Hebron, Cardiology, Barcelona, Spain
| | - L Dux-Santoy
- University Hospital Vall d"Hebron, Cardiology, Barcelona, Spain
| | - A Sao-Aviles
- University Hospital Vall d"Hebron, Cardiology, Barcelona, Spain
| | - A Lopez-Sainz
- University Hospital Vall d"Hebron, Cardiology, Barcelona, Spain
| | - C Granato
- University Hospital Vall d"Hebron, Cardiology, Barcelona, Spain
| | - L Servato
- University Hospital Vall d"Hebron, Cardiology, Barcelona, Spain
| | - G Casas
- University Hospital Vall d"Hebron, Cardiology, Barcelona, Spain
| | | | - L La Mura
- University Hospital Vall d"Hebron, Cardiology, Barcelona, Spain
| | - L Galian
- University Hospital Vall d"Hebron, Cardiology, Barcelona, Spain
| | - I Ferreira
- University Hospital Vall d"Hebron, Cardiology, Barcelona, Spain
| | - A Evangelista
- University Hospital Vall d"Hebron, Cardiology, Barcelona, Spain
| | | |
Collapse
|
35
|
Casas G, Oristrell G, Limeres J, Barriales R, Gimeno JR, Garcia Pavia P, Zorio E, Villacorta E, Jimenez Jaimez J, Bayes A, Garcia Pinilla JM, Palomino AJ, Evangelista A, Ferreira I, Rodriguez-Palomares JF. P1442 Outcomes of patients with left ventricular noncompaction and preserved ejection fraction. Eur Heart J Cardiovasc Imaging 2020. [DOI: 10.1093/ehjci/jez319.870] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
BACKGROUND
Left ventricular noncompaction (LVNC) has a wide phenotypic expression. Prognosis of patients with preserved ejection fraction (pEF) remains uncertain.
PURPOSE
To describe the characteristics and natural history of this subgroup of patients.
METHODS
LVNC patients were included in a multicentric registry. Those with pEF (LVEF > 50%) were considered for the analysis.
RESULTS
491 LVNC pts from 10 Spanish centres were recruited from 2000 to 2018. 239 (49%) had baseline pEF. Compared to those with reduced EF (rEF), they were younger, with no differences in gender and had less comorbilities (Table 1). Mean LVEF was 62% (SD 8). 18 pts (9% of the available CMR) had fibrosis even though LV volumes and LVEF were normal.
Family screening was completed in 199 pts, being positive in 113 (57%). Genetic testing was performed in 146 index cases, being positive in 80 (55%): ACTC1 (40), MYH7 (17), TTN (8), HCN4 (6) and other individual variants.
During a median follow-up of 4.9 years (IQR 2.1-7.3), there was a significant decrease in LVEF: last LVEF was 30- 40% in 5 pts (2%) and 40-50% in 21 (9%) (p = 0.01 compared to baseline LVEF). 6 pts (2.5%) died during follow-up, only 1 of cardiovascular cause. 9 patients (4%) presented heart failure (HF) and 25 (10.5%) ventricular tachycardia or fibrillation (VT/VF). All cardiovascular outcomes were less frequent compared to rEF (Image 1, all p < 0.05). In multivariate analysis (including demographic, imaging, genetic and family aggregation parameters) the only predictor for HF was change in LVEF (OR 0.89, mean LVEF at the event 47%, p = 0.01 compared to no HF). Fibrosis was not associated with VT/VF.
CONCLUSIONS
Patients with LVNC and pEF have an overall excellent prognosis, which is markedly better than those with rEF. However, there is progressive decrease in LVEF, associated with heart failure, and moderate risk of life threatening arrhythmias. Therefore, periodic follow-up should be promoted.
Table 1 LVNC pEF (n = 239) LVNC rEF (n = 252) p Men, n (%) 131 (55) 146 (58) 0.65 Median age at diagnosis (IQR) - yr 38 (23-54) 58 (42-72) 0.01 Median follow up (IQR) - yr 4.9 (2.1-7.3) 3.9 (1.4-7.9) 0.04 QRS (SD) - ms 93 (18) 117 (32) 0.01 LGE, n (%) 18 (9) 52 (30) 0.01
Abstract P1442 Figure. Image 1
Collapse
Affiliation(s)
- G Casas
- University Hospital Vall d"Hebron, Cardiology, Barcelona, Spain
| | - G Oristrell
- University Hospital Vall d"Hebron, Cardiology, Barcelona, Spain
| | - J Limeres
- University Hospital Vall d"Hebron, Cardiology, Barcelona, Spain
| | - R Barriales
- University Hospital Complex A Coru??a, A Coruna, Spain
| | - J R Gimeno
- Hospital Universitario Virgen Arrixaca, Murcia, Spain
| | - P Garcia Pavia
- University Hospital Puerta de Hierro Majadahonda, Madrid, Spain
| | - E Zorio
- University Hospital La Fe, Valencia, Spain
| | - E Villacorta
- Hospital Clinico Universitario, Salamanca, Spain
| | | | - A Bayes
- Germans Trias i Pujol Hospital, Badalona, Spain
| | | | - A J Palomino
- University Hospital 12 de Octubre, Madrid, Spain
| | - A Evangelista
- University Hospital Vall d"Hebron, Cardiology, Barcelona, Spain
| | - I Ferreira
- University Hospital Vall d"Hebron, Cardiology, Barcelona, Spain
| | | |
Collapse
|
36
|
La Mura L, Teixido-Tura G, Guala A, Ruiz-Munoz A, Lopez Sainz A, Valente F, Pisaniello M, Strada S, Granato C, Galian Gay L, Gonzalez-Alujas T, Servato ML, Ferreira I, Rodriguez-Palomares JF, Evangelista A. P1601 Relationship between aortic distensibility and aortic regurgitation assessed by CMR in bicuspid valve patients. Eur Heart J Cardiovasc Imaging 2020. [DOI: 10.1093/ehjci/jez319.1019] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Funding Acknowledgements
Spanish Ministry of Economy and Competitiveness RTC-2016-5152-1, ISCIII PI17/00381, La Marató de TV3 (20151330), Eur FP7/People 267128 and CIBERCV
BACKGROUND
The severity of aortic regurgitation can be evaluated with cardiac magnetic resonance (CMR) through calculation of regurgitant fraction (RF) in phase contrast sequences acquired at the aortic root (as close as possible to the aortic valve). However, the impact of aortic distensibility in this evaluation remains unkown.
PURPOSE
The aim of the study was to evaluate the relation between aortic distensibility and RF valve in bicuspid aortic valve patients.
METHODS
We enrolled bicuspid aortic valve patients without significant aortic stenosis (maximum velocity <2.5 m/s) and connective tissue disease. All patients underwent a CMR study with phase contrast sequences for evaluation of regurgitant fraction at the level of the aortic valve. Aortic regurgitation was considered as mild, moderate or severe depending on RF value (mild <15%; moderate 15-30%; severe >30%). Furthermore we used cine-sequences of aortic root, ascending and proximal descending aorta to estimate aortic diameters and distensibilities, using Art Fun software. Distensibility was calculated as (change in aortic area between systole and diastole/diastolic area)/brachial pulse pressure.
RESULTS
A total of 98 bicuspid aortic valve patients were included (30% female, 49.7 ± 14.5 years). 75 (76,5%) AR was mild, 17 (17,4%) moderate and 6 (6,1%) severe. RF valvewas significantly correlated with aortic root diameter (r= 0.430 y p < 0.001 )and aortic distensibility at the level of the ascending (r = 0.273 p =0.016) and descending aorta (r = 0.502 and p< 0.001). Aortic distensibility was positively correlated with RFvalve even after adjustment for aortic diameter ( p = 0.002 and p <0.001 respectively) . (Table) (IMG)
CONCLUSIONS
In our study, aortic regurgitation in bicuspid valve patients, evaluated by CMR using RF valve, is related to aortic distensibility. Thus, aortic distensibility should be included in the evaluation of aortic regurgitation by CMR as additional parameter. However, longitudinal studies are needed to evaluate the impact of including aortic distensibility in the evaluation of AR severity by CMR.
AR SEVERITY MILD MODERATE SEVERE Descending aorta distensibility(mean ± std. deviation) 2693,68 ± 997,5 3285,8 ±1952,7 5042,99 ±2873,44 Correlation between AR severity (by RFvalve) and descending aorta distensibility
Abstract P1601 Figure.
Collapse
Affiliation(s)
- L La Mura
- University Hospital Vall d"Hebron, Barcelona, Spain
| | | | - A Guala
- University Hospital Vall d"Hebron, Barcelona, Spain
| | - A Ruiz-Munoz
- University Hospital Vall d"Hebron, Barcelona, Spain
| | | | - F Valente
- University Hospital Vall d"Hebron, Barcelona, Spain
| | - M Pisaniello
- University Hospital Vall d"Hebron, Barcelona, Spain
| | - S Strada
- University Hospital Vall d"Hebron, Barcelona, Spain
| | - C Granato
- University Hospital Vall d"Hebron, Barcelona, Spain
| | - L Galian Gay
- University Hospital Vall d"Hebron, Barcelona, Spain
| | | | - M L Servato
- University Hospital Vall d"Hebron, Barcelona, Spain
| | - I Ferreira
- University Hospital Vall d"Hebron, Barcelona, Spain
| | | | | |
Collapse
|
37
|
Guala A, Teixido-Tura G, Ruiz-Munoz A, Gandara M, Madrenas L, Izagirre N, Lopez Sainz A, Valente F, Galian L, Gonzalez-Alujas T, Servato L, Sao Aviles A, Evangelista A, Ferreira I, Rodriguez-Palomares J. P1447 Ascending aorta longitudinal strain in bicuspid aortic valve patients: a comparison with healthy volunteers and patients with degenerative aortic aneurysm. Eur Heart J Cardiovasc Imaging 2020. [DOI: 10.1093/ehjci/jez319.875] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Funding Acknowledgements
Spanish Ministry of Economy and Competitiveness RTC-2016-5152-1, ISCIII PI17/00381, La Marató de TV3 (20151330), Eur FP7/People 267128 and CIBERCV
Background
Histological findings of fibrillin-1 deficiency in bicuspid aortic valve (BAV) ascending aorta (AAo), as observed in Marfan (MFS), supported the existence of intrinsic aortic wall abnormalities, but recent studies reported the absence of an intrinsic impairment in stiffness. A recent study in MFS showed that AAo longitudinal strain was reduced in MFS and predicted dilation and aortic events. This parameter has not been studied in BAV.
Purpose
We investigated whether ascending aorta longitudinal strain is intrinsically altered in BAV with respect to tricuspid aortic valve (TAV) individuals.
Methods
80 BAV, 31 healthy volunteers (HV) and 29 TAV with AAo aneurysm, all without moderate valvular disease, were consecutively included. AAo dilation was defined as a z-score > 2. The 1.5T CMR protocol included a set of 2D cine CMR stacks covering the proximal aorta in saggital, coronal and axial views. AAo longitudinal strain was computed by an in-house Matlab code performing a feature tracking of the aortic valve in each of the cine images.
Results
Twenty (25%) of BAV had AAo dilation. AAo longitudinal strain was lower in non-dilated BAV compared to HV, but the difference was not significant in multivariate analysis adjusted for AAo diameter and systolic blood pressure. Similarly, the difference between dilated BAV and dilated TAV found in univariate analysis was not confirmed by multivariate analysis. On the other hand, both dilated BAV and TAV showed decreased AAo longitudinal strain compared to HV, which were confirmed in multivariate analyses.
Conclusions
AAo longitudinal strain, a marker of aortic stiffness with predictive value in MFS, is not altered in BAV patients compared to TAV matched for dilation prevalence. Reduced AAo longitudinal strain was independently associated with dilation in both BAV and TAV.
Table 1 HV vs. NON-DILATED BAV DILATED BAV vs DILATED TAV HV vs. DILATED BAV HV vs. DILATED TAV HV NON-DILATED BAV Univariate /multivariate p-value DILATED TAV DILATED BAV Univariate /multivariate p-value Univariate/ Multivariate p-value Univariate p-value N 31 20 29 60 Age [years 35 ± 8 49 ± 16 <0.001/ NS 66 ± 13 49 ± 14 <0.001 / <0.001 <0.001 / 0.052 <0.001 / NS Sex [% male] 42 35 0.629 24 42 0.097 / NS 0.969 0.149 BSA [m2] 1.83 ± 0.17 1.81 ± 0.14 0.702 1.95 ± 0.24 1.82 ± 0.22 0.015 / <0.001 0.881 0.030 / NS SBP [mmHg] 119 ± 11 132 ± 16 0.002 / 0.029 133 ± 17 138 ± 19 0.304 <0.001 / NS <0.001 / NS DBP [mmHg] 69 ± 11 73 ± 6 0.099 / NS 77 ± 9 79 ± 11 0.455 <0.001 / 0.016 0.004 / 0.023 Ascending aorta diameter [mm] 26 ± 4 33 ± 3 <0.001 / 0.006 46 ± 7 43 ± 6 0.032 / NS <0.001 / 0.001 <0.001 /0.007 AAo long strain [%] 10.5 ± 3.6 8.4 ± 4.1 0.067/ NS 5.9 ± 2.7 7.7 ± 3.6 0.023 / NS 0.001 / 0.002 <0.001 / 0.023 Demographics and uni- and multivariate analyses of AAo longitudinal strain
Collapse
Affiliation(s)
- A Guala
- University Hospital Vall d"Hebron, Barcelona, Spain
| | | | - A Ruiz-Munoz
- University Hospital Vall d"Hebron, Barcelona, Spain
| | - M Gandara
- University Hospital Vall d"Hebron, Barcelona, Spain
| | - L Madrenas
- University Hospital Vall d"Hebron, Barcelona, Spain
| | - N Izagirre
- University Hospital Vall d"Hebron, Barcelona, Spain
| | | | - F Valente
- University Hospital Vall d"Hebron, Barcelona, Spain
| | - L Galian
- University Hospital Vall d"Hebron, Barcelona, Spain
| | | | - L Servato
- University Hospital Vall d"Hebron, Barcelona, Spain
| | - A Sao Aviles
- University Hospital Vall d"Hebron, Barcelona, Spain
| | | | - I Ferreira
- University Hospital Vall d"Hebron, Barcelona, Spain
| | | |
Collapse
|
38
|
Guala A, Teixido-Tura G, Dux-Santoy L, Granato C, Ruiz-Muñoz A, Valente F, Galian-Gay L, Gutiérrez L, González-Alujas T, Johnson KM, Wieben O, Sao Avilés A, Evangelista A, Rodriguez-Palomares J. Decreased rotational flow and circumferential wall shear stress as early markers of descending aorta dilation in Marfan syndrome: a 4D flow CMR study. J Cardiovasc Magn Reson 2019; 21:63. [PMID: 31607265 PMCID: PMC6791020 DOI: 10.1186/s12968-019-0572-1] [Citation(s) in RCA: 28] [Impact Index Per Article: 5.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/04/2019] [Accepted: 08/28/2019] [Indexed: 12/13/2022] Open
Abstract
BACKGROUND Diseases of the descending aorta have emerged as a clinical issue in Marfan syndrome following improvements in proximal aorta surgical treatment and the consequent increase in life expectancy. Although a role for hemodynamic alterations in the etiology of descending aorta disease in Marfan patients has been suggested, whether flow characteristics may be useful as early markers remains to be determined. METHODS Seventy-five Marfan patients and 48 healthy subjects were prospectively enrolled. In- and through-plane vortexes were computed by 4D flow cardiovascular magnetic resonance (CMR) in the thoracic aorta through the quantification of in-plane rotational flow and systolic flow reversal ratio, respectively. Regional pulse wave velocity and axial and circumferential wall shear stress maps were also computed. RESULTS In-plane rotational flow and circumferential wall shear stress were reduced in Marfan patients in the distal ascending aorta and in proximal descending aorta, even in the 20 patients free of aortic dilation. Multivariate analysis showed reduced in-plane rotational flow to be independently related to descending aorta pulse wave velocity. Conversely, systolic flow reversal ratio and axial wall shear stress were altered in unselected Marfan patients but not in the subgroup without dilation. In multivariate regression analysis proximal descending aorta axial (p = 0.014) and circumferential (p = 0.034) wall shear stress were independently related to local diameter. CONCLUSIONS Reduced rotational flow is present in the aorta of Marfan patients even in the absence of dilation, is related to aortic stiffness and drives abnormal circumferential wall shear stress. Axial and circumferential wall shear stress are independently related to proximal descending aorta dilation beyond clinical factors. In-plane rotational flow and circumferential wall shear stress may be considered as an early marker of descending aorta dilation in Marfan patients.
Collapse
Affiliation(s)
- A. Guala
- Hospital Universitari Vall d’Hebron, Department of Cardiology. CIBER-CV. Vall d’Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Paseo Vall d’Hebron 119-129, 08035 Barcelona, Spain
| | - G. Teixido-Tura
- Hospital Universitari Vall d’Hebron, Department of Cardiology. CIBER-CV. Vall d’Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Paseo Vall d’Hebron 119-129, 08035 Barcelona, Spain
| | - L. Dux-Santoy
- Hospital Universitari Vall d’Hebron, Department of Cardiology. CIBER-CV. Vall d’Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Paseo Vall d’Hebron 119-129, 08035 Barcelona, Spain
| | - C. Granato
- Hospital Universitari Vall d’Hebron, Department of Cardiology. CIBER-CV. Vall d’Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Paseo Vall d’Hebron 119-129, 08035 Barcelona, Spain
| | - A. Ruiz-Muñoz
- Hospital Universitari Vall d’Hebron, Department of Cardiology. CIBER-CV. Vall d’Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Paseo Vall d’Hebron 119-129, 08035 Barcelona, Spain
| | - F. Valente
- Hospital Universitari Vall d’Hebron, Department of Cardiology. CIBER-CV. Vall d’Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Paseo Vall d’Hebron 119-129, 08035 Barcelona, Spain
| | - L. Galian-Gay
- Hospital Universitari Vall d’Hebron, Department of Cardiology. CIBER-CV. Vall d’Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Paseo Vall d’Hebron 119-129, 08035 Barcelona, Spain
| | - L. Gutiérrez
- Hospital Universitari Vall d’Hebron, Department of Cardiology. CIBER-CV. Vall d’Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Paseo Vall d’Hebron 119-129, 08035 Barcelona, Spain
| | - T. González-Alujas
- Hospital Universitari Vall d’Hebron, Department of Cardiology. CIBER-CV. Vall d’Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Paseo Vall d’Hebron 119-129, 08035 Barcelona, Spain
| | - K. M. Johnson
- Departments of Medical Physics & Radiology, University of Wisconsin – Madison, Madison, WI USA
| | - O. Wieben
- Departments of Medical Physics & Radiology, University of Wisconsin – Madison, Madison, WI USA
| | - A. Sao Avilés
- Hospital Universitari Vall d’Hebron, Department of Cardiology. CIBER-CV. Vall d’Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Paseo Vall d’Hebron 119-129, 08035 Barcelona, Spain
| | - A. Evangelista
- Hospital Universitari Vall d’Hebron, Department of Cardiology. CIBER-CV. Vall d’Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Paseo Vall d’Hebron 119-129, 08035 Barcelona, Spain
| | - J. Rodriguez-Palomares
- Hospital Universitari Vall d’Hebron, Department of Cardiology. CIBER-CV. Vall d’Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Paseo Vall d’Hebron 119-129, 08035 Barcelona, Spain
| |
Collapse
|
39
|
Guala A, Izagirre N, Ruiz Munoz A, Dux-Santoy L, Madrenas L, Gandara M, Granato C, Valente F, Gutierrez L, Galian L, Servato L, La Mura L, Evangelista A, Rodriguez-Palomares JF, Teixido Tura G. P4131Abnormal flow pattern in the main pulmonary artery of Marfan patients is related to local dilation. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz745.0703] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Introduction
Marfan syndrome (MFS) is a hereditary connective tissue disorder caused by mutation in the FBN1 gene. Main pulmonary artery (MPA) dilation is very prevalent in MFS patients. Indeed, the old Ghent nosology considered main pulmonary artery (MPA) dilation as diagnostic criterion of MFS patients. Although clinical complications related to pulmonary dilation in MFS are rare, this may potentially lead to MPA dissection or be a marker of vascular disease in MFS. Studies regarding potential causes of MPA dilation in MFS patients are very scarce.
Purpose
Through 4D flow CMR, we aimed to assess whether flow abnormalities exist in the MPA of MFS patients and their relation to local diameter.
Methods
Fifty-five consecutive Marfan syndrome adults (MFS) and 22 healthy volunteers (HV) were prospectively enrolled. All subjects underwent non-contrast-enhanced 4D flow-MRI, obtaining 4D flow field and a 3D angiography. The MPA was segmented from the 3D angiography, and the segmentation was used to mask 4D velocity data. Four, equidistant analysis planes were placed in the MPA between the pulmonary valve and the pulmonary artery bifurcation. Common descriptors of large arteries hemodynamics were computed at each plane: maximum velocity, systolic flow reversal ratio (a descriptor of the amount of systolic backward flow) and circumferentially-averaged axial and circumferential wall shear stress (WSS). Pulmonary artery diameters were measured on axial images. MPA dilation was defined as a diameter larger than 27 mm in women and 29 mm in men. Systolic (SBP) and diastolic (DBP) systemic blood pressure were measured at the brachial artery with a calibrated cuff immediately after the scan.
Results
Compared with HV, MFS patients presented similar age, BSA, SBP and maximum blood velocity, but had larger MPA diameter (27.8 vs 25.1 mm, p<0.001) and higher DBP (75.5 vs 66.8 mmHg, p=0.003). According to the used threshold, 45% (27) of MFS patients had MPA dilation. Compared with HV, Marfan patients presented an increased systolic flow reversal ratio in the proximal part of the MPA (Figure 1). In MFS patients axial WSS was reduced in central sections of the MPA, while the circumferential component was not difference with respect to HV. All these flow abnormalities were also present in the subset of 28 MFS patients without pulmonary artery dilation. In multivariable analysis, MPA diameter was independently related to age (B=0.056; p=0.032), sex (B=−2.3; p=0.02) and axial (B=6.4; p=0.039) and circumferential (B=33.9; p<0.001) WSS.
Figure 1
Conclusions
Dilation of the main pulmonary artery is prevalent in Marfan syndrome patients. Abnormal increase in systolic vortexes and reduction in axial WSS were present in dilated and non-dilated MPA in MFS patients. Axial and circumferential WSS were independently related to MPA diameter. The eventual predictive role of abnormal pulmonary flow pattern in pulmonary artery dilation in MFS patients remain to be established
Acknowledgement/Funding
Instituto de Salud Carlos III (PI14/0106), La Maratό de TV3 (20151330), CIBERCV and FP7/People (267128)
Collapse
Affiliation(s)
- A Guala
- University Hospital Vall d'Hebron, Barcelona, Spain
| | - N Izagirre
- University Hospital Vall d'Hebron, Barcelona, Spain
| | - A Ruiz Munoz
- University Hospital Vall d'Hebron, Barcelona, Spain
| | - L Dux-Santoy
- University Hospital Vall d'Hebron, Barcelona, Spain
| | - L Madrenas
- University Hospital Vall d'Hebron, Barcelona, Spain
| | - M Gandara
- University Hospital Vall d'Hebron, Barcelona, Spain
| | - C Granato
- University Hospital Vall d'Hebron, Barcelona, Spain
| | - F Valente
- University Hospital Vall d'Hebron, Barcelona, Spain
| | - L Gutierrez
- University Hospital Vall d'Hebron, Barcelona, Spain
| | - L Galian
- University Hospital Vall d'Hebron, Barcelona, Spain
| | - L Servato
- University Hospital Vall d'Hebron, Barcelona, Spain
| | - L La Mura
- University Hospital Vall d'Hebron, Barcelona, Spain
| | | | | | | |
Collapse
|
40
|
Ruiz Munoz A, Guala A, Dux-Santoy L, Teixido-Tura G, Sao-Aviles A, Granato C, Lopez-Sainz A, Servato ML, La Mura L, Galian L, Casas G, Gonzalez-Alujas T, Ferreira I, Evangelista A, Rodriguez-Palomares JF. P1827Maximum systolic flow deceleration rate in the false lumen by 4D-flow MRI is associated with aortic dilatation in patients with chronic descending aorta dissection. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz748.0579] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Introduction
Patent false lumen (FL) in aortic dissection has been associated with poor prognosis mainly due to aortic expansion. Although morphologic variables have been related to aortic dilatation as expression of high pressure in the FL, they do not reflect flow characteristics. We propose the maximum systolic flow deceleration rate (MSDR) in the FL, quantified by 4Dflow, assuming that flow should be strongly decelerated during systole under high pressure.
Methods
Twenty-nine patients with a patent FL after aortic dissection (no Marfan syndrome) and with a follow-up of at least 3 years underwent a contrast-enhanced 4D-flow MR. FL acceleration was calculated during the cardiac cycle in a sub-volume of the descending aorta (5 cm around the level of the pulmonary bifurcation). MSDR was determined as the maximum minus the minimum acceleration in systole over the corresponding time interval (Figure 1a). Aortic growth rate (GR) was defined as the difference between final and initial aortic diameters obtained by angio-CT over the period of follow-up. Population was divided into tertiles based on GR.
Results
Demographic, clinical variables or basal aortic diameter did not show differences among GR groups (Table 1). MSDR was statistically different in patients with a GR <1mm/year (group 1) compared to fast-dilating patients (groups 2, 3) (Figure 1c). MSDR showed a positive linear correlation with GR resulting in a Pearson's correlation of 0.481 (p=0.008) (Figure 1b).
Table 1. Demographic and other variables Tertile 1 Tertile 2 Tertile 3 p-value Age (year) 63.4 (±13.5) 62.5 (±13.6) 64.6 (±6.7) 0.902 BSA (m2) 2.0 (±0.2) 1.8 (±0.2) 1.9 (±0.1) 0.213 Men 6 (86%) 4 (57%) 4 (100%) 0.210 Hypertension 4 (66%) 5 (71%) 4 (100%) 0.438 Atherosclerosis 1 (17%) 1 (14%) 0 (0%) 0.699 Initial diameter 45.0 (±7.69) 36.0 (±4.2) 37.0 (±6.5) 0.078 Final diameter 49.5 (±6.74) 44.9 (±5.7) 59.2 (±9.8) 0.049* Follow-up (year) 11.8 (±8.79) 7.9 (±3.3) 8.1 (±4.0) 0.921 Aortic GR (mm/year) 0.3 (±0.3) 1.2 (±0.3) 2.6 (±1.0) 0.001* MSDR (cm/s3) 1212 (±468) 2411 (±1034) 2558 (±1098) 0.005* Values are mean (±SD) or n (%).
Conclusion
MSDR of flow in the FL derived from 4D-flow RM is related to GR of dissected descending aorta. It is useful to discriminate mild vs. significant aorta enlargement and identify patients who may benefit from earlier therapy.
Collapse
Affiliation(s)
- A Ruiz Munoz
- University Hospital Vall d'Hebron, Cardiology, Barcelona, Spain
| | - A Guala
- University Hospital Vall d'Hebron, Cardiology, Barcelona, Spain
| | - L Dux-Santoy
- University Hospital Vall d'Hebron, Cardiology, Barcelona, Spain
| | - G Teixido-Tura
- University Hospital Vall d'Hebron, Cardiology, Barcelona, Spain
| | - A Sao-Aviles
- University Hospital Vall d'Hebron, Cardiology, Barcelona, Spain
| | - C Granato
- University Hospital Vall d'Hebron, Cardiology, Barcelona, Spain
| | - A Lopez-Sainz
- University Hospital Vall d'Hebron, Cardiology, Barcelona, Spain
| | - M L Servato
- University Hospital Vall d'Hebron, Cardiology, Barcelona, Spain
| | - L La Mura
- University Hospital Vall d'Hebron, Cardiology, Barcelona, Spain
| | - L Galian
- University Hospital Vall d'Hebron, Cardiology, Barcelona, Spain
| | - G Casas
- University Hospital Vall d'Hebron, Cardiology, Barcelona, Spain
| | | | - I Ferreira
- University Hospital Vall d'Hebron, Cardiology, Barcelona, Spain
| | - A Evangelista
- University Hospital Vall d'Hebron, Cardiology, Barcelona, Spain
| | | |
Collapse
|
41
|
Guala A, Teixido Tura G, Rodriguez-Palomares JF, Ruiz Munoz A, Granato C, Galian L, Valente F, Servato L, Villalva N, Gutierrez L, Lopez Sainz A, Gonzalez-Alujas T, Sanchez V, Forteza A, Evangelista A. P1821Proximal aorta longitudinal but not circumferential strain predicts aortic events and aortic root dilation rate in marfan syndrome patients. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz748.0573] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Background
The most common cardiovascular complications in Marfan syndrome (MFS) are aortic root dilation and type A aortic dissections. Elective aortic root surgery is indicated when maximum aortic diameter is larger than a defined threshold or in the case of fast-progressing dilation. However, maximum aortic diameter is limited for the prediction of aortic events. Indeed, a large international registry of acute aortic syndromes reported that as much as 40% of aortic dissections happen with maximum aortic diameter lower than 50 mm. Consequently, there is a need for new, non-invasive biomarkers to improve the prediction of aortic complications.
Purpose
The aim of the present study was to assess if proximal aorta circumferential and longitudinal strain and ascending aorta distensibility were associated with progressive aortic dilation and incidence of aortic events in Marfan syndrome patients.
Methods
Eighty seven Marfan syndrome patients free from previous cardiac/aortic surgery or dissection, were prospectively included in a multicenter follow-up. Patients were diagnosed by original Ghent criteria. Proximal aorta longitudinal and circumferential strain and distensibility were computed from baseline cine CMR images by means of feature-tracking. The predictive capacity of each stiffness biomarkers was separately tested with multivariable linear regression analysis (aortic growth) and with Cox logistic regression analysis (aortic events), both corrected for clinical and demographic variables, including baseline maximum aortic diameter.
Results
During a follow-up of 81.6±17 months, mean diameter growth-rate was 0.65±0.67 mm/year and z-score growth rate was 0.07±0.13 / year. Elective aortic root replacement was performed in 11 patients while two patients presented type A aortic dissection.Baseline proximal aorta longitudinal strain was independently related to diameter growth-rate (p=0.001), z-score growth-rate (p=0.018) and aortic events (p=0.018). Conversely, neither circumferential strain nor distensibility were independent predictors of diameter growth-rate (p=0.385 and p=0.381, respectively), z-score growth-rate (p=0.515 and p=0.484, respectively) and aortic events (p=0.064 and p=0.205, respectively).
Conclusions
Proximal aorta longitudinal strain predicts aortic root dilation and major aortic events in Marfan syndrome patients beyond aortic root diameter and clinical and demographic characteristics.
Acknowledgement/Funding
ISCIII PI14/0106, La Maratό de TV3 (20151330) and CIBERCV. Guala A. FP7/People n° 267128
Collapse
Affiliation(s)
- A Guala
- University Hospital Vall d'Hebron, Barcelona, Spain
| | | | | | - A Ruiz Munoz
- University Hospital Vall d'Hebron, Barcelona, Spain
| | - C Granato
- University Hospital Vall d'Hebron, Barcelona, Spain
| | - L Galian
- University Hospital Vall d'Hebron, Barcelona, Spain
| | - F Valente
- University Hospital Vall d'Hebron, Barcelona, Spain
| | - L Servato
- University Hospital Vall d'Hebron, Barcelona, Spain
| | - N Villalva
- University Hospital Vall d'Hebron, Barcelona, Spain
| | - L Gutierrez
- University Hospital Vall d'Hebron, Barcelona, Spain
| | | | | | - V Sanchez
- University Hospital 12 de Octubre, Madrid, Spain
| | - A Forteza
- University Hospital Puerta de Hierro Majadahonda, Madrid, Spain
| | | |
Collapse
|
42
|
Marcos Garces V, Gonzalez J, Gavara J, Rios-Navarro C, Bonanad C, Chorro FJ, Ortiz JT, Rodriguez J, Mendieta G, Rodriguez-Palomares JF, Valente F, Garcia-Dorado D, Lopez-Lereu MP, Monmeneu JV, Bodi V. P1475Risk stratification after STEMI. Ejection fraction by echocardiography as the gatekeeper for a selective use of cardiac magnetic resonance. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz748.0240] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Introduction
Cardiac magnetic resonance (CMR) has emerged as the most potent non-invasive imaging technique for risk stratification after ST-segment elevation myocardial infarction (STEMI) but an indiscriminate use in all patients is unfeasible. Echocardiography (Echo) has been universally used for prognostication in this scenario. We hypothesized that left ventricular ejection fraction (LVEF) by Echo can represent the gatekeeper for selecting those patients who benefit most from CMR for prognostic purposes.
Methods
Data were obtained from a large prospective registry of reperfused STEMI patients (n=516) in whom Echo (2D and Doppler variables) and CMR (cine images, microvascular obstruction and infarct size) were simultaneously recorded at pre-discharge (7±2 days). Major adverse cardiac events (MACE) were defined as a combined clinical end-point: death or re-admission for acute heart failure (whichever occurred first). Patients were categorized in reduced LVEF (r-LVEF, <40%), mid-range LVEF (mr-LVEF, 40–49%) and preserved LVEF (p-LVEF, ≥50%). Hierarchical multivariate Cox regression analyses including first clinical+Echo variables and then CMR variables where carried out. C-statistics, “net reclassification” (NRI) and “integrated discrimination” (IDI) indexes were obtained.
Results
During a mean and median follow-up of 4 years, 86 first MACE (17%) were registered (39 deaths and 47 re-admissions for acute heart failure). In the whole study group (n=516), the independent predictors of MACE were time to revascularization (min), GRACE score, CMR-LVEF (%) and CMR-microvascular obstruction (% of LV mass); C-statistic 0.82 (p<0.001). The MACE rate in patients with r-LVEF, mr-LVEF and p-LVEF was 47%, 23% and 11% by Echo-LVEF and 45%, 17% and 8% by CMR-LVEF. LVEF was lower by CMR than by Echo (51±13 vs. 54±10, p<0.001) and r-LVEF was more frequently detected by CMR (n=94, 18%) than by Echo (n=48, 9%), p<0.001. CMR significantly improved clinical+Echo stratification in those 112 patients (22%) with mr-Echo-LVEF (C-statistitics 0.74 vs 0.82; NRI and IDI: p<0.05) but it did not in those 355 patients (69%) with p-Echo-LVEF (C-statistitics 0.75 vs 0.76; NRI and IDI: non-significant) and in those 49 patients (9%) with r-Echo-LVEF (C-statistitics 0.77 vs 0.77; NRI and IDI: non-significant).
Figure 1. Risk stratification after STEMI
Conclusions
Applied in an individualized manner, Echo-LVEF appears as a useful gatekeeper for a selective use of CMR soon after STEMI for prognostic purposes. The event rate is high in patients with reduced Echo-LVEF and low in those with preserved Echo-LVEF; CMR does not seem to significantly improve risk stratification in these scenarios. Nevertheless, the occurrence of mid-range Echo-LVEF permits discriminating the specific subset of STEMI patients (less than a quarter) who really benefit from pre-discharge CMR in terms of risk assessment.
Acknowledgement/Funding
Funded by “Instituto de Salud Carlos III”/FEDER (PIE15/00013, PI17/01836, and CIBERCV16/11/00486 grants) and Generalitat Valenciana (GV/2018/116).
Collapse
Affiliation(s)
- V Marcos Garces
- University Hospital Clinic of Valencia, Department of Cardiology, Valencia, Spain
| | - J Gonzalez
- University Hospital Clinic of Valencia, Department of Cardiology, Valencia, Spain
| | - J Gavara
- INCLIVA Biomedical Research Institute, Valencia, Spain
| | | | - C Bonanad
- University Hospital Clinic of Valencia, Department of Cardiology, Valencia, Spain
| | - F J Chorro
- University Hospital Clinic of Valencia, Department of Cardiology, Valencia, Spain
| | - J T Ortiz
- Hospital Clinic de Barcelona, Department of Cardiology, Barcelona, Spain
| | - J Rodriguez
- Hospital Clinic de Barcelona, Department of Cardiology, Barcelona, Spain
| | - G Mendieta
- Hospital Clinic de Barcelona, Department of Cardiology, Barcelona, Spain
| | | | - F Valente
- Vall d'Hebron University Hospital, Department of Cardiology, Barcelona, Spain
| | - D Garcia-Dorado
- Vall d'Hebron University Hospital, Department of Cardiology, Barcelona, Spain
| | - M P Lopez-Lereu
- ERESA, Cardiovascular Magnetic Resonance Unit, Valencia, Spain
| | - J V Monmeneu
- ERESA, Cardiovascular Magnetic Resonance Unit, Valencia, Spain
| | - V Bodi
- University Hospital Clinic of Valencia, Department of Cardiology, Valencia, Spain
| |
Collapse
|
43
|
Casas G, Oristrell G, Limeres J, Sao-Aviles A, Barriales R, Garcia-Pavia P, Diez C, Zorio E, Villacorta E, De Antonio M, Garcia-Pinilla JM, Valverde M, Evangelista A, Ferreira-Gonzalez I, Rodriguez-Palomares JF. P5555Predictors of systemic embolisms in a large cohort of left ventricular noncompaction patients. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz746.0499] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Left ventricular noncompaction (LVNC) is associated with an increased risk of systemic embolisms (SE). However, incidence and risk factors are not well established.
Purpose
To evaluate the rate of SE in LVNC and describe risk factors.
Methods
LNVC patients were included in a multicentric registry. Those with SE were considered for the analysis.
Results
514 patients with LVNC from 10 Spanish centres were recruited from 2000 to 2018. During a median follow-up of 4.2 years (IQR 1.9–7.1), 23 patients (4.5%) had a SE. Patients with SE (Table 1) were older at diagnosis, with no differences in gender and had similar cardiovascular risk factors. They were more frequently under oral anticoagulation (OAC). Besides, they had a more reduced LVEF, and more dilated LV and left atrium (LA). Late gadolinium enhancement (LGE) was more frequent, altogether suggesting a more severe phenotype.
Patients with SE had non-significantly higher rates of hospitalization for heart failure (33% vs 24%, p=0.31) and atrial fibrillation (35% vs 19%, p=0.10). In multivariate analysis, only LA diameter was an independent predictor of SE (OR 1.04, p=0.04). A LA diameter>45 mm had an independent 3 fold increased risk of SE (OR 3.04, p=0.02) (Image 1).
Table 1 Systemic embolisms (n=23) No systemic embolisms (n=491) p Men, n (%) 15 (65) 289 (56) 0.52 Median age at diagnosis (IQR), yr 60 (48–76) 48 (30–64) 0.02 Median follow up (IQR), yr 5.9 (3.1–7.8) 4.2 (1.8–7.1) 0.18 Hypertension, % 8 (33) 118 (24) 0.31 Diabetes mellitus, % 3 (14) 39 (8) 0.41 OAC, % 19 (83) 118 (24) 0.01 LVEF (SD), % 37 (15) 48 (17) 0.01 LVEDD (SD), mm 58 (11) 54 (10) 0.04 LVESD (SD), mm 45 (13) 38 (11) 0.01 LA diameter (SD), mm 46 (9) 39 (9) 0.01 LVEDV CMR (SD), mL 193 (75) 163 (70) 0.12 LVESV CMR (SD), mL 121 (64) 85 (64) 0.04 LGE, % 9 (40) 88 (18) 0.04
Conclusions
LVNC carries a moderate mid-term risk of SE, which appears to be irrespective of atrial fibrillation and associated with age, LV dilatation and systolic dysfunction and mainly LA dilatation. This subgroup of patients should be considered for oral anticoagulation in primary prevention.
Collapse
Affiliation(s)
- G Casas
- University Hospital Vall d'Hebron, Cardiology, CIBER-CV, Barcelona, Spain
| | - G Oristrell
- University Hospital Vall d'Hebron, Cardiology, CIBER-CV, Barcelona, Spain
| | - J Limeres
- University Hospital Vall d'Hebron, Cardiology, CIBER-CV, Barcelona, Spain
| | - A Sao-Aviles
- University Hospital Vall d'Hebron, Cardiology, CIBER-CV, Barcelona, Spain
| | - R Barriales
- University Hospital Complex A Coruña, A Coruna, Spain
| | - P Garcia-Pavia
- University Hospital Puerta de Hierro Majadahonda, Madrid, Spain
| | - C Diez
- University Hospital of Bellvitge, Barcelona, Spain
| | - E Zorio
- University Hospital La Fe, Valencia, Spain
| | - E Villacorta
- Hospital Clinico Universitario, Salamanca, Spain
| | - M De Antonio
- Germans Trias i Pujol University Hospital, Barcelona, Spain
| | | | - M Valverde
- University Hospital 12 de Octubre, Madrid, Spain
| | - A Evangelista
- University Hospital Vall d'Hebron, Cardiology, CIBER-CV, Barcelona, Spain
| | | | | |
Collapse
|
44
|
Mila L, Teixido Tura G, Granato C, Limeres J, Servato L, Lopez-Sainz A, Gutierrez L, Galian L, Gonzalez-Alujas T, Rodriguez-Palomares J, Evangelista A. 6126Peripheral aneurysms in Marfan patients are common and are related to age and advanced aortic disease. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz746.0152] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Peripheral aneurysms are not included in the diagnostic criteria for Marfan syndrome (MFS); however, their real prevalence in MFS is unknown. Furthermore, they are commonly seen in other genetic entities such as Loeys-Dietz syndrome.
We aimed to investigate the prevalence of peripheral aneurysm in Marfan syndrome.
Methods
Patients with clinical criteria of Marfan syndrome and identified FBN1 mutation were evaluated. Only patients with either MRI or CT angiography assessing peripheral vessels were included in this study. MRI and CT angiography studies were retrospectively evaluated to detect the presence of peripheral aneurysms. Aortic dissection-related arterial dilations were excluded. Aortic events and those related to aneurysm complications were collected during follow-up.
Results
Two hundred and nine patients with Marfan and FBN1 mutation were evaluated. Of these 136 (65.1%) had undergone either MRA or CTA with peripheral artery study during follow-up. Mean age at the last follow-up visit was 42.4±14.1yrs; 54.4% were men, and mean follow-up 7.3±3.1 years. Sixty-six aneurysms were identified in 42 (30.9%) patients. The most common locations were the iliac arteries in 23. The rest were: renal (7), vertebral (5), splenic (5), coeliac (3), brachiocephalic (1), subclavian (3), carotid (3), axillary (2), internal mammary (3), femoral (2), hypogastric (3), bronchial (2), coronary (1), hepatic (1), lumbar (1), gastroduodenal (1) and popliteal (1). Twenty-six patients (61.9%) had more than one peripheral aneurysm, and only 4 required surgery.
Patients with peripheral aneurysms were older (47.2±14.3yrs vs 40.2±13.6yrs, p=0.06) and more frequently men (69.0% vs 47.9% p=0.026). Although patients with peripheral aneurysms did not more frequently have aortic dissection (16.7% vs 17.0%, p=0.586), they did more frequently have aortic surgery (73.8% vs 47.9% p=0.05).
Conclusions
Peripheral aneurysms are present in one third of Marfan syndrome patients and are related to age and more advanced aortic disease. Systematic use of whole-body vascular assessment in Marfan patients can provide a comprehensive evaluation of the entire arterial system, identifying other sites of vascular involvement at risk of potential complications, and the subgroup of patients with more aggressive vascular disease expression.
Collapse
Affiliation(s)
- L Mila
- University Hospital Vall d'Hebron, Barcelona, Spain
| | | | - C Granato
- University Hospital Vall d'Hebron, Barcelona, Spain
| | - J Limeres
- University Hospital Vall d'Hebron, Barcelona, Spain
| | - L Servato
- University Hospital Vall d'Hebron, Barcelona, Spain
| | | | - L Gutierrez
- University Hospital Vall d'Hebron, Barcelona, Spain
| | - L Galian
- University Hospital Vall d'Hebron, Barcelona, Spain
| | | | | | | |
Collapse
|
45
|
Guala A, Galian L, Teixido Tura G, Dux-Santoy L, Ruiz Munoz A, Granato C, Valente F, La Mura L, Gutierrez L, Lopez Sainz A, Johnson KM, Wieben O, Sao Aviles A, Evangelista A, Rodriguez-Palomares JF. 477Partial fusion of two aortic valve leaflets is related to alterations in ascending aorta flow: 4D flow CMR study. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz747.0127] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Introduction
Bicuspid aortic valve (BAV) is the most common congenital valve defect. It consists in the fusion of two aortic valve leaflets, and it is associated with a high prevalence of proximal aorta dilation. Dilation is highly prevalent (around 30%) in BAV patient relatives with a tricuspid valve (TAV) identified by echocardiography. However, the presence of partial aortic valve leaflet fusion (also called mini-raphe or forme fruste BAV, see figure 1A) is easily missed by echocardiography. A recent study reported that 44% of patients from a small cohort of BAV patient relatives with aortic dilation followed by CT showed mini-raphe.
Purpose
We aimed to use 4D flow CMR to assess if the presence of mini-raphe is associated with aortic flow alterations, which may be concurs in the etiology of aortic dilation in BAV patient relatives.
Methods
Twenty BAV patients first-degree relatives with partial fusion (<50%) of aortic valve leaflets and proximal aorta dilation were identified by CT or cine CMR and prospectively included. One-hundred twenty-five BAV and 95 patients with TAV from our prospective dataset of 4D flow CMR were included for comparison. Propensity score matching was used throughout the study to correct the comparisons between mini-raphe and BAV and mini-raphe and TAV patients for differences in age, maximum aortic diameter, sex, height, weight, proximal aortic pulse wave velocity and, only for BAV, fusion pattern. The hemodynamic parameters previously related to aortic dilation were computed. They were jet angle, normalized flow displacement and systolic flow reversal ratio (SFRR, identifying through-plane vortexes) were computed and compared in the ascending aorta and in the aortic arch.
Results
The presence of mini-raphe was statistically-significantly associated with increase in jet angle (Figure 1B), flow displacement (Figure 1C) and vortexes (Figure 1D) in most of the ascending aorta and aortic arch when mini-raphe patients were compared with TAV patients. The severity of flow asymmetry found in mini-raphe patients was lower than the one characteristic of BAV patients, but vortexes were even higher in a small region at the distal ascending aorta.
Figure 1
Conclusion
Partial fusion of the aortic valve leaflets is related to increase in proximal aorta flow eccentricity and vorticity. These flow abnormalities are not as marked as those associated with BAV. Data regarding prevalence of mini-raphe as evaluated with CT or cine CMR are needed, especially in familiar of BAV patients.
Acknowledgement/Funding
European FP7/People 267128; Spanish Ministry of Economy and Competitiveness RTC-2016-5152-1 and Instituto de Salud Carlos III PI14/0106
Collapse
Affiliation(s)
- A Guala
- University Hospital Vall d'Hebron, Barcelona, Spain
| | - L Galian
- University Hospital Vall d'Hebron, Barcelona, Spain
| | | | - L Dux-Santoy
- University Hospital Vall d'Hebron, Barcelona, Spain
| | - A Ruiz Munoz
- University Hospital Vall d'Hebron, Barcelona, Spain
| | - C Granato
- University Hospital Vall d'Hebron, Barcelona, Spain
| | - F Valente
- University Hospital Vall d'Hebron, Barcelona, Spain
| | - L La Mura
- University Hospital Vall d'Hebron, Barcelona, Spain
| | - L Gutierrez
- University Hospital Vall d'Hebron, Barcelona, Spain
| | | | - K M Johnson
- University of Wisconsin-Madison, Departments of Medical Physics & Radiology, Madison, United States of America
| | - O Wieben
- University of Wisconsin-Madison, Departments of Medical Physics & Radiology, Madison, United States of America
| | - A Sao Aviles
- University Hospital Vall d'Hebron, Barcelona, Spain
| | | | | |
Collapse
|
46
|
Lopez Sainz A, Granato CH, Azqueta M, Barros AJ, Mosquera V, Lopez-Ayerbe J, Calvo F, Fernandez Tarrio R, Revilla A, Potocnik M, Fresneda PC, Forteza A, Gil Albarova O, Rodriguez-Palomares JF, Evangelista A. P5596Something is moving in acute aortic syndrome management and mortality. Results of Spanish registry of acute aortic syndrome (RESA-III). Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz746.0540] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
The impact of recent advances on the management of acute aortic syndrome (AAS) is usually reported by centres with great experience in aortic diseases. Current data on the management of this specific disease in Spain remains unknown.
Purpose
The Spanish Registry of Acute Aortic Syndrome (RESA-III) was established to assess current results in the management of AAS in a large cohort of hospitals from the same geographical area.
Methods
All patients admitted for AAS to 29 Spanish tertiary hospitals were enroled over 18 months (2017/2018).
Results
574 patients, (68% men; mean age 64±14y; range 18–99) were prospectively and consecutively included. Aortic dissection was the underlying disease in 474 (82.6%) (375 type A, 99 type B), aortic haematoma in 76 (13.2%) (43 type A and 33 type B) and penetrating ulcer in 24 (4.2%) (7 type A and 17 type B). From the subgroup of type A AAS (74% n=425), 81% underwent surgical treatment and medical management was chosen in the remaining 19%. 78 patients did not undergo surgery principally because of severe comorbidities (n=34) or advanced age (n=24), patient refusal (n=7), or presence of an intramural haematoma (n=2). Regarding the cohort of patients with type B AAS (26% n=149), 52% were managed only medically, 37% with endovascular treatment, and 11% underwent open surgery. Endovascular treatment was indicated owing to recurrent pain (n=19), progressive vessel dilation (n=9), dissection expansion (n=5), peripheral (n=5) or visceral ischaemia (n=4), high blood pressure (n=18), peripheral bleeding (n=17) or haemodynamical instability (n=8).
Overall type A mortality during hospitalisation was 36.4%; 26.4% in surgically treated and 79.4% in medically-treated patients (p=0.001). In type B AAS, overall mortality was 19.1%; 21.9% in the treated medically subgroup, 43.8% in those treated with open surgery and 7.8% in the endovascular treatment cohort (p=0.004).
Conclusion
Despite significant advances in acute aortic syndrome diagnosis and management, in-hospital mortality remains high. In type A AAS, medical management rate was too high (19%); however, in type B AAS, endovascular treatment yielded excellent results with less mortality than medical management (7.8% vs 19.1%, respectively). Our data support the need for continued improvement in the management of acute aortic syndrome.
Collapse
Affiliation(s)
| | - C H Granato
- University Hospital Vall d'Hebron, Barcelona, Spain
| | - M Azqueta
- Hospital Clinic de Barcelona, Barcelona, Spain
| | - A J Barros
- Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
| | - V Mosquera
- University Hospital Complex A Coruña, A Coruna, Spain
| | | | - F Calvo
- Hospital of Meixoeiro, Vigo, Spain
| | | | - A Revilla
- University Hospital Clinic of Valladolid, Valladolid, Spain
| | - M Potocnik
- University Hospital of Bellvitge, Barcelona, Spain
| | - P C Fresneda
- Hospital Universitario Virgen del Rocío, Sevilla, Spain
| | - A Forteza
- University Hospital Puerta de Hierro Majadahonda, Madrid, Spain
| | | | | | | |
Collapse
|
47
|
Valente F, Bodi V, Gavara J, Pineda V, Monmeneu J, Roque A, Gutierrez L, Casas G, Galian L, Teixido G, Gonzalez-Alujas MT, Cuellar H, Garcia-Dorado D, Evangelista A, Rodriguez-Palomares JF. 4936Cardiac magnetic resonance strain analysis predicts functional recovery following acute ST-segment elevation myocardial infarction. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz746.0006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Background
Late gadolinium enhancement (LGE) is the clinical reference standard for estimation of infarct extension and prediction of functional recovery following reperfused acute ST-segment elevation myocardial infarction (STEMI). Nevertheless, myocardial edema, microvascular obstruction and intramyocardial hemorrhage as well as the timing of image acquisition after contrast administration may influence the extent of LGE and underestimate the potential for recovery. Dobutamine stress testing has been recommended to more accurately predict functional recovery when infarct transmurality is between 25 to 75%. We hypothesized that cardiac magnetic resonance (CMR) tissue tracking strain analysis may provide additional value to LGE for the prediction of functional recovery.
Methods
In 370 patients with STEMI who underwent successful primary percutaneous revascularization and were studied with CMR within 3–5 days of the event, peak systolic longitudinal (LS), circumferential (CS) and radial (RS) strain were analyzed with routine SSFP images of 3 long-axis and a stack of short-axis slices (Tissue Tracking, CVI42®, Figure panel A and B). Inversion-recovery echogradient sequences were analyzed 20 minutes after contrast administration for LGE transmurality (Panel C). All per-segment analysis was performed according to the AHA 16-segment model. CMR was repeated at 6 months and functional recovery was defined as persistent normokinesia or improvement of wall motion score from baseline to 6-month CMR.
Results
At baseline CMR, of a total of 5920 segments 70.4% were normokinetic, 7.2% were hypokinetic, 21.9% were akinetic and 0.6% were dyskinetic. All strain parameters decreased significantly with worsening wall motion. At follow-up, 81.5% of the segments showed functional recovery. All strain parameters were significantly associated with functional recovery (p<0.001) and showed higher predictive value for improvement of wall motion than LGE transmurality (ROC AUC 0.713 LS, 0.710 CS, 0.683 RS and 0.660 LGE). For basal CMR dysfunctional segments, a CS <−10.7% showed the highest accuracy (66%) to predict wall motion improvement, with 58% sensitivity, 76% specificity, 75% positive predictive value (PPV) and 59% negative predictive value (NPV). These results were comparable to LGE transmurality <50% (65% accuracy, 59% sensitivity, 73% specificity, 74% positive predictive value and 58% negative predictive value). Nevertheless, adding CS analysis to a 50% LGE transmurality cutoff was the best combination for prediction of functional recovery and increased the overall accuracy to 70%, with 76% sensitivity, 64% specificity, 65% PPV and 75% NPV.
CS analysis in an inferior STEMI
Conclusions
Acute CMR tissue tracking strain analysis complements LGE assessment for prediction of functional recovery following an STEMI. The combination of LGE infarct transmurality under 50% and a CS strain higher than −10.7% showed the highest accuracy for prediction of recovery of function.
Collapse
Affiliation(s)
- F Valente
- University Hospital Vall d'Hebron, Barcelona, Spain
| | - V Bodi
- University Hospital Clinic of Valencia, Valencia, Spain
| | - J Gavara
- Research Foundation Hospital of Valencia (INCLIVA), Valencia, Spain
| | - V Pineda
- University Hospital Vall d'Hebron, Barcelona, Spain
| | - J Monmeneu
- University Hospital Clinic of Valencia, Valencia, Spain
| | - A Roque
- University Hospital Vall d'Hebron, Barcelona, Spain
| | - L Gutierrez
- University Hospital Vall d'Hebron, Barcelona, Spain
| | - G Casas
- University Hospital Vall d'Hebron, Barcelona, Spain
| | - L Galian
- University Hospital Vall d'Hebron, Barcelona, Spain
| | - G Teixido
- University Hospital Vall d'Hebron, Barcelona, Spain
| | | | - H Cuellar
- University Hospital Vall d'Hebron, Barcelona, Spain
| | | | | | | |
Collapse
|
48
|
Dentamaro I, Sao-Aviles A, Teixido G, Galian L, Gutierrez L, Gonzalez-Alujas MT, Calvo F, Sanchez V, Alegret J, Colonna P, Moreo A, Citro R, Chirillo F, Rodriguez-Palomares JF, Evangelista A. P3373Predictors of dilatation of ascending aorta in patients with bicuspid aortic valve, a longitudinal multicenter study. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz745.0249] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Introduction
The bicuspid aortic valve (BAV) is frequently associated to dilation of the ascending aorta. Some cross-sectional studies have related the aortic dilation with morphotype and valvular dysfunction. The aim of this longitudinal multicenter study was to analyze the progression of the aortic dilation and to identify its predictors.
Methods
We included 459 patients (mean age 52±17; 325 men 70.8%) with BAV, without aortic coarctation. The BAV morphotype, significant valvular dysfunction and dilation of the aortic root and ascending aorta were established by echocardiography. The patients were followed annually, with an average of 7.5±3.2 years.
Results
77% of the patients had BAV with a fusion between left and right cusps, 21% between right and non coronary cusps and 2% between left and non coronary cusps, with a raphe in 77% of these patients. Risk factors included: 35% hypertension, 20% smoking, 5% diabetes and 18% dyslipidemia. The baseline study showed a maximum root diameter of 36±6.2 mm and ascending aorta of 39±8.1 mm. In 7% the aortic root was>45 mm, while in 32% the ascending aorta>45 mm. There was no valvular dysfunction in 17% of patients, while the 8% had significant aortic stenosis and 35% significant aortic regurgitation. The annual growth of the aortic root was 0.33±0.2 mm and for the ascending aorta was 0.38±0.3 mm. At the end of follow-up, 16% of the patients had a root>45 mm and 41% an ascending aorta>45 mm. The annual progression of aortic diameters was not related to valvular morphotype, valvular dysfunction or cardiovascular risk factors. The univariate analysis showed a significant relationship between the annual growth of the aortic root and arterial hypertension (p=0.028) and the annual growth of the ascending aorta with the male sex (p=0.019), smoking (p=0.046) and significant (moderate or severe) aortic stenosis (p=0.013). Diabetes mellitus and the presence of raphe were found to be slightly protective (p=0.049 and p=0.031, respectively). In the multivariate analysis, only the male sex and significant aortic stenosis were independent predictors of dilation of the ascending aorta.
Conclusions
In patients with bicuspid aortic valve, the progression of the dilation of the aortic root is related to hypertension and the growth of the ascending aorta with the male sex and the presence of significant aortic stenosis. Both bicuspid valve morphotype, basal aortic diameter or age were not related to the progression of aortic dilation.
Collapse
Affiliation(s)
- I Dentamaro
- University Hospital Vall d'Hebron, Barcelona, Spain
| | - A Sao-Aviles
- University Hospital Vall d'Hebron, Barcelona, Spain
| | - G Teixido
- University Hospital Vall d'Hebron, Barcelona, Spain
| | - L Galian
- University Hospital Vall d'Hebron, Barcelona, Spain
| | - L Gutierrez
- University Hospital Vall d'Hebron, Barcelona, Spain
| | | | - F Calvo
- Hospital of Meixoeiro, Cardiology Department, Vigo, Spain
| | - V Sanchez
- University Hospital 12 de Octubre, Cardiology Department, Madrid, Spain
| | - J Alegret
- Hospital Universitario Joan XXIII, Cardiology Department, Tarragona, Spain
| | - P Colonna
- Polyclinic Hospital of Bari, Cardiology Department, Bari, Italy
| | - A Moreo
- Niguarda Ca' Granda Hospital, Milan, Italy
| | - R Citro
- AOU S. Giovanni e Ruggi, Cardiology Department, Salerno, Italy
| | - F Chirillo
- Bassano del Grappa General Hospital, Cardiology Department, Bassano Del Grappa, Italy
| | | | | |
Collapse
|
49
|
Merenciano Gonzalez HM, Marcos-Garces V, Gavara J, Rios-Navarro C, Ortiz JT, Rodriguez J, Mendieta G, Rodriguez-Palomares JF, Valente F, Garcia-Dorado D, Lopez-Lereu MP, Monmeneu JV, Nunez E, Nunez J, Bodi V. P6397Ejection fraction by cardiac magnetic resonance 6 months after STEMI: impact on risk stratification in chronic phase. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz746.0993] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Background
Left ventricular ejection fraction (LVEF) has traditionally been used as the cornerstone for risk stratification after STEMI and it can be accurately quantified by cine cardiovascular magnetic resonance (CMR). In recent years, the additional prognostic value of contrast CMR-derived infarct size (IS) and microvascular obstruction (MVO) soon after infarction has been demonstrated. The usefulness of CMR-derived LVEF in chronic phase for risk stratification late after STEMI is unclear.
Purpose
We hypothesized that 6-month CMR-derived LVEF can contribute in the prediction of clinical events late after STEMI beyond pre-discharge LVEF, IS and MVO.
Methods
Data were obtained from a prospective registry of reperfused STEMI patients (n=456) who were stable 6 months after infarction and in whom 1-week and 6-month CMR-derived LVEF, IS and MVO were sequentially quantified. Major adverse cardiac events (MACE) were defined as a combined clinical end-point that included death or re-admission for acute decompensated heart failure (r-ADHF), whichever occurred first, occurring after the 6-month CMR.
Results
During a mean and median follow-up of 6 years, 56 late MACE (12%, 32 deaths and 24 r-ADHF) were registered. From 1-week to 6-month, CMR parameters exhibited significant dynamic changes (p<0.001): LVEF improved (52±12 vs. 56±13%), IS decreased (21±14 vs. 18±12% of LV mass) and MVO vanished (2±4 vs. 0±1% of LV mass). At 6-month CMR, 60 patients (13%) displayed reduced LVEF (<40%), 69 (15%) mid-range LVEF (40–50%) and 327 (72%) preserved LVEF (≥50%). Late MACE rates were 28% in patients with reduced LVEF, 14% in those with mid-range LVEF and 9% in those with preserved LVEF at 6-month CMR (p<0.001 for the trend). After adjustment for baseline characteristics and for 1-week and 6-month CMR parameters, more preserved LVEF at 6 months independently associated with a lower risk of MACE late after STEMI (hazard ratio 0.96 [0.94–0.98] per 1% increase).
Conclusions
Dramatic dynamic changes occur in CMR parameters within the first months after STEMI. Reassessment of CMR-derived LVEF in chronic phase in those patients who remain stable provides relevant prognostic information for long-term risk stratification.
Acknowledgement/Funding
Funded by “Instituto de Salud Carlos III”/FEDER (PIE15/00013, PI17/01836, and CIBERCV16/11/00486 grants) and Generalitat Valenciana (GV/2018/116).
Collapse
Affiliation(s)
| | - V Marcos-Garces
- University Hospital Clinic of Valencia, Department of Cardiology, Valencia, Spain
| | - J Gavara
- INCLIVA Biomedical Research Institute, Valencia, Spain
| | | | - J T Ortiz
- Hospital Clinic de Barcelona, Department of Cardiology, Barcelona, Spain
| | - J Rodriguez
- Hospital Clinic de Barcelona, Department of Cardiology, Barcelona, Spain
| | - G Mendieta
- Hospital Clinic de Barcelona, Department of Cardiology, Barcelona, Spain
| | | | - F Valente
- University Hospital Vall d'Hebron, Department of Cardiology, Barcelona, Spain
| | - D Garcia-Dorado
- University Hospital Vall d'Hebron, Department of Cardiology, Barcelona, Spain
| | - M P Lopez-Lereu
- ERESA, Cardiovascular Magnetic Resonance Unit, Valencia, Spain
| | - J V Monmeneu
- ERESA, Cardiovascular Magnetic Resonance Unit, Valencia, Spain
| | - E Nunez
- University Hospital Clinic of Valencia, Department of Cardiology, Valencia, Spain
| | - J Nunez
- University Hospital Clinic of Valencia, Department of Cardiology, Valencia, Spain
| | - V Bodi
- University Hospital Clinic of Valencia, Department of Cardiology, Valencia, Spain
| |
Collapse
|
50
|
Guala A, Rodriguez-Palomares JF, Ruiz Munoz A, Dux-Santoy L, Villalva N, Granato C, Galian L, Gutierrez L, Gonzalez-Alujas T, Gandara M, Sanchez V, Forteza A, Garcia-Dorado D, Evangelista A, Teixido Tura G. P412Prognostic value of proximal aorta longitudinal strain for aortic events and dilation in Marfan syndrome patients. Eur Heart J Cardiovasc Imaging 2019. [DOI: 10.1093/ehjci/jez118.001] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- A Guala
- University Hospital Vall d"Hebron, Department of Cardiology, Barcelona, Spain
| | | | - A Ruiz Munoz
- University Hospital Vall d"Hebron, Department of Cardiology, Barcelona, Spain
| | - L Dux-Santoy
- University Hospital Vall d"Hebron, Department of Cardiology, Barcelona, Spain
| | - N Villalva
- University Hospital Vall d"Hebron, Department of Cardiology, Barcelona, Spain
| | - C Granato
- University Hospital Vall d"Hebron, Department of Cardiology, Barcelona, Spain
| | - L Galian
- University Hospital Vall d"Hebron, Department of Cardiology, Barcelona, Spain
| | - L Gutierrez
- University Hospital Vall d"Hebron, Department of Cardiology, Barcelona, Spain
| | - T Gonzalez-Alujas
- University Hospital Vall d"Hebron, Department of Cardiology, Barcelona, Spain
| | - M Gandara
- University Hospital Vall d"Hebron, Department of Cardiology, Barcelona, Spain
| | - V Sanchez
- University Hospital 12 de Octubre, Madrid, Spain
| | - A Forteza
- University Hospital Puerta de Hierro Majadahonda, Madrid, Spain
| | - D Garcia-Dorado
- University Hospital Vall d"Hebron, Department of Cardiology, Barcelona, Spain
| | - A Evangelista
- University Hospital Vall d"Hebron, Department of Cardiology, Barcelona, Spain
| | - G Teixido Tura
- University Hospital Vall d"Hebron, Department of Cardiology, Barcelona, Spain
| |
Collapse
|